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The first part of this thesis describes the synthesis, solution studies and biological 
evaluation of 2-keto-3-deoxy-ulosonic acids.  A synthetic route was developed for 2-keto-
3-deoxy-gluconate (D-KDG) and 2-keto-3-deoxy-galactonate (D-KDGal) that provided the 
targets via concise four step routes from naturally occurring sugar substrates.  These 
routes make use of Horner-Wadsworth-Emmons reactions between the anion of ethyl 2-
((tert-butyldimethylsilyl)oxy)-2-(dimethoxy-phosphoryl) acetate 1 with enantiopure sugar-
derived aldehydes to afford silyl-enol ethers that could be globally deprotected to give the 
target 2-keto-3-deoxy-ulosonic acids in high purity (Scheme I).  The effect of temperature 
on the isomeric composition of these C6-sugars was studied and they were then supplied 
as substrates for the directed evolution of a stereochemically promiscuous aldolase from 
Sulfolobus solfataricus, to develop mutant aldolases with high diastereoselectivity for the 
aldol reaction of D-glyceraldehyde 6 and pyruvate 7 to exclusively afford either D-KDG or 
D-KDGal.   




The synthetic methodology was then applied to the synthesis of enantiopure 2-keto-3-
deoxy-D-xylonate (D-KDX) and 2-keto-3-deoxy-L-arabonate (L-KDA) and these C5-sugars 
were fully characterised by 1H and 13C NMR spectroscopy for the first time and had their 
enantiopurity confirmed by optical rotatory dispersion analysis.  The kinetic parameters for 
D-KDX and L-KDA using KDG aldolase were determined using a modified thiobarbituric 
acid assay, with good catalytic efficiencies being found for each enantiomer (0.45 and 
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0.53 s-1mM-1).  This gives a more complete understanding of the metabolism of S. 
solfataricus confirming that the archaeon uses the same KDG aldolase for the catabolism 
of not only the diastereotopic C6-sugars D-KDG and D-KDGal but also for the 
enantiomeric C5-sugars D-KDX and L-KDA. 
The second part of this thesis is directed towards development of methodology for the 
total synthesis of histrionicotoxin (HTX).  As part of this synthesis, an aza-Michael reaction 
was required to convert bis-α,β-unsaturated ester 4 into mono-β-amino ester 5 in high 
enantiomeric excess.  Chapter 4 describes the development of methodology that allows 
the stereoselective mono-addition of a nitrogen nucleophile to 4, with subsequent 
oxidative nitrogen deprotection to reveal the primary amino functionality.  Chapter 5 then 
details the progress made towards HTX including synthesis of the acyclic carbon 
backbone, aza-Michael addition, cyclisation and attempted spirocyclisation. 
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It’s not that I’m so smart, it’s just that I stay with problems longer. 
  ─ Albert Einstein 
 
 
Very few people will die to save the life of someone else although perhaps for a good 
person someone might possibly die.  But God shows his great love for us in this way: 
Christ died for us while we were still far away from him. 







Members of the archaea family were first classified as a domain that was distinct to 
eukarya and bacteria in 1990,1 and have been the centre of intense study over the last 30 
years.  Researchers from the Centre for Extremophile Research (CER) at Bath,2-10 along 
with other groups,11-16 have studied the archaeon Sulfolobus solfataricus in detail since its 
discovery around solfataric hot springs.17 They have found that this archaeon metabolises 
C6-sugars to 2-keto-3-deoxy-ulosonic acid intermediates, before a 2-keto-3-deoxy-
gluconate aldolase (KDG aldolase) catabolises these intermediates further to pyruvate 
and another short-chain sugar.  The first part of this thesis will describe efficient syntheses 
of C6-2-keto-3-deoxy-ulosonic acids in diastereomerically pure form (Figure 1a) as 
substrates for in vivo directed evolution studies on KDG aldolase and enantiopure C5-2-
keto-3-deoxy-ulosonic acids to allow enzyme kinetic studies to be carried out to enable a 
fuller understanding of the metabolic pathway of S. solfataricus for pentose sugars.  
 











1.2 Sulfolobus solfataricus 
S. solfataricus is a hyperthermophilic archaeon that grows optimally at 80-85 ◦C and pH 2-
4.  Whilst S. solfataricus grows autotrophically in its geothermal habitat by the oxidation of 
elemental sulphur, it is an opportunistic heterotroph,3 able to survive on a variety of carbon 
sources.  It metabolises glucose and galactose via a modified Entner-Doudoroff pathway, 
which is a non-phosphorylated variant of the classical pathway proceeding with no net 
production of ATP (Scheme 1).  All three enzymes involved in the catabolism of D-glucose 
2 (glucose dehydrogenase, gluconate dehydratase and KDG aldolase) are also able to 
catabolise D-galactose 3 to pyruvate 7 and D-glyceraldehyde 6.  The “promiscuous” nature 
of these enzymes is in stark contrast to the majority of bacteria and eukaryotes that 
catabolise D-galactose via the Deley Doudoroff pathway.18  The enzyme responsible for 
the final step of this pathway, KDG aldolase, has been studied in particular detail because 
of its central role in the metabolic pathway, and the significance of carbon-carbon bond 
forming reactions in synthetic chemistry.2-7  In this respect it is a potentially versatile 
thermostable biocatalyst for catalysing the aldol reaction of pyruvate with a range of non-
phosphorylated sugars.   
 
Scheme 1 Entner-Doudoroff catabolism of D-glucose and D-galactose S. solfataricus 




1.3 KDG Aldolase from S. solfataricus 
KDG aldolase is a tetrameric enzyme, made up of four identical protein sub-units (Figure 
2).  It is categorized as a type-1 aldolase, since it forms a Schiff base complex between an 
active-site lysine residue and the donor substrate, mediating catalysis via transient 
formation of enamine intermediates.  It can be efficiently expressed in Escherichia coli and 
the recombinant enzyme shows physical properties and kinetic parameters 
indistinguishable to that of the enzyme purified directly from S. solfataricus cells. 
Figure 2 KDG aldolase tetramer with monomer A highlighted in red.  The blue and red 





Significantly for the application of S. solfataricus as a biocatalyst, the diastereoselectivity 
of the recombinant ‘wild-type’ enzyme with its natural substrates, D-KDG and D-KDGal, 
could be transformed from a ratio of 55:45 D-KDGlu/D-KDGal to values of 93% d.e. and 
88% d.e. in favour of  D-KDGlu or D-KDGal respectively, by mutation of key amino acid 
residues in the enzyme active site.7  This rational site-directed mutagenesis approach was 
made possible by knowledge of the high resolution X-ray crystal structures of pyruvate 7, 
D-KDG and D-KDGal covalently bound as Schiff base complexes to Lysine-155 in the 
active site of the enzyme (Figure 3).4  The crystal structures revealed that a key difference 
in the binding of the two sugar molecules existed around the C4-C6 backbone of the 
molecule.  The C5-OH and C6-OH of D-KDG were bound to a conserved network of 
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active-site water molecules resulting in the C4-C6 backbone presenting a relatively 
hydrophobic region towards threonine-157, whilst the C4-OH of D-KDGal was hydrogen 
bonded to the OH of tyrosine-130 and the OH of threonine-157.  Therefore, initially 
threonine-157 was subjected to saturation mutagenesis with 20 single residue mutants 
created for all proteinogenic amino acids.  A much improved d.e. for D-KDG was found for 
two of the mutants: 79% d.e. for phenylalanine-157; and 75% d.e. for cysteine-157.  A 
double mutant combining one of these point mutations with another mutation of tyrosine-
132 to valine-132 gave an impressive d.e. of 93% (Scheme 2).  To shift the 
diastereoselectivity of the reaction towards D-KDGal, a series of mutants were also 
generated that aimed to disrupt the network of active-site water molecules that stabilised 
D-KDG formation over that of D-KDGal.  After a first round of double mutations increased 
the d.e. to 72% for D-KDGal, a triple mutant, valine-157:Leucine-198:Glutamine-181, that 
was designed to create a hydrophobic pocket gave a good d.e. of 88% (Scheme 2).   
Figure 3 S.solfataricus KDG aldolase complexed with (a) pyruvate 7 (Schiff base Fo – Fc 
map contoured at 2.5 σ),(b) D-KDG (Schiff base Fo – Fc map contoured at 2.5 σ) and (c) D-




1.4 Directed Evolution of Sulfolobus solfataricus 
A contrasting and complimentary approach was proposed for the development of mutant 
KDG aldolases with improved diastereoselectivity and substrate scope.  This approach 
would involve the directed evolution of KDG aldolase by in vivo screening of libraries of 
randomly generated mutants.  This approach has previously been attempted by other 
groups as an alternative to or compliment to site-directed mutagenesis.19-21  The technique 
has generated improved mutant enzymes with amino acid mutations that are often 
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Scheme 2 Best mutant aldolases for the diastereoselective aldol reaction of pyruvate 7 





far from the active site, with results having served to improve the understanding of subtle 
factors governing enzyme recognition of substrates and enzymatically catalysed 
stereoselective reactions.22 
There are essentially three stages involved in directed evolution.  First the generation of a 
library of mutant enzymes, which is normally achieved using an error prone polymerase 
chain reaction (ep-PCR) followed by DNA base shuffling,23-24 and sub-cloning of the genes 
of the new mutant aldolases into an expression vector to generate a first generation 
plasmid library.  Secondly the plasmid library must be transformed into bacterial cells and 
after an initial growth of colonies these colonies are tested for the desired activity using a 
high-throughput technique.  The high-throughput techniques employed generally fall into 
two categories: (i) screening using a high-throughput assay that is preferably automated; 
(ii) an in vivo selection approach, where the bacteria colonies only survive if a mutant 
enzyme has the required properties.  Finally, the best mutant colonies are selected, the 
enzyme activity is checked for the desired property and its DNA is sequenced to 
determine the amino acid sequence of the mutant enzyme.  These three stages can be 
repeated in an iterative fashion until enzymes with the desired activity and kinetic 
parameters are identified.  
 For example, Wong and co-workers have published a seminal report that describes the 
directed evolution of D-2-keto-3-deoxy-phosphogluconate aldolase (KDPG aldolase) from 
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E. coli, where they aimed to improve the enzymes ability to accept non-phosphorylated 
substrates.25  They generated a library of mutant enzymes using a standard ep-PCR 
protocol that gave an average mutation rate of 2-3 bases per gene.  After sub-cloning the 
enzyme into an expression vector and transforming the vector in E. coli, the mutants were 
evaluated using a coupled enzyme assay in which pyruvate formed during the reaction 
was reduced to lactate by lactate dehydrogenase.  Concomitant oxidation of NADH to 
NAD+ was then monitored by absorbance at 340nm using a microtiter plate reader.  The 
best four mutants were selected and subjected to DNA shuffling to generate 384 new 
mutants that were analysed for activity using this high-thoughput screening methodology.  
Again the best two mutants (KA2 and KA3) were selected and subjected to a further round 
of ep-PCR to generate 1024 variants, from which high-throughput screening identified two 
improved mutants (KA3.1 and KA3.3).  The best mutant enzyme from the three rounds of 
mutation had greatly improved kinetic parameters for the retro-aldol reaction of D-KDG, 
exhibiting a 25-fold decrease in Km and a 3-fold increase in kcat (Table 1). 
Table 1 Kinetic parameters for D-KDG cleavage by recombinant wild-type KDPG aldolase, 
and for the best mutants generated via directed evolution 
Entry Enzyme Km (mM) kcat (s-1) kcat/Km (mM-1s-1) 
1 Wild Type 284.9 4.6 0.016 
2 KA2 14.3 8.3 0.58 
3 KA3 12.8 13.9 1.09 
4 KA3.1 2.4 0.05 0.021 
5 KA3.2 12.1 5.2 0.43 
 
These types of directed evolution techniques have been employed by other groups and 
used to alter enzyme substrate specificity,26 thermal stability,27 resistance to organic 
solvents28 and stereoselectivity.29  Recently Toone and co-workers have presented their 
work on the directed evolution of KDPG aldolases from E. coli and Thermatoga 
maritima.30-31  They aimed to increase the enzymes tolerance for unfunctionalised non-
polar aldehydes, choosing as a test substrate 2-keto-4-hydroxyoctanoate (KHO), whose 
catalytic efficiency was decreased by 104-106-fold when compared to KDPG.    Again 
aldolase mutants were generated by ep-PCR and these were transformed into an 
auxotrophic E. coli PB25 cell line to allow an in vivo selection approach.  The E. coli PB25 
auxotrophs had both pyruvate kinase gene sequences interrupted, which ensured that 
only colonies that were supplemented with exogenous pyruvate could survive.  Colony 
selection was therefore based on rescue of those mutant auxotrophs that could catalyse 
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retro-aldol cleavage of KHO when it was added as a supplement to the growth media.  
Based on transformation controls, Toone estimated that 5x107 variants were screened 
when these variants were plated. Plasmid DNA was recovered and sequenced for the 
colonies that were surviving after 120 hours, and the kinetic parameters for KHO cleavage 
for each new mutant evaluated (Table 2).  All the mutants, entries 2-8, showed increased 
catalytic efficiency, but this was mainly due to a reduction in the value of Km with only a 
small increase in the turn-over number observed for three of the mutants (entries 3, 6 and 
8).  The authors reasoned that the intracellular concentrations of KHO must have been 
low, which had led to the main selection pressure being to reduce the value of Km.  They 
concluded that for their in vivo selection to be more successful the intracellular 
concentration of substrate must be increased or the aldolase enzyme should be localised 
to the periplasm where the concentration of small molecules like KDO is generally 
unregulated by the cell. 
Table 2 Kinetic parameters for KDPG aldolase mutants for the retro-aldol cleavage of 
KHO 
Entry Enzyme Km (mM) Kcat (s-1) kcat/Km (mM-1/s-1) 
1 Wild Type 200 0.40 2.2 
2 Mutant 1 9 0.07 9.3 
3 Mutant 2 90 0.50 5.5 
4 Mutant 3 20 0.14 7 
5 Mutant 4 23 0.36 16 
6 Mutant 5 14 0.75 54 
7 Mutant 6 8 0.13 17 
8 Mutant 7 49 1.2 25 
 
For the directed evolution of the KDG aldolase from S. solfataricus, ep-PCR work in the 
CER has resulted in the generation of libraries of 104–105 mutants as potential 
biocatalysts for screening.  These mutant aldolases have been expressed within a 
pyruvate kinase deficient E. coli auxotroph that is unable to survive without the addition of 
exogenous pyruvate to the growth media.30,32  This enables a high-thoughput 
methodology to be used to assess each mutants’ activity towards aldol substrates using a 
life/death selection assay.  It is intended that the transformed cells will be cultured on 
media supplemented with pyruvate, with colonies that grow being transformed onto two 
separate daughter plates.  Each daughter plate would contain minimal media with 
sufficient supplements, nucleotide bases and minerals for the auxotrophs to survive, with 
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the proviso that pyruvate is available to them.31  The daughter plates will have one 
additional supplement: one will be presented with D-KDG; and the other daughter plate 
will be presented with D-KDGal.  By comparing the growth of colonies on each plate over 
time, mutant KDG aldolases would be identified that are only capable of surviving on one 
of the daughter plates, thus identifying a mutant with retro-aldol cleavage activity for only 
one of the sugar diastereomers.  The principle of microscopic reversibility then predicts 
that this mutant KDG aldolase would catalyse a highly stereoselective aldol condensation 
reaction.  This would then be confirmed by identifying and purifying a diastereoselective 
mutant colony and screening it for the aldol condensation of pyruvate 7 with D-
glyceraldehyde 6. 
These directed evolution studies of KDG aldolase could only be carried out in an efficient 
manner if gram quantities of enantiopure D-KDG and D-KDGal in >99% e.e. were 
available as substrates for preparation of the agar medium for each of the daughter 
plates.  Therefore, one of the major aims of my research program was to develop efficient 
methodology for the synthesis of D-KDG and D-KGal. 
 
1.5 Studies of S. solfataricus Metabolism of C5-Substrates  
Recently, Danson and co-workers have published details of the catabolic pathway that S. 
solfataricus employs for metabolism of the five carbon sugars D-xylose 8 and L-arabinose 
9 (Scheme 3), which along with D-glucose and D-galactose are the four most commonly 
occurring sugars in nature.6  Glucose dehydrogenase, that is responsible for the oxidation 
of D-glucose 2 to D-gluconate 4, also catalyses the oxidation of D-xylose 8 and L-
arabinose 9.  Conversely, gluconate dehydratase that dehydrates D-gluconate 4 to D-KDG 
has no activity with D-xylonate 10 or L-arabinonate 11.  Instead a specific dehydratase 
dehydrates the C5 sugars to D-KDX and L-KDA.  There are then two competing catabolic 
pathways; approximately half of the catabolised sugar is converted to 2-oxoglutarate 13,11 
whilst the remainder is catabolised to pyruvate 7 and glycolaldehyde 14.  KDG aldolase 
was shown to catalyse the aldol condensation reaction of glycolaldehyde 14 and pyruvate 
7 and so could potentially be responsible for the catabolism of both D-KDX and L-KDA, 
but enantiomerically pure D-KDX and L-KDA were not commercially available to enable 
the direct measurement of their kinetic parameters with KDG aldolase.  Therefore, a 
coupled enzyme assay was conducted to establish if KDG aldolase could catabolise both 
C5-sugars.  This involved separate incubation of D-xylonate 10 and L-arabinonate 11 with 
semi-purified D-xylonate dehydratase to give crude samples of D-KDX and L-KDA. These 
sugars were then cleaved via separate incubation with KDG aldolase to give pyruvate 7 
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and glycolaldehyde 14 in both cases, suggesting that both substrates could indeed be 
catabolised by KDG aldolase.  We wished to determine the kinetic parameters for both D-
KDX and L-KDA for comparison with the previously recorded kinetic parameters for D-
KDG and D-KDGal.  Consequently, an efficient chemical synthesis of enantiopure D-KDX 
and L-KDA was also required to enable us to carry out kinetic studies on these sugars 
using KDG aldolase. 
  
Scheme 3 The catabolism of D-xylose 8 and L-arabinose 9 in S. solfataricus via a non-




1.6 Previous Syntheses of Higher 2-Keto-3-Deoxy-Ulosonic Acids 
The synthesis of the higher 2-keto-3-deoxy-ulosonic acids is an important research area 
as many compounds of this class have been shown to be important components of 
biologically important processes.33  Thus, DAH 15 (Figure 4) is an intermediate in the 
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shikimate pathway, which in plants and micro-organisms is responsible for the 
biosynthesis of aromatic amino acids from glucose.34-35  Its synthesis has received much 
attention as it is thought that selective disruption of the shikimate pathway could lead to 
inhibition of micro-organism growth.36  Contrastingly, KDO 16 is an essential constituent of 
lipopolysaccharides on the cell surfaces of Gram-negative bacteria, where they play a role 
in cell-cell communication.37  Developing novel anti-bacterial agents that target the 
biosynthetic pathway of KDO 16 is a promising area of research as anti-bacterial agents 
could be selective and efficacious, since KDO 16 is not found as a constituent on the 
surface of human cells.  However, in bacteria KDO 16 is a critical building block for 
assembly of lipopolysaccharide membranes, and so interrupting its biosynthesis would 
seriously undermine bacterial cell viability.38  The C9-sugars KDN 17 and Neu5Ac 18, 
commonly termed sialic acids, of which there are more than 50 naturally occurring 
members, are found in humans and higher animals as well as in protozoa, viruses and 
bacteria.  Amongst diverse biological functions they are known to be very important in 
cellular and molecular recognition, including proliferation of cancer cells and infection by 
microbes.39  Since von Itzstein and co-workers found that Zanamvir 19 is an effective 
inhibitor of the influenza virus neuraminidase (IC50 = 1nM) for the treatment for influenza A 
and B, many drug development programmes have focused on the development of sialic 
acid derivatives as potential antiviral treatments.40 
 




The majority of the syntheses of 15-19 described to date involve the addition of a suitable 
C2- or C3-nucleophile to a suitable sugar residue, and further functional group elaboration 
to a particular 2-keto-3-deoxy-ulosonic acid target.  Herein, some of the more important 
synthetic strategies that have been used to prepare this important class of sugar natural 




1.6.1 Propargylic Nucleophilic Addition Methodology 
Of the various nucleophilic reactions employed in the synthesis of 2-keto-3-deoxy-ulosonic 
acids, propargylic anions have received much attention.  Initially Wu and co-workers 
developed a two step methodology for the selective oxidation of terminal alkynes to 2-
keto-esters,41 which along with diastereoselective propargylation allowed them to 
synthesise the protected methyl ester of the C4-epimer of DAH 26 (Scheme 4).42  They 
found that reaction of propargyl bromide 20 in the presence of zinc dust with aldehyde 21 
(derived from glucose) provided the C7-terminal alkyne 22 in an anti/syn ration of 3.3:1.  
The anti isomer was purified and then TBS protected to afford 23.  Oxidation that involved 
treatment of 23 with NBS in the presence of AgNO3 to form bromoalkyne 24, followed by 
KMnO4 oxidation in a methanol/water solvent system to give 25 in 43% yield.  25 was then 
deprotected under acidic conditions and acetylated to give the target compound 26 in an 
overall yield of 24% from 20. 
Scheme 4 Wu synthesis of DAH C4-epimer 26 
 
 
Wu and co-workers went on to employ this methodology for the synthesis of KDO 16 and 
Neuc5Ac 19,43-44 whilst Crich and Navuluri have shown that the protected methyl ester of 
KDN 17 can be prepared using a modification of this protocol (Scheme 5).45  Thus, they 
found that reacting propargyl magnesium bromide 27 with lactone 28 gave a single 
product isomer 29, which was presumed to be due to chelation of the organometallic 
reagent to the lactone ether groups.  Reduction of 29 proceeded with excellent syn 
selectivity when NaBH4 was used at -15 °C in methanol to give 31 (syn/anti 100:3), which 
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the authors accredited to an alkoxyborohydride intermediate 30 being generated in the 
course of lactol ring opening, that resulted in hydride ion being delivered intramolecularly 
to give the syn diastereomer.  A number of methods were then investigated for the 
terminal alkyne oxidation, with the two step NBS/KMnO4 procedure of Wu, followed by 
deprotection and peracetylation, giving the best results for large scale synthesis of the 
protected methyl ester of KDN 33 in 35% overall yield. 




1.6.2 Dithiane Nucleophilic Addition Methodology 
Schmidt and co-workers have shown that dithiane esters of the general type 34 can act as 
good nucleophiles for the synthesis of DAH 15 and KDO 16.46-47  For the synthesis of DAH 
15, addition of lithiated dithio ester 34 in the presence of magnesium bromide to benzyl 
protected D-arabinose 35 afforded the syn addition product 36 (Scheme 6).  This dithiane 
was then treated with N-iodosuccinimide to cleave the dithiane, with the resultant lactol 37 
being benzyl protected selectively at C(2) using benzyl bromide with sodium hydride as 
base.  Free radical deoxygenation of the C(3) hydroxyl group of 38 using Barton’s 
procedure was achieved by converting the C(3) hydroxyl into its 3-O-thiobenzoyl 
derivative that proceeded in quantitative yield, followed by treatment with tributyltin 
hydride and AIBN to yield 39.48  Subsequent hydrogenolysis of the benzyl groups gave 
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KDN 15 in an overall yield of 27% over seven steps.  More recently Yamasaki and co-
workers have shown that dithiane 34 can also be reacted with a mannofuranose-5,6-cyclic 
sulphate to stereoselectively introduce the C2-fragment.49  They then used a similar 
strategy to Schmidt to unmask the α-keto acid moiety and deprotect the sugar to afford 
KDO 16 in 26% overall yield over seven steps. 





1.6.3 Acrylate Nucleophilic Addition Methodology 
Ethyl α-(bromomethyl)-acrylate 40 is a noteworthy example of a C3-synthon that has been 
demonstrated to undergo diastereoselective tin and indium mediated addition to aldoses, 
allowing rapid access to 2-keto-3-deoxy-ulosonic acids.50-52  Thus Chan and Li prepared 
KDN 17 in just two steps from D-Mannose 41 in an impressive 61% yield (Scheme 7).  
Initial coupling of 40 and 41 in the presence of indium in water proceeded to afford a 
mixture of diastereomers 42 and 43 with good levels of diastereoselectivity (syn/anti 5:1).  
The choice of water as the reaction medium was key to the success of the synthesis as it 
allowed an unprotected sugar to be used as a substrate, obviating the requirement for 
protection and deprotection of the alcohol functionalities.  Recrystallization from 
methanol/ethyl acetate provided the pure syn diastereomer 42 in an excellent 64% yield.  
The α-keto acid functionality was then revealed by ozonolysis of the alkene group to afford 
17 in 95% yield from 41.  Whitesides has extended this methodology to other 2-keto-3-
deoxy-ulosonic acids,52 in particular reporting that C(2) acetylated nitrogen aldoses also 
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undergo diastereoselective coupling with 40, which provided direct access to derivatives 
of Neu5Ac 18 over just three steps from suitably functionalised N-aldoses. 




1.6.4 Horner-Wadsworth-Emmons Methodology 
Ramage and co-workers showed that the use of a Horner-Wadsworth-Emmons (HWE) 
reaction was a powerful strategy for the introduction of a masked α-keto acid group, 
demonstrating their methodology for the synthesis of DAH 15 and KDO 16 (Scheme 8).53  
Thus 45, which had been prepared from D-mannose by a series protection, reduction, 
deprotection and oxidation steps was oxidised to aldehyde 46.  Reaction of this aldehyde 
with Wittig reagent 47 gave the adduct 48 as a mixture of cis- and trans-geometrical 
isomers that could be deprotected by sequential acid and base treatment to give KDO 16 
in an overall 12% yield. 
Later Dondoni and co-workers demonstrated that an alternative ylid 50 could be 
successfully reacted with protected sugars for the synthesis of DAH 15 and KDN 16.54  An 
initial Wittig reaction was used to couple a protected derivative 51 of D-mannose with ylid 
50 to give 52 in 82% yield (Scheme 9).  This was then subjected to an oxa-Michael 
reaction that proceeded under thermodynamic control with mediocre stereoselectivity 
(syn/anti 70:30), however the major syn-addition product 53 could be isolated by flash 
chromatography in 54% yield.  Later the acyl thiazole moiety was converted into an 
aldehyde group and then oxidised with Ag2O to give the required α-keto acid functionality, 
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further functional group isomerisations eventually afforded KDN 17 in an overall yield of 
14% from 51.  
Scheme 8 Ramage and co-workers HWE synthesis of KDO 16 
 




1.6.5 Pericyclic Approaches for the Synthesis of 2-Keto-3-Deoxy-Ulosonic Acids 
Queneau and co-workers first showed that the hetero Diels-Alder reaction could be 
applied for the synthesis of 2-keto-3-deoxy-ulosonic acid derivatives, although they found 
that the reaction proceeded with poor stereoselectivity.55  Wu and co-workers then 
showed that better levels of stereoselectivity could be achieved when a Lewis acid was 
added to the hetero Diels-Alder reaction of suitable dienes with ethyl glyoxylate 57, which 
allowed them to synthesise various derivatives of KDO 16 and DAH 17.56-58  More recently 
they showed that this methodology could be applied to the total synthesis of the 
peracetylated ethyl ester of Neu5Ac 18 (Scheme 10).59  Thus, Wittig reaction of aldehyde 
58 with a phosphonium anion gave an enone that was protected as its MOM ether and 
treated with TBSOTf and Et3N to give silyl-enol ether 59 in 60% yield over the three steps.  
The hetero Diels-Alder reaction between 59 and ethyl glyoxylate 57 catalyzed by 
(salen)cobalt(II) complex afforded 60 in 62% isolated yield with a d.e. of 92%.  After 
trialing a number of methods for the introduction of electrophilic nitrogen functionality at 
C(5) treatment with sodium azide (3 equiv.) in the presence of CAN (2.5 equiv.) at 
reduced temperature gave 62% yield of the desired azide isomer 61.  This was 
stereoselectively reduced using NaBH4 and the resultant alcohol protected as its MOM 
ether.  Oxidation at C(2) to create the crucial α-keto acid functionality was achieved by 
treating the MOM ether with MoO5.Py.HMPA to afford 62, and then a series of 
deprotection/reduction/protection steps to furnish the desired Neu5Ac derivative 63 in an 
overall yield of 3% in eleven steps. 




Yao and co-workers went on to demonstrate that a toluene solution of nitrone 66 
undergoes a highly stereoselective 1,3-dipolar cycloaddition reaction when heated in the 
presence of methyl acrylate 67 (Scheme 11).60  Initially aldehyde 64 was reacted with a 
sugar-derived hydroxylamine 65 in the presence of MgSO4 to furnish nitone 66 bearing 
Vasella’s chiral auxiliary.  The 1,3-dipolar cycloaddition reaction of nitrone 66 with methyl 
acrylate 67 then afforded isoxazolidine 68 as the major product in 90% yield.  Removal of 
the chiral auxiliary followed by reductive cleavage of the N-O bond of the isoxazolidine 
revealed α-hydroxy-γ-amino carboxylate 69 with the desired stereochemistry.  Dess-
Martin periodinane 70 then successively oxidised the α-alcohol group to α-keto acid 71, 
which was deprotected to afford 2-keto-3-deoxy-ulosonic acid 72 in an overall yield of 
20% in eight steps. 





Burke and co-workers have shown that the Ireland-Claisen [3,3]-sigmatropic 
rearrangement can also be employed for the synthesis of 2-keto-3-deoxy-ulosonic acids 
(Scheme 12).61  Initially diene 73 was synthesised over four steps from D-mannitol.  
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Alkylation of the stannylene acetal of 73 by tert-butyl bromoacetate 74, that proceeded 
with concomitant cyclisation provided the desymmetrized dioxane 75.  Conversion of 75 to 
the silyl-ketene acetal 76, followed by Ireland-Claisen [3,3]-sigmatropic rearrangement 
and hydrolysis of the intermediate silyl-ester allowed for the stereoselective synthesis of 
78 in 76% yield.  Double asymmetric Sharpless dihydroxylation was then trialed using a 
range of chiral ligands, with the endocyclic double bond being dihydroxylated from the 
undesired face in all cases, which the authors attributed to the C(6) substituent overriding 
the influence of the chiral ligands.  Therefore the configuration of the diol fragment was 
inverted and then oxidation at C(2), using the Wu methodology (vide supra), and 
deprotection afforded KDO 16 in an overall yield of 17% from D-mannitol. 
 






1.6.6 Radical Methodology 
Early work on allylic radicals and Barton ester radicals showed that single electron 
reactions could be used for the synthesis of α-keto acids under mild reaction conditions.62-
67  Barton’s approach is exemplified by his synthesis of KDO derivative 90 from a readily 
accessible protected aldonic acid 84 (Scheme 13).  Coupling of N-hydroxy-2-thiopyridone 
85 with the acid fragment of 84, gave Barton ester 86 that underwent radical reaction with 
ethyl α-(-trifluoro-acetoxy)acrylate 87 when irradiated with UV light.  Intermediate 88 was 
not isolated, but reacted in situ with phenylhydrazine in pyridine to give the 
phenylhydrazone derivative 89.  Sequential treatment of 89 with TBAF, followed by 
hydrochloric acid in ethanol afforded the hydrazone derivative of KDO 90 in an overall 
yield of 41% over five steps. 
Scheme 13 Barton radical decarboxylation reaction for the synthesis of KDO derivative 90 
 
 
More recently, in the course of their studies into transition metal mediated radical 
reactions, Linker and co-workers have developed complimentary oxidative and reductive 
radical reactions for the formal synthesis of the C(7) epimers of KDO 96 and 102 (Scheme 
14).68  They discovered that manganese (III) acetate promotes the oxidative radical 
coupling of acetic acid with acyclic alkene 91 in an excellent yield of 90%, but with a 
mediocre stereoselectivity of 36% d.e.  Attempts to optimise the reaction conditions did 
not improve the diastereoselectivity, although the product diastereomers could be 
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separated by flash chromatography, allowing 92 to be isolated and converted to lactone 
93, which had been previously advanced to manno-KDO 97 by condensation with 
tris(dimethylamino)-methane 94, followed by treatment with singlet oxygen generated in 
situ by bubbling oxygen through a solution of 94 in the presence of a catalytic quantity of 
methylene blue whilst irradiating the reaction mixture with a Argaphoto-B lamp.  Acid 
catalysed hydrolysis of the resultant 2-keto-lactone 96 afforded the target 2-keto-3-deoxy-
ulosonic acid 97.69  Alternatively, they demonstrated that a carbohydrate fragment could 
act as the radical precursor in the presence of a suitable metal.  Thus protected sugar 98 
was reacted with ethyl acrylate 99 and samarium (II) iodide in the presence of various 
additives.  The best coupling reactions were attained when tert-butanol was used as an 
additive at -78 
◦
C, affording the key intermediate 101 in 78% yield, albeit with mediocre 
stereoselectivity of 36% d.e.  The reversal of diastereoselectivity compared to the 
manganese (III) acetate mediated radical reaction was rationalized by invoking transition 
state 100 where the O-isopropylidene group shields one face of the samarium complex, 
causing the acrylate to preferentially approach the radical from the Si face. 











1.6.7 Rhodium-Mediated Carbenoid Rearrangement Methology 
López-Herrera and co-workers have demonstrated the efficacy of rhodium mediated 
carbene chemistry for the synthesis of KDO 16, KDN 17 and other derivatives.36,70  Thus, 
initial reaction of ethyl diazoacetate with protected sugar 103, and subsequent treatment 
with acetic anhydride in pyridine provided 104, which underwent facile rhodium mediated 
rearrangement of the acetyl substituent that has been proposed to proceed via carbonyl 
oxygen nucleophilic attack on the intermediate rhodium species, which affords 105 in 
excellent yield (Scheme 15).  Transformation of enol ester 105 to the corresponding 2-
hydrazone derivative, followed by oxidation with MnO2 gave the diazo compound 106.  
Attempted deprotection of the carbenoid group and insertion into an alcohol bond using 
UV light or silver oxide proved unsuccessful, however when acetyl deprotection with 
sodium methoxide was followed by oxidation with by mCPBA the desired product 107 was 
isolated as the sole product, which after acetonide deprotection gave KDO 16 in a 
reported yield of 77% over nine steps. 





1.6.8 Metathesis Methodogy 
Ring closing metathesis has been applied for the synthesis of key intermediate ring 
systems for the synthesis of KDN 17, Neuc5Ac 18 and other 2-keto-3-deoxy-ulosonic acid 
derivatives.71-73  Most recently Rutjes and co-workers have reported the synthesis of DAH 
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15 starting from protected sugar 108, involving ring closing metathesis of a highly 
substituted α-alkoxyacrylate 111, with subsequent functionalization via an iodohydrin 
elimination (Scheme 16).  Alcohol 109 was prepared from the protected sugar 108 using 
standard Wittig methodology.  Generation of α-alkoxyacrylate 111 involved reaction 109 
with α-bromoester 110, followed by N-methylation and base catalysed elimination.  111 
was then treated with Grubbs 2nd generation catalyst to give enol-ether 112 in good yield.  
The synthesis was completed by iodohydroxylation of the enol ether bond and subsequent 
reduction of the iodo group to afford 113, followed by hydrogenolysis of the benzyl groups 
and ester hydrolysis to afford DAH 15 in 39% overall yield over eight steps. 




1.6.9 Organocatalytic Methodology 
Improving on previous work using masked pyruvic acid equivalents in organocatalytic 
systems,74-75 Enders and co-workers have recently reported a highly enantioselective 
proline catalysed synthesis of 2-keto-3-deoxy-ulosonic acid precursors.76  Trialing a range 
of enantiomerically pure pyrrolidine analogues for the reaction of 2-methyl propanal 114a 
with pyruvic acid dimethyl acetal 115 showed that (S)-proline 116 gave the best 
enantioselectivities (73% e.e.).  The temperature, solvent and reaction time were 
optimised for the (S)-proline 116 catalysed reaction and the methodology was trialed with 
a number of aldehydes (Table 3).  For the higher 2-keto-3-deoxy-ulosonic acid precursors 
excellent levels of stereoselectivity were recorded (≥99% e.e., 90-92% d.e.), although this 
success was tempered by long reaction times and low yields due to Mannich-elimination 
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and self-condensation of acetal 115.  The 2-keto acetal products 117a-e are potential 
precursors to 2-keto-3-deoxy-ulosonic acids, but the authors did not manage to hydrolyse 
and oxidise the acetals to the corresponging 2-keto-ulosonic acids. 
Scheme 17 (S)-proline catalysed reaction of pyruvic acid dimethyl acetal with a range of 
aldehydes 
 
Table 3 (S)-proline 116 catalysed reaction of pyruvic acid dimethyl acetal 115 with 
aldehydes 114a-e 
Adehyde R Time Yield % de % e.e. 
117a i-Pr 8 48 - 93 
117b c-Hex 10 37 - 85 
117c 
 
5 38 91 ≥99 
117d 
 
7 31 90 ≥99 
117e 
 
9 35 92 ≥99 
 
1.6.10 Enzymatic Methodology 
The biosynthesis of higher 2-keto-3-deoxy-ulosonic acids normally involves the tandem 
action of three or more enzymes.  This is exemplified by the biosynthesis of KDN 17: (i) 
kinase mediated phosphorylation of a sugar precursor 118; (ii) an aldol type reaction with 
pyruvate 7 (or pyruvate equivalent) mediated by an aldolase; (iii) removal of the 
phosphate group mediated by a phosphatase (Scheme 18).77-79 
A number of groups have used the enzymes employed for the synthesis of KDO 16 and 
Neu5Ac 18 for the preparation of 2-keto-3-deoxy-ulosonic acid derivatives.80-83  Wong  
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Scheme 18 Biosynthesis of KDN 1779 
(i) Phosphorylation 
 
(ii) Aldol reaction with pyruvate enolate equivalent 




and co-workers published particularly impressive results for the synthesis of KDO 16 and 
its analogues.82  They first identified a Gram-negative bacterium, Aureobacterium 
barkerei, which contained high levels of KDO aldolase, and then isolated the bacterium’s 
aldolase in a more pure form by ammonium sulphate precipitation.  This enzyme 
catalysed reaction of D-arabinose 123 with pyruvate 7, using an excess of pyruvate 7 to 
drive the equilibrium towards aldol products, affording the desired aldol product in a yield 
of 67% after purification by ion exchange chromatography.  The substrate scope was 
studied and it was shown that more than 20 natural and unnatural sugars were accepted 
as aldose substrates.  They observed that substrates with an R-configuration at C(3) gave 
36 
 
higher rates of aldol reaction (Table 4).  It was also discovered that the substituent on C(2) 
of the sugar had little effect on stereoselectivity of the reaction, which was governed by 
the enzyme delivering pyruvate 7 to the Re face of the aldehyde. 




Table 4 Substrate scope of KDO aldolase from Aureobacterium barkerei 




















D-ribose  L-mannose  
a. Measured at pH 7.5 with 500 mM sugar and 10 mM pyruvate 
 
Hilvert and co-workers have recently published impressive results for the synthesis of 2-
keto-3-deoxy-ulosonic acids from protected sugars and oxaloacetate 127 (generates in 
situ pyruvate enolate) catalysed by the putative Diels-Alderase macrophomate synthase 
(MPS),84 which has previously been used to catalyse aldol reaction of oxaloacetate 127 
with a variety of aromatic and aliphatic aldehydes.85  Good to excellent levels of 
diastereoselectivity were achieved for a variety of protected sugars (from 4:1 to >19:1 dr), 
so the total synthesis of KDN 17 was attempted starting from protected D-mannose 124 
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(Scheme 20).  The aldol reaction proceeded with a good dr of 8:1, but with a mediocre 
yield of 39% that was attributed in part to the instability of the aldehyde starting material 
under aqueous conditions.  Global deprotection of 128 by treatment with 10% TFA 
afforded KDN 17 in 14% yield over six steps. 
Scheme 20 Hilvert enzymatic synthesis of KDN 17 
 
 
MPS - macrophomatee synthase 
 
1.6.11 Synthesis from Non-Sugar Based Starting Materials 
The synthesis of 2-keto-3-deoxy-ulosonic acids from non-sugar starting materials is a 
particularly difficult challenge, normally requiring a great number of synthetic steps, such 
as Johnson and co-workers’ synthesis of DAH 15 in 23 steps from cycloheptatriene in 8% 
yield.86  However, a number of groups have chosen this approach to showcase novel 
methodology and/or ingenious synthetic strategies.87-91  Kang and co-workers have 
reported the highly diastereoselective synthesis of Neu5Ac 18 via intramolecular 
phenylselenoamidation and asymmetric dihydroxylation (Scheme 21).91  Initially primary 
alcohol 129 was regioselectively benzylated and the required amino group introduced by 
reacting the unprotected allylic alcohol with trichloroacetonitrile in the presence of DBU to 
furnish 130.  Exposing 130 to benzeneselenyl bromide in the presence of an acid 
scavenger and dehydrating agent, propylene oxide and methyl trichloroacetimidate 
respectively, provided oxazoline 131 that could be partially hydrolysed in the presence of 
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pyridinium para-toluenesulfonate, and have the benzeneselenyl group oxidatively 
eliminated to afford trans-alkene 133.  After optimisation, it was found advantageous to 
incorporate the amine and hydroxyl groups into the oxazolidin-2-one ring of 135 that 
underwent highly stereoselective dihydroxylation reactions.  Thus, 133 was dihydroxylated 
in high d.e., deprotected and the amino group re-acetylated to furnish pentaol 134 with a 
dr of 18:1.  All the required chiral functional groups had been introduced, so the terminal 
benzyloxy functionality was transformed into an α-keto acid following Wasserman’s 
protocol, followed by acetonide deprotection to afford Neu5Ac 18 in an overall yield of 
10%. 








1.7 Bio-occurrence of C6-2-Keto-3-Deoxy-Ulosonic Acids 
D-KDG and D-KDGal are key intermediates in the metabolism of D-glucose 2 and D-
galactose 3 by many organisms.  In the non-phosphorylative Entner-Doudoroff pathway, 
found in fungi and archaea, a dehydratase catabolises D-gluconate 4 (or D-galactonate 5) 
to D-KDG (or D-KDGal) respectively, before they are catabolised further by an aldolase to 
afford D-glyceraldehyde 6 and pyruvate 7 (Section 1.2).  In the classical Entner-Doudoroff 
pathway,92-93 the 6-phosphorylated form of D-KDG is an intermediate that is catabolised by 
KDPG aldolase to give D-glyceraldehyde 6 and pyruvate 7.  Meanwhile, the DeLey-
Doudoroff pathway that catabolises D-galactose 4 to pyruvate 7, which was first 
discovered in a strain of Pseudomonas sacharophila and has since been found to operate 
in many other bacteria,18,94-96 also generates D-KDGal as an intermediate (Scheme 22).  
In detail, this bacterium oxidises D-galactose 3 in the presence of NAD+ to D-galactono-γ-
lactone 137, which is enzymatically hydrolyzed to galactonate 138.  Acid 138 is 
subsequently dehydrated to D-KDGal by a galactonic acid dehydratase, then 
phosphorylated before being catabolised to pyruvate 7 and D-gylceraldehyde-3-phosphate 
140. 




D-KDG has been shown to be an intermediate in the metabolism of alginate 141 by 
Sphingomonas sp. strain A1, a Gram-negative bacterium (Scheme 23).97  Alginate 141, 
which is a polysaccharide made up of repeating (1 4) β-D-mannuronate and α-L-
guluronate residues found naturally in bacteria, algae and seaweed, is first transferred to 
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the cell’s cytoplasm where alginate lyases degrade it into its constituent 
monosaccharides.  These are then non-enzymatically converted into 4-deoxy-L-erythro-5-
hexulose uronic acid (DEH) 144, and this sugar is reduced to D-KDG by DEH reductase.  
The D-KDG produced is then phosphorylated to afford 145 that is then cleaved to 
pyruvate 7 and glyceraldehyde-3-phosphate 140 via a retro-aldol reaction.  
 




D-KDG has also been shown to be both an intermediate in the catabolism of pectin and a 
regulator of gene expression for the catabolism of pectin 146 by the bacterium Erwinia 
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chrysanthemi (Scheme 24).98-100  This bacterium causes soft-rot disease by degradation of 
plant cell walls, which leads to death of the plant tissue and provides nutrients for bacterial 
growth.  Robert-Baudouy and co-workers have shown that most of the genes involved in 
pectin degradation, which is the first step in the degradation of the plant cell walls, are 
controlled by a single down-regulated gene.  When D-KDG interacts with this regulatory 
gene it induces pectin catabolism pathways.101  
 
Scheme 24 Pathway for pectin catabolism by E. chrysanthemi 
 
It is well known that higher 2-keto-3-deoxy-ulosonic acids play an important structural role 
in specific prokaryotes as constituents of lipopolysaccharides (Section 1.6).  D-KDGal has 
been identified as a constituent of the extracellular polysaccharides of Azotobacter 
vinelandii, where it is attached to rhamnose by a β-(2 2) gylcosidic bond (Figure 5).102-103  
It is thought that these extracellular lipopolysaccharides play a role in intercellular 
communication affecting cell proliferation, cell-cell adhesion and cell migration. 






1.8 Previous Syntheses of D-KDG and D-KDGal 
1.8.1 Rhodium-Mediated Carbenoid Rearrangement Methology 
Rhodium mediated decomposition of β-acetoxy-α-diazoesters has been used by the 
Herrera group to prepare higher 2-keto-3-deoxy-ulosonic acids (Section 1.6.7) and for the 
synthesis of D-KDG (Scheme 25).104  Thus, protected aldehyde 149 was prepared in two 
steps from D-glucose 2, and treated with methyl diazoacetate 150 to give β-acetoxy-α-
diazoester 151 after acetyl protection of the two hydroxyl groups.  Addition of a catalytic 
quantity of rhodium acetate successfully induced rearrangent to give enol ester 152, which 
was subjected to acidic conditions and isolated as the barium salt of D-KDG.  The overall 
yield for this synthesis was considerably lower than that achieved by the Herrara group for 
the synthesis of KDN 17 (19% compared to 85%), which was due in part to the addition of 
methyl diazoacetate to aldehyde 149 affording just a 54% yield of product. 
 





1.8.2 Synthesis from Non-Sugar Based Starting Materials 
Mikami and co-workers showed that a glyoxylate-ene reaction mediated by stannic 
tetrachloride was a suitable starting point for the synthesis of D-KDG from non-sugar 
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starting materials.105  The initial ene-reaction of 153 with methyl glyoxalate 154 proceeded 
with excellent selectivity furnishing allylic alcohol 155 exclusively in the E-configuration 
(Scheme 26).  After benzyl deprotection of the secondary hydroxyl group and silyl 
deprotection, a Sharpless epoxidation reaction on homoallylic alcohol 156 gave epoxide 
157 with good stereoselectivity (>90% e.e.).  Two-step epoxide ring-opening was then 
carried out by treatment of 157 with phenyl isocyanate followed by BF3.OEt2, inducing ring 
closure to give carbonate 159.  O-Acetylation, O-debenzylation and oxidation with PDC 
gave α-keto ester 161 that was hydrolysed to complete the synthesis over eleven steps 
with an overall yield of 21%. 
 




1.8.3 Horner-Wadsworth-Emmons Methodology 
Ramage and co-workers prepared aldehyde 149 in a similar way to the Herrera group, but 
instead of using methyl diazoacetate to introduce the α-keto acid group they employed 
their Wittig methodology to introduce the masked α-keto acid of D-KDG (Scheme 27).53  
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Unfortunately, acidic deprotection, which had been successful in the synthesis of KDO 16 
(Scheme 8), led to degradation.  However, they found that treatment with a methanolic 
solution of iodine (1% v/v) gave the deprotected triol 164, but in a very low 9% yield, so 
that final treatment with barium hydroxide afforded D-KDG in a very disappointing overall 
4% yield. 




1.8.4 β-Elimination Methodology 
Thiem and Limberg have shown that triethylamine catalysed β-elimination of benzoyl 
protected lactone 166 allows access to both D-KDGal and D-KDG in arguably the most 
concise and high yielding route to date (Scheme 28).  Starting from lactone 165, the 
selective protection of the hydroxyl groups in the side chain was followed by benzoylation 
of the remaining hydroxyl groups to furnish 166.  Treatment with a catalytic quantity of 
triethylamine led to β-elimination via an E1cB mechanism, with concomitant epimerisation 
at the δ-position to give a mixture of epimers 167 and 168.106  However, purification by 
column chromatography allowed both epimers to be isolated and subsequent hydrolysis 
furnished D-KDGal and D-KDG in an impressive 32% and 14% overall yield respectively 








1.8.5 Enzymatic Methodology 
Aldolases from both bacteria and filamentous fungi have been used to prepare D-KDG 
and D-KDGal (Scheme 29).107-116  Thus Augé and Delest found that when the filamentous 
fungus Aspergillus niger was grown on 2% D-gluconate 4 as the sole sugar source, it 
produced high concentrations of KDG aldolase.109  The enzyme was partially purified by 
heat treatment of the ground cells followed by precipitation with acetone.  Incubation of D-
glyceraldehyde 6 and pyruvate 7 (1.1 equivalents), with the isolated KDG aldolase, 
afforded a diastereomeric mixture of D-KDG and D-KDGal in a ratio of 87:13.  More 
recently they have reported that crude cell extracts from the filamentous fungus 
Aspergillus terreus catalysed the aldol reaction of a range of aldehydes with pyruvate 
giving high levels of stereoselectivity.108  Using this method, D-glyceraldehyde 6 was 
incubated with pyruvate 7 (1 equivalent) and the crude cell extracts of A. terreus to afford 
D-KDG in 100% d.e.  Meanwhile Wong and co-workers have used KDO aldolase from the 
Gram-positive bacterium Aureobacterium barkerei and found that the enzyme promotes 
attack of pyruvate 7 at the Re face of aldehydes,82 therefore giving complementary 
stereoselectivity to the fungal aldolase studied by Augé and Delest.  The enzyme was 
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partially purified by ammonium sulfate precipitation of crude cell extracts, and then 
incubated with D-glyceraldehyde 6 and pyruvate 7 to give D-KDGal (>97% d.e.).  2-Keto-
3-deoxy-6-phosphogluconate aldolase (KDPG aldolase) has also been employed to 
catalyse the reaction of non-phosporylated substrates by Toone and co-workers.117  They 
incubated KDPG aldolase D-glyceraldehyde with pyruvate to give D-KDG stereoselectively 
(>97% d.e.) in 30% isolated yield.  More recently they improved the catalytic activity of 
KDPG aldolase from E. coli for the reaction of D-glyceraldehyde 6 and pyruvate 7, by 
mutation of key active site residues.113 




1.9 Bio-occurrence of C5-2-Keto-3-Deoxy-Ulosonic Acids  
It has been well documented that D-KDX and L-KDA are metabolites of the five carbon 
aldose sugars D-xylose 8 and L-arabinose 9 in some fungi, bacteria and archaea. 101,6,118  
Makino and co-workers have shown that when Azospirillum brasiliense is grown on L-
arabinose 9 as the sole carbon source, that L-arabinose 9 is catabolised to 2-oxoglutarate 
13 via L-KDA as an intermediate (Scheme 30).118  In this pathway, L-arabinose 9 is first 
oxidised to L-arabino-γ-lactone 169 by a NAD(P)+-dependant dehydrogenase.  This 
lactone 169 is then cleaved by a lactonase to afford L-arabonate 11 that is then 
dehydrated to L-KDA.  Further dehydration affords 2-oxoglutarate semialdehyde 12 that is 
then converted by a NAD(P)+-dependant dehydrogenase to 2-oxoglutarate 13, which is 
utilised by the bacterium in the citric acid cycle, for the synthesis of glutamine, or for the 
transport of nitrogen.  Evidence for this pathway has also been found for Pseudonomas 
fragi,119 Pseudomonas saccharophila, 118,120-121 Pseudomonas aeruginosa,122 Rhibium 
japonicum,123-125 Herbaspirillum seropedicae, 126 Aspergillus ustus,114,127 and S. 
solfataricus.6  Despite the numerous references to D-KDX and L-KDA in the literature, 
there are few reported syntheses, which is perhaps due to the reported instability of these 
sugars to acidic and basic conditions where they have been observed to degrade at pH 








1.10 Previous Syntheses of C5-2-Keto-3-Deoxy-Ulosonic Acids 
1.10.1 Nucleophilic Methodology 
There is only one instance of the chemical synthesis of the C5-2-keto-3-deoxy-ulosonic 
acids D-KDX and L-KDA.  In this example pyruvic acid 7 and glycolaldehyde 14 were 
allowed to react under neutral conditions to furnish a racemic mixture of D-KDX and L-
KDA in 85% yield (Scheme 31).120,130-131 
Scheme 31 Stoolmiller synthesis of D-KDX and L-KDA 
 
 
1.10.2 Horner-Wadsworth-Emmons Methodology 
Horne and co-workers have shown that the HWE methodology can also be applied to the 
synthesis of 173, the protected methyl ester derivative of L-KDA (Scheme 32).132  They 
reacted the lithium anion of phosphonate ester 171 with L-glyceraldehyde acetonide 170 
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to furnish 172 as a mixture of cis- and trans-geometrical isomers.  Reductive elimination of 
the trichloro-tert-butoxyl carbonate group was achieved by treatment of an AcOH/H2O 
solution of 172 with 20 molar equivalents of zinc dust and purification by silica gel column 
chromatography, which afforded α-keto methyl ester 173 in overall 67% yield.  The 
authors did not proceed to deprotect the diol moiety or hydrolyse ester 173 to L-KDA. 
Scheme 32 Horne HWE methodology for the synthesis of L-KDA derivative 
 
1.10.3 β-Elimination Methodology 
Theim and co-workers have also applied their β-elimination methodology to the synthesis 
of the methyl ester derivative 178 of L-KDA (Scheme 33).106  Selective silyl protection of 
the primary hydroxyl group of L-arabinono-1,4-lactone with tert-butylchlorodiphenylsilane 
furnished 175, followed byenzoylation of the remaining hydroxyl groups and treatment of 
the crude product with Et3N resulted in efficient β-elimination to afford 3-deoxy-2-
enolactone 176.  The silyl protecting group was then removed using a buffered THF 
solution of tetrabutylammonium fluoride to give 177.  The authors found that standard 
acidic deprotection procedures led to decomposition, which they concluded was a result of 
instability of the sodium salt of L-KDA.  This problem was avoided by employing a mild 
debenzoylation method involving treatment of a THF/methanol solution of 177 with N-
methylpyrrolidine, subsequent acidification with Amberlite IR-120 (H+) resin afforded the 
methyl ester derivative 178 of L-KDA in overall 18% yield. 
 
1.10.4 Enzymatic Methodology 
Meanwhile a few groups have used enzymic methodology for the synthesis of D-KDX and 
L-KDA, although the products were not fully characterised and their structure inferred from 
derivatisation studies carried out in situ.120,133-135  Having studied the metabolism of L-
49 
 
arabinose 9 to 2-ketoglutarate 13 by cell-free extracts of Pseudomonas saccharophila 
(Scheme 30), Abele and Stoolmiller employed L-arabonate dehydratase for the synthesis 
of L-KDA, which was isolated by paper chromatography.120,133  L-KDA synthesised by this 




method appeared to be only 80% pure when subjected to an enzyme assay.  In a similar 
manner Frost and co-workers have used mutant E. coli cultures that express an L-
arabonate dehydratase to convert L-arabinose 9 to L-KDA before reacting it in situ to 
afford 1,2,4-butanetriol.134  Abdel-Fatah and Elshafei have demonstrated that 2-keto-3-
deoxy-L-arabonate aldolase, present in cell-free extracts of Aspergillus ustus, can be used 
for the synthesis of L-KDA from glycolaldehyde 14 and pyruvate 7, however the 
entantiomeric excess of the product was not determined (Scheme 34).135  In this case the 
L-KDA synthesised was not isolated being characterised indirectly using a thiobarbituric 
acid assay, and used to compare the enzyme efficacy towards various aldehyde and acid 
substrates. 
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Two chemical syntheses of D-KDG were initially investigated with the expectation that any 
successful methodology developed could then be applied to the synthesis of D-KDGal.  
The first unsuccessful approach involved introducing the α-keto acid functionality by 
oxidation of the terminal 1,2-diol of a suitably protected C6-substrate.  The second 
successful strategy consisted of a Horner-Wadsworth-Emmons (HWE) reaction to give a 
silyl-enol ether that would then be globally deprotected to afford enantiomerically pure D-
KDG.  Once the two target sugars were synthesised, their structure and the effect of 
temperature on their isomeric composition in solution would be investigated, before they 
were then employed as substrates for the directed evolution of KDG aldolase from S. 
solfataricus. 





2.2 Strategy A: Oxidative Synthetic Strategy for the Synthesis of D-KDG 
Initially an oxidative strategy was envisaged for the synthesis of the target sugars 
(Scheme 35).  It was proposed that D-KDG could be synthesised from the chiral pool 
starting material D-mannitol 179 by acetonide protection of the terminal diol functionality 
and oxidative cleavage of the central carbon-carbon bond of bis-acetonide 180.  
Diastereoselective metal mediated allylation of 181 would then form alcohol 182, which 
would be protected as benzyl ether 183 before dihydroxylation and oxidation would give α-
keto acid 185.  Deprotection of both the acetonide and benzylic protecting groups would 
then give D-KDG in seven steps.  If this synthetic strategy was successful, a related 









2.2.1 Bis-Acetonide Protection of D-Mannitol 
D-Mannitol 179 has been used as the starting point for the synthesis of many chiral 
compounds, because it is a readily available and inexpensive chiral pool reagent.  A 
number of different protocols are available for the selective protection of the different 
hydroxyl groups of D-mannitol, including the use of: benzaldehyde (1,3:4,6 protection);1 
2,3-butadione (1,2:5,6 protection);2 or trityl chloride (1:6 protection).3  
For the synthesis of D-KDG the acetonide protecting group was chosen to achieve 1,2:5,6 
protection.  This reaction has been studied systematically by the Kuszmann group using 
GC-MS and NMR spectroscopic analysis.4  They showed that the choice of reagents, 
solvent and reaction time were crucial for achieving good yields.  Prolonged reaction times 
favoured the formation of tri-acetonide products whilst some solvent/reagent combinations 
gave mono-acetonide and various isomeric bis-acetonide impurities.  Following their 
optimised method, D-mannitol 179 was reacted with anhydrous zinc (II) chloride in dry 
acetone for 22 hours at 15-20 °C.  The crude product was purified by recrystallisation 
from carbon tetrachloride to give the desired product 180 as a white crystalline solid in 








2.2.2 Oxidative Cleavage of D-Mannitol Bis-Acetonide 
Cleavage of the carbon-carbon bond of 1,2-diols can be achieved with a variety of 
reagents, however, there was clear literature precedent for the use of sodium periodate to 
cleave bis-acetonide 180.  The mechanism for the sodium periodate cleavage of 1,2-diols, 
according to Buist,5 involves initial formation of a cyclic periodate ester 186, which then 
decomposes to give two molecules of aldehyde (Scheme 37). 







A sodium bicarbonate mediated sodium periodate protocol, developed by Schmid and co-
workers, was followed (Scheme 38).6  The base was added to neutralise any acetic acid 
by-product formed, which is believed to cause an increase in product polymerisation.  
After purification of the crude product by distillation, the desired aldehyde 181 was 
obtained in 65% yield.  The enantiomeric excess was initially confirmed by polarimetry 
that gave     
   +60.4 (c 2.25, EtOAc).  There is some disagreement in the literature over 
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the exact optical rotatory power of 181, with optical rotation values ranging from      = 
+54 to      = +80.
7-10  Since obtaining 181 in an enantiopure form was crucial for the 
successful synthesis of enantiomerically pure D-KDG, further proof of the enantiomeric 
excess of 181 was acquired by chiral derivatisation.  Accordingly 181 was reacted with 
(R)-α-methylbenzylamine, reduced in situ with sodium borohydride and analysed by 1H 
NMR spectroscopy.  This showed that the diastereomeric excess of the secondary amine 
product 187 was >97% inferring an enantiopurity for 181 of >97% e.e.  D-Glyceraldehyde 
acetonide 181 was reacted immediately, as it is known to be unstable and prone to 
racemisation, even when stored under an inert atmosphere in a refrigerator. 
Scheme 38 Schmid base mediated sodium periodate methodology for the synthesis of D-




2.2.3 Metal-Mediated Allylation of D-Glyceraldehyde Acetonide 
Methodology for the addition of metal-allyl species to aldehydes and ketones is an 
important research area, offering a valuable alternative to conventional aldol 
methodologies for creating homoallylic alcohols.  Luche’s aqueous procedure was 
followed, whereby aldehyde 181 was treated with excess allyl bromide 188 and zinc dust 
in a NH4Cl(aq)/THF reaction medium (Scheme 39).
11 




The diastereoselectivity of the reaction (anti/syn 6:1) was determined by reaction of the 
crude product with benzyl bromide using KOt-Bu as base, followed by comparison of the 
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1H NMR spectrum of the products with literature data, vide infra.  Interestingly, the major 
anti product 182 was obtained as predicted by the Felkin-Anh model (Scheme 40), rather 
than a chelated-Cram model (Scheme 41).  The absence of chelation is probably due to 
water solvation of the zinc ions preventing metal chelation to the carbonyl group of 181. 









2.2.4 Benzyl Protection and Dihydroxylation 
Alcohols 182 and 189 were protected as their corresponding benzyl ethers and the two 
diastereomers 183 and 190 (anti/syn 6:1) effectively separated by silica gel column 
chromatography (Scheme 42).  Comparing the 1H and 13C NMR spectra to literature 
values it was possible to assign the main diastereomer as having an anti-configuration.12  
The anti-diastereomer 183 was then dihydroxylated via treatment with OsO4 and NMO to 
give diol 184,13 as a 1:0.9 mixture of diastereomers, in good yield after purification. 
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Scheme 42 Benzyl protection and dihydroxylation of alcohol-acetonides 182 and 189 
 
 
2.2.5 Attempted Oxidation of 1,2-Diol 184 
Oxidation of the 1,2-diol fragment of 184 to its corresponding α-keto acid (or ester) 
required the use of a mild oxidant, since cleavage of the terminal C-C bond could 
potentially occur under oxidative conditions to give a C5-carboxylic acid with loss of 
carbon dioxide.  Initially a range of literature oxidation protocols were trialled on 1,2-
octanediol 191, which led to varied amounts of 2-oxooctanoic acid 192, heptanoic acid 
193 and starting material 191 (Table 5). 
Scheme 43 Oxidation of 1,2-octanediol 191 
 






114 2-IBA (0.6) Oxone (5.4) 193 (54%) 
214 2-IBA (0.2) Oxone (1.8) 193 (71%) 
315 IBX (1.5) - 191 + impurities 
415 IBX (4.0) - 192 (65%) 
516 TEMPO (0.02) TCCA (2) 192 + 193 
617 TEMPO (2.2) NaClO (3.6) 192 (90%) 
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Two successful methods, for the oxidation of 1,2-octanediol 191 were identified, using 
either an excess of 2-iodoxybenzoic (IBA) acid or tetramethylpiperidine N-oxide 
(TEMPO)/sodium hypochlorite.  These reagents were employed for the oxidation of diol 
184, but the desired α-keto acid 185 could not be observed in the 1H NMR spectra of the 
complex mixture of products formed for either method.  1H NMR and mass spectroscopic 
analysis revealed the disappearance of starting material 184 and also some evidence of 
debenzylation.  Variation of the reaction parameters (temperature, time and molar 
equivalents of oxidants and co-oxidants) of these oxidation reactions gave no evidence of 
any successful oxidation to α-keto acid products. 





2.3 Strategy B: Horner-Wadsworth-Emmons for the Synthesis of D-KDG 
A careful search of the literature revealed that Thompson and co-workers had 
demonstrated that trichloro-tert-butyloxy carbonate protected phosphonate ester 171 
could act as an acyl anion equivalent when reacted with aldehydes (Scheme 45).18  This 
HWE reaction was successful for reacting a range of acid sensitive aldehydes 194a-d with 
the enol-ether products 195a-d being deprotected in high yield by treatment with zinc dust 
to afford α-keto acid products 196a-d. 





Other groups went on to apply this type of HWE methodology for the synthesis of the 
higher 2-keto-3-deoxy-ulosonic acids DAH 15, KDO 16 and KDN 17 (see Sections 1.6.4 
and 1.8.3).  Inspired by this work, an alternative synthetic strategy for the synthesis of D-
KDG was proposed, which aimed to introduce the key α-keto acid functionality in a 
masked form using a HWE reaction (Scheme 46).  The convergent synthesis would 
involve HWE reaction of the anion of ethyl 2-((tert-butyldimethylsilyl)oxy)-2-
(dimethoxyphosphoryl) acetate 1 with the known lactol 198, followed by global 
deprotection to afford D-KDG in just four steps. 
Scheme 46 HWE retrosynthetic strategy for the synthesis of D-KDG 
 
 
2.3.1 Synthesis of Lactol 198 
The commercially available lactone 197 was a good starting point for the synthesis of D-
KDG as it could be reduced in just one step to afford the desired lactol 198 (Scheme 
47).19 The reduction of lactones to lactols is a reliable transformation that does not usually 
result in over reduction to alcohols, as is often observed for the DIBAL reduction of esters.  
The success of the reaction is due to DIBAL generating a stable tetrahedral intermediate 
201, which affords lactol 198 on aqueous work-up at low temperature.  In the case of 
lactone 197, DIBAL reduction gave lactol 198 in good yield as a white solid that required 
no further purification. 




2.3.2 Phosphonate Ester Synthesis 
The Michaelis and Arbuzov reactions are the standard methods for the synthesis of 
phosphonates.  The former involves the treatment of alkyl halides with alkyl metal 
derivatives of dialkyl phosphites (Scheme 48(i)), whilst the latter method involves reaction 
of a trialkyl phosphite with an alkyl halide (Scheme 48(ii)). 




The synthesis of phosphonate ester 204 has been previously reported using an unusual 
p-TSA catalysed coupling of a dialkyl phosphite 202 and ethyl glyoxalate 203 in refluxing 
benzene.20  This methodology was repeated, substituting toluene for benzene, to 
successfully give phosphonate 204 in good yield and purity after silica gel column 
chromatography (Scheme 49).  The hydroxyl functionality of 204 was then O-silyl 
protected using a standard protocol involving treatment with TBSCl, DMAP and imidazole 
to give ethyl 2-(dimethoxyphosphoryl)-2-hydroxyacetate 1 as a fragrant colourless oil.21  
 




2.3.3 HWE Reaction for the Synthesis of Silyl-Enol Ether 199 
The HWE and related Wittig reactions are powerful synthetic procedures.  This is because 
the precursors are easily prepared, the reactions are high yielding and the alkene bond is 
normally generated in a regioselective and stereoselective manner.  For the HWE 
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reaction, initial reversible nucleophilic attack of the deprotonated phosphonate anion 205 
at the carbonyl bond of an aldehyde or ketone gives oxyanion 207 (Scheme 50).  The 
oxyanion 207 then decomposes irreversibly with oxygen transfer to the phosphorous atom 
via a 4-membered cyclic transition state 208 to afford an alkene 209.  This process is 
thermodynamically favourable because of the strength of the phosphorous oxygen double 
bond being formed (P=O bond energy is 575 kJmol-1).  There are two key advantages that 
the HWE reaction has over the Wittig reaction.  Firstly, the by-products of the HWE 
reaction are phosphonate salts 210, which are water soluble and so can be easily 
removed by an aqueous work-up.  Secondly, the HWE reaction can be conducted under 
milder conditions of base and temperature, which helps prevent racemisation of 
stereocentres in the α-position of the aldehyde, which was crucial for the successful 
synthesis of enantiopure D-KDG.22  
Scheme 50 HWE reaction mechanism 
 
Phosphonate ester 1 was deprotonated using LHMDS at -78 °C and then reacted with 
lactol 198 (Scheme 51).  After allowing the reaction mixture to stir-warm to room 
temperature over 20 minutes, the crude product was isolated and purified by silica gel 
chromatography to give silyl-enol ether 199 as an inconsequential mixture of E/Z-
geometrical isomers in 67% yield as a colourless oil. 





2.3.4 Silyl Protecting Group Deprotection 
Silyl-enol ether 199 was efficiently deprotected using a standard method involving 
treatment of 199 with an acetic acid buffered acetonitrile suspension of cesium fluoride to 
give α-keto ester anomers β-200 and α-200 in high yield and good purity requiring no 
further purification (Scheme 52).23 The structures of anomers β-200 and α-200 were 
proven by mass spectrometry and NMR spectroscopic data.  Thus a mass ion with m/z 
269.1001 corresponding to [M+Na]+ (required 269.0996) showed that the TBS protecting 
group had been cleanly removed, which was confirmed by 1H and 13C NMR spectroscopic 
analysis that showed no TBS peaks, and that the alkene bond of 199 was no longer 
present.  The 13C NMR spectrum had no ketone carbonyl resonances present, but there 
were two resonances at 109 ppm as expected for the C(2) hemiacetal of the two anomers.  
In order to identify the conformation of the two isomeric forms of 200 it was first necessary 
to deduce whether the hydroxyl substituent at the anomeric centre was in the equatorial or 
axial positions.  A survey of similar 2-keto-3-deoxy-ulosonic acid derivatives previously 
reported revealed that when the anomeric hydroxyl substituent is equatorial there is a 
significant downfield shift for the H3 equatorial resonance whilst the H3 axial resonance is 
unaffected.24-27   A chemical shift difference for H3 equatorial and axial resonances of 0.2-
0.4 ppm indicates that the anomeric hydroxyl substituent is in the equatorial position.  
Both isomers of 200 have chemical shift difference between H3 equatorial and axial 
resonances in this range (0.25 and 0.28 ppm), which indicates that β-200 has a 2C5 
conformation and α-200 has a 5C2 conformation.  Assignment of the major isomer of 200 
as β-200 followed from analysis of the coupling constants in the 1H NMR spectrum (Table 
6), since a large J(3a4), smaller J(3e4), and much smaller J(6a5) and J(6e5) were consistent with 
the structure of β-200 where H4 is axial and H5 is equatorial.   
Scheme 52 Deprotection of the silyl group of 199 
 
Table 6 1H NMR coupling constant of deprotection products β-200 and α-200 (JH,H in Hz) 
Compound J(3,3) J(3a,4) J(3e,4) J(6,6) J(6a,5) J(6e,5) 
β-200 13.8 8.3 6.0 12.5 2.9 2.0 
α-200 15.1 5.4 4.4 12.4 5.9 5.0 
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2.3.5 Acetonide and Ester Deprotection of α/β-200 for the Synthesis of D-KDG 
Deprotection of the acetonide and ester groups of α/β-200 was then carried out using the 
methodology painstakingly optimised for the synthesis of D-KDX (that will be fully 
discussed in the following chapter Section 3.2).  Therefore, treatment of α/β-200 with 
HCl(aq) at pH 1.9 followed by enzymatic hydrolysis of the ethyl ester 211 with Novozyme 
435 (Nov 435) gave D-KDG,     
   -16.8 (c 0.24, D2O at pH 6)(lit.
28     
   -21.1 (c 5.67, 
H2O)  This furnished D-KDG in an excellent yield of 85%, with spectral data matching that 
reported in the literature (Scheme 53). 
Scheme 53 Final steps in the synthesis of D-KDG 
 
D-KDG had been synthesised over four steps in 34% overall yield from inexpensive 
commercially available starting materials using a HWE reaction and novel global 
deprotection methodology.  Not only was this good methodology for the synthesis of D-
KDG, but by varying the chiral aldehyde starting materials for the initial HWE reaction 
other 2-keto-3-deoxy-ulosonic acid isomers such as D-KDGal could be easily accessed. 
 
2.4 Synthesis of D-KDGal  
When planning the synthesis of D-KDGal, D-tartaric acid 217 was identified as a 
commercially available C4-synthon with the correct stereochemistry to synthesise D-
KDGal.  Navarro had already shown that the acetonide protected diester of D-tartaric acid 
212 could be reduced to diol 213, followed by a one-pot oxidation and (Z)-selective Wittig 
reaction to give γ-hydroxyl mono-olefination product 214 (Scheme 54).29 Similarly, 
Seebach has shown that three molecular equivalents of DIBAL could be used to reduce 
212 to lactol 215, with a Wittig reaction then affording the γ-hydroxyl mono-olefination 
product 216 (Scheme 55).30 More recently, Tomioka developed Seebach’s strategy further 
by optimising the DIBAL reduction methodology and telescoping the reaction via addition 
of a deprotonated phosphonate ester.31 The reaction scope was shown to enable a range 
of phosphonate esters to be used and had been scaled-up from 1 mmol to a 40 mmol 




Scheme 54 Navarro methodology for the synthesis of α,β-unsaturated ester 214 
 
Scheme 55 Seebach methodology for the synthesis of α,β-unsaturated ester 216 
 
 
Therefore, the Tomioka protocol was employed to react acetonide diester 212 with 
phosphonate ester 1, successfully giving the desired product 218 in 36% yield over two 
steps (Scheme 56).  The low yield was a little disappointing, however two reactions had 
been carried out in one pot, using cheap starting materials, with pure product being 
efficiently separated from over-reduced and di-olefinated side-products by silica gel 
column chromatography. 
Scheme 56 Synthesis of Silyl-Enol Ether 218 
 
 
O-silyl deprotection was then carried out using the same CsF/AcOH methodology that 
was used to successfully deprotect the D-KDG precursor 199.  Spectroscopic analysis of 
the crude product revealed that the deprotection had been successful, but surprisingly 219 
was not a mixture of pyranose anomers as previously observed for D-KDG precursor 200.  
A peak at δ 192 ppm in the 13C NMR spectrum indicated that the free ketone was present, 
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and this was confirmed by the diastereotopic C(3)HAHB shifted to δ 3.1 ppm and 3.2 ppm 
because of their position α to a ketone functional group (downfield compared to the 
C(3)H2 peaks of α/β-200 found at δ 2.3-1.9 ppm).  The acetonide deprotection and ester 
hydrolysis method developed for the synthesis of D-KDG was then carried out to afford D-
KDGal in an overall yield of 17% over just four steps with     
   -5.5 (c 3.6, MeOH-H2O 
1:1)(lit.32     
   +7.3 (c 2.0, H2O), with spectroscopic data matching that reported in the 
literature (Scheme 57). 
Scheme 57 Final steps for the synthesis of D-KDGal 
 
 
2.5 Sugar Isomeric Composition in Solution 
Unlike most small molecules, sugars do not exist in solution as one structure, but instead 
can occur as mixtures of as many as seven isomers at equilibrium.  Attempts have been 
made to accurately predict the isomeric composition of sugars, using molecular 
mechanics to predict the free energies of isomers,33-35 but these methods often fail to 
systematically predict sugar composition in aqueous solution.  This is in part due to 
calculations modelling sugar molecules in the gas phase or in apolar solvents, rather than 
in aqueous solution.  In aqueous solution, solvation of the sugar molecules plays a 
significant role in stabilising different isomeric forms, which is a factor that cannot easily 
be predicted.  Therefore, to discover the isomeric composition of sugars in solution, there 
is still no substitute for experimental evidence.  In the past many methods have been 
applied to this problem: polarimetry;36 circular dichroism;37 IR;38 GLC;39 and Raman 
spectroscopy.40  By far the most regularly used technique has been 1H, 13C NMR 
spectroscopic analysis and in the case of phosphorylated sugars, 31P NMR.41-42 More 
recently, preparation of molecules containing 13C labels and integrating 13C NMR signals 
has proven to be a powerful technique for discovering the presence of minor isomers.43 
The isomeric composition of D-KDGal and D-KDG in solution was determined using a 
combination of 1D and 2D 1H and 13C NMR experiments.  The assignments of isomers for 
D-KDGal and D-KDG were confidently made for the pyranose and acyclic forms using 
their distinct coupling constants and chemical shifts respectively.  However, the 
assignments of the furanose isomers could only be made tentatively using the previous 
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assignments of Thiem who synthesised D-KDGal and D-KDG and reported 1H NMR 
spectra that closely matched our results.44 
 
2.5.1 D-KDGal Isomeric Composition in Solution  
The 1H NMR spectrum for D-KDGal is complicated by overlapping resonances of the five 
isomers that are present (Figure 7).  This could be deconvoluted by total correlation 
spectroscopy (TOCSY), where a resonance of a nucleus is correlated with chemical shifts 
of all nuclei of the same kind that are within its spin system. This technique allowed 
identification of which resonances pertained to which isomer, even when many 
resonances were overlapping in the parent 1H NMR spectrum (Figure 9).  The coupling 
constants for H3ax and H3eq to H4 allowed the major constituent isomer to be identified as 
the α-pyranose isomer, since the large H3ax to H4 coupling constant of 11.5 Hz must be 
due to an axial-axial interaction (Figure 8).  For sugars, pyranose forms are generally 
more stable than their corresponding furanose and acyclic isomers, so it was unsurprising 
that only minor amounts of the β–furanose, α-furanose and acyclic forms were present 
(11%, 9% and 3% of the isomeric compostition respectively).  Consideration of the 
structure of the α-pyranose isomer reveals why this isomer is favoured over the β-
pyranose isomer (72% and 5% of the isomeric composition respectively).  For the α-
pyranose isomer, apart from the C(2)-OH, all of the ring substituents are in equatorial 
positions, minimising 1,3-diaxial steric repulsions.  However, for the β-pyranose isomer, its 
lowest energy chair conformer has all three hydroxyl groups in unfavourable axial 
positions. 




Figure 8 1H NMR spectrum of D-KDGal with 1.6 ppm – 2.2 ppm region showing key 






















Figure 10 TOCSY 1H NMR spectra of D-KDGal (percentage of isomeric composition in 
parantheses) 
 
i.α-pyranose form (72%)-irradiated at 2.08 ppm 
 
 
ii. β-furanose form (11%)-irradiated at 1.60 ppm)  
 
iii. α-furanose form (9%)-irradiated at 4.38 ppm 
 
 
iv. β-pyranose form (5%)-irradiated at 2.45 ppm 
 





2.5.2 Isomeric composition of D-KDG in solution 
Again, TOCSY and COSY NMR analysis allowed the even more complicated 1H NMR 
spectrum of D-KDG to be deconvoluted (Figure 12 and 13).  The main isomer, making up 
45% of the isomeric mixture, was shown to be the β-pyranose ring form due to a large 
coupling constant for H3ax to H4 of 12.2 Hz as a result of H4 positioned in the axial position.  
The composition of isomers for D-KDG was found to be significantly different to that of D-
KDGal.  The β-pyranose isomer of D-KDG was not nearly as relatively stable as the α-
pyranose isomer of D-KDGal, which is due to the D-KDG β-pyranose isomer having its 
C(4) hydroxyl group in its axial position.  It is also interesting to note that there was no 
acyclic isomer present for D-KDG (cf. D-KDGal (3%)).  





It is interesting to compare these results with those obtained previously for D-sorbose 
(Figrue 14i) and D-fructose (Figure 14ii), 45-46 which are ketose ‘equivalents’ of D-KDGal 
and D-KDG respectively (Figure 14 (i) and (ii)).  It is striking that D-sorbose has the highest 
level of α-pyranose isomer (98%), just like D-KDGal, whilst D-fructose has its β-pyranose 
isomer as the major constituent (65%), but with substantial percentages of the furanose 




Figure 12 1H NMR spectrum of D-KDG in D2O 
 
Figure 13 TOCSY 1H NMR spectra of D-KDG (percentage of isomeric composition in 
parantheses) 
i. β-pyranose form (45%)-irradiated at 1.81 ppm  
 
ii. α-furanose form (22%)-irradiated at 2.49 ppm  
 
iii. β-furanose form (21%)-irradiated at 2.26 ppm  
 





Figure 14 Isomeric composition of (i) D-sorbose and (ii) D-fructose in solution 
(i) D-sorbose at 27 °C45 
 
 
(ii) D-fructose at 31 °C46 
 
 
2.6 Variation of the Isomeric Composition of D-KDG and D-KDGal with Temperature 
It has been shown that D-KDG and D-KDGal are efficiently catabolised by KDG aldolase.  
The mechanism of action for this aldolase, which has been substantiated by X-ray 
structures of substrates and intermediates bound to its active site, involves reaction of a 
lysine residue with the acylic isomer of the sugar to form a Schiff base intermediate, 
before a tyrosine mediated retro-aldol reaction occurs to catalyse reversible cleavage of 
the carbon-carbon bond (Scheme 58).47  Since the enzyme acts on the sugar in its acyclic 
form this prompts the question; how is it possible that D-KDG and D-KDGal are such good 
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substrates for this enzyme despite having a small percentage of their acyclic isomers 
present in aqueous solution?  
Scheme 58 Mechanism of KDG aldolase from S. solfataricus47 
 
It is known that temperature, solvent and time have an effect on the isomeric composition 
of sugars in solution.36  Since S. solfataricus is a hyperthermophilic archaeon that grows 
optimally at 80 °C, it was decided to determine how the isomer composition of sugars can 
change as a function of temperature, with the aim of determining whether more of the 
acyclic form predominates at higher temperatures.  A sample of each sugar was heated to 
the desired temperature and then left to equilibrate for one hour before acquiring a 
quantitative 1H NMR spectrum, the isomer ratio being determined by the relative peak 
integrals of the different isomeric forms.   
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The results proved most striking for D-KDG (Figure 15).  Increasing the temperature from 
25 °C to 60 °C gave a definite and gradual increase in the percentage of acyclic isomer 
present, from 0% at room temperature to 16% at 60 °C, with a concomitant decrease in 
the major β-pyranose isomer from 45% to 22%.  The same trend could be seen for D-
KDGal (Scheme 16); with the percentage of acyclic isomer increasing from 3% at room 
temperature to 16% at 60 °C, and the major α-pyranose isomer decreasing from 72% to 
48%.  The respective quantities of both α- and β-furanose isomers also increase with 
temperature for both D-KDG and D-KDGal, but to a lesser extent than that observed for 
the acyclic isomers. 
Figure 15 Isomeric composition as a function of temperature for D-KDG 
 
 
Figure 16 Isomeric composition as a function of temperature for D-KDGal 
 
 
The increase in percentage of acyclic and furanose isomers with temperature has not 
been reported previously for ulosonic acids, but it is interesting to note that the trend is 
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paralleled for aldoses and ketoses.48  For example, Lichtenthaler has reported that the 
isomeric ratios of α-D-glucopyranosyl-D-fructoses, were affected by temperature to varying 
extents in D2O, with a general increase in the percentage of furanose isomers observed 
as temperature increased.42  In addition, Serriani has published work on the effect of 
temperature on the isomeric composition of D-2-pentuloses (Figure 17 i and ii).49  He 
observed a similar trend for increased formation of acyclic isomer as observed for D-KDG 
and D-KDGal.  The trend to form a greater amount of acyclic isomer at higher temperature 
would be expected from considerations of entropy, whereby the acyclic form has greater 
conformational mobility and therefore becomes more energetically stable than the cyclic 
forms with increasing temperature.36  However, some studies have shown that the 
enthalpy term can also be significant: with the acyclic and furanose isomers having higher 
enthalpy and increasing in proportion with increasing temperature.50  Furthermore, the ring 
closure formation of hemiacetals is exothermic and therefore the equilibrium towards the 
cyclised products is favoured at lower temperature.36 
The increased acyclic percentage composition of these 3-deoxy-hex-2-ulosonic acids at 
raised temperatures goes some way to explaining how KDG aldolase can efficiently 
catabolise these sugars.  However, whilst conducting the variable temperature 1H NMR 
experiments it was also demonstrated that the rate of mutarotation of these 2-keto-3-
deoxy-ulosonic acids was relatively rapid at room temperature in D2O, since the 
percentage isomeric composition five minutes after raising the solution temperature from 
25 °C to 40 °C, matched the isomeric composition after one hour.  Therefore, con-
sumption of the small amount of open-chair isomer of D-KDG and D-KDGal present will 
perturb the isomer equilibrium, resulting in mutarotation to afford more open-chain form, 
thus allowing the retro-aldol reaction to go to completion. 
Figure 17 Results reported by Serianni on the isomeric composition of D-2-pentuloses as 









Conditions: 0.3M pentulose, 15% (v/v) D2O, 50 mM acetate buffer, pH 4.0. 
 
However, it must also be noted that although the mechanism of KDG aldolase has been 
reported to proceed via an acyclic intermediate,47 initial coordination of these sugars to the 
protein in one or other cyclic forms followed by a subsequent protein induced ring opening 
event cannot be discounted.  Indeed Kragl has concluded that this type of initial 
coordination event occurs for the sialic acid aldolase catalysed retro-aldol reaction,51 citing 
NMR results from Brossmer as further evidence.52  Activation of this kind by KDG aldolase 
would further explain how the enzyme can efficiently catabolise these 3-deoxy-hex-2-
ulosonic acids efficiently.   
 
2.7 Conclusion 
D-KDG and D-KDGal have been synthesised via a concise four step route from naturally 
occurring sugar substrates.  These routes make use of HWE reactions between the anion 
of ethyl 2-((tert-butyldimethylsilyl)oxy)-2-(dimethoxy-phosphoryl) acetate 1 with 
enantiopure sugar-derived aldehydes to afford silyl-enol ethers that could be globally 
deprotected to give the target 2-keto-3-deoxy-ulosonic acids in high purity.  This synthetic 
methodology will be of interest to the wider biochemistry community since it should 
provide efficient routes to this class of α-keto sugars that are ubiquitous metabolites for 
archaea, bacteria and eukarya.   
These C6-sugars are now being used as substrates for the directed evolution of a 
stereochemically promiscuous aldolase from S. solfataricus to develop mutant aldolases 
with high diastereoselectivity for the aldol reaction of D-glyceraldehyde 6 and pyruvate 7 to 
exclusively afford either D-KDG or D-KDGal (Section 1.4).  This project has already begun 
in collaboration with members of the CER at Bath where libraries of 104–105 aldolase 
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mutants have been generated by ep-PCR.  The initial validation of these libraries has 
been carried out by transforming plasmids into a pyruvate kinase deficient E. coli 
auxotroph and their growth on minimal media supplemented with pyruvate revealed a 
number of extant colonies after incubation for 72 hours.  The growth of the mutant E.coli 
auxotroph colonies on pyruvate supplemented minimal media demonstrates that these E. 
coli auxotroph libraries are viable and therefore the directed evolution project screening 
for retro-aldolase activity towards D-KDG and D-KDGal can now begin.  Daughter plates 
will be prepared with one plate supplemented with D-KDG and the other with D-KDGal, 
with comparison studies identifying mutant colonies that are diastereoselective in the 
retro-aldol direction.  The principle of microscopic reversibility then predicts that a mutant 
KDG aldolase that catalyses a diastereoselective retro-aldol reaction, will also catalyse a 
stereoselective aldol condensation reaction.  This will be confirmed by identifying and 
purifying the aldolase gene sequence of diastereoselective mutant colonies and screening 
the resultant mutant aldolases for reaction in the aldol condensation direction of D-
glyceraldehyde 6 with pyruvate 7.  If the high-throughput screening methodology is 
successful for this directed evolution towards D-KDG and D-KDGal, the same 
methodology will then be used to screen for mutants with increased substrate scope, in 
particular to discover mutants that accept aldose substrates with increased chain length or 
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As described in Section 1.5, previous studies into the metabolism of D-xylose 8 and L-
arabinose 9 by the archaeon S. solfataricus had shown that some of the enzymes 
involved in their metabolism were promiscuous towards these sugars and their 
metabolites.  In order to confirm this hypothesis, efficient stereoselective syntheses of D-
KDX and L-KDA (Figure 18) are now described, and the kinetic parameters of KDG 
aldolase (isolated from S. solfataricus) for the retro-aldol cleavage of these two 
enantiomers determined.1 
Figure 18 Structures of the enantiomers D-KDX and L-KDA 
 
 
3.2 Synthesis of D-KDX 
It was decided to apply the methodology developed in the previous chapter for the 
synthesis of D-KDG and D-KDGal to the synthesis of the C5-sugar D-KDX (Scheme 59).  
Therefore, D-glyceraldehyde acetonide 181 would be synthesised and reacted with the 
HWE phosphonate substrate 1 to furnish the protected C5-sugar 222.  This would then be 
globally deprotected to furnish D-KDX in just five steps from D-mannitol 179. 




3.2.1 Horner-Wadsworth-Emmons reaction for the synthesis of D-KDX-acetonide 
ethyl ester 223 
Phosphonate ester 1 was deprotonated using LHMDS at -78 °C and then reacted with D-
glyceraldehyde acetonide 181 to give an inconsequential mixture of (E)- and (Z)-
geometrical isomers of silyl-enol ester 222 in good yield. Desilylation using CsF then gave 
α-keto-ester 223 in high yield, with no further purification required (Scheme 60).  
Scheme 60 HWE step 
 
3.2.2 Deprotection Attempts 
All that remained for the successful synthesis of D-KDX was the removal of the acetonide 
protecting group and hydrolysis of the ester functionality.  Ordinarily, these transform-
ations are straightforward reactions that have been achieved using a host of different 
reagents and reaction conditions.  However, D-KDX proved to be an extremely 
challenging and elusive target that was found to be unstable under many of the conditions 
trialed. 
Attempted base- and acid-promoted deprotection of α-keto ester 223 
Initially a series of acidic deprotection protocols were trialed, with the expectation that the 
acetonide deprotection step would proceed with concomitant ester hydrolysis.  For 
example, after stirring α-keto ester 223 in 0.1 M HCl(aq)/acetonitrile for two hours, the 
crude reaction product was concentrated and partitioned between water and ethyl acetate.  
Analysis of the organic extracts showed that ester 224 had been formed in good yield 
after acetonide deprotection.  Encouraged by this early success the reaction was repeated 
with a longer reaction time of 24 hours.  However, analysis of the organic extracts 
revealed no organic products.  Furthermore, when the aqueous phase was concentrated 
and analysed in D2O by 
1H NMR spectroscopy, a complex mixture of products was 
observed.  There were numerous peaks between δ 5.0-7.5 ppm at chemical shifts 
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corresponding to alkenyl protons, suggesting that unwanted dehydration reactions had 
occurred.  This was not wholly unexpected, since it has previously been observed that D-
KDX is prone to dehydration under acidic conditions.2  It was tentatively suggested, from 
analysis of the 1H and 13C NMR spectra, that these dehydration products were furan-2-
carboxylic acid 225 and mono-dehydration products 226 and 227 (Scheme 61).  Indeed 
this conclusion was later justified by further decomposition studies on an authentic sample 
of D-KDX, vide infra. 
Scheme 61 Attempted acid- and base-mediated deprotection of α-keto ester 223 
 
Given the problems encountered with this deprotection reaction, subsequent trials were 
conducted in deuterated solvents with levels of substrate conversion and product 
compositions monitored by in-process 1H NMR spectroscopic analysis.  For acidic 
conditions, a range of organic and mineral acids (p-TSA, Ambelite IR 120+, H2SO4, HCl) 
were trialed, which resulted in elimination reactions occurring simultaneously with 
acetonide deprotection and saponification.  Unfortunately, a series of basic ester 
hydrolysis methods were also unfruitful, giving complex mixtures of products that did not 
contain any D-KDX. 
Attempted hydrogenolytic deprotection 
It was well known that benzyl esters could be reduced under hydrogenation conditions to 
their corresponding carboxylic acid derivatives, which in the proposed synthesis of D-KDX 
would obviate the problematic acidic and basic hydrolysis methods.  Therefore, 
phosphonate ester 1 was transesterified with benzyl alcohol to give benzyl ester 228.  
Elaboration of 228, using the HWE/desilylation methodology already described, 
successfully gave α-keto benzyl ester 229 in good yield (Scheme 62).  Unfortunately, 
hydrogenolysis of 229 to remove the benzyl substituent proved problematic.  Stirring an 
ethanolic mixture of 229 with 10% palladium on carbon catalyst under an atmosphere of 
H2 for one hour resulted in all of the starting material being consumed to afford polar 
baseline products.  After work-up, analysis of the crude product by 1H NMR clearly 
showed that there were no aromatic proton peaks present, confirming the successful 
removal of the benzyl group.  However, the NMR spectroscopic also data indicated the 
formation of a complex mixture of products that, despite having peaks in the correct  
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regions, did not match the 1H or 13C NMR spectra of D-KDX.  
Scheme 62 Synthesis of benzyl ester 229 and its attempted hydrogenolytic deprotection 
 
3.2.3 Lipase-Catalysed Hydrolysis of α-Keto Ester 223 
After the failure of both acid- and base-catalysed hydrolysis and hydrogenolytic methods, 
an enzyme-catalysed hydrolysis method was investigated.  It was hoped that by trialing a 
range of commercially available lipases, an enzyme could be found that would efficiently 
hydrolyse the ethyl ester of 223 to afford D-KDX, under very mild conditions.  Lipases are 
a special type of esterase that catalyse the hydrolysis of esters that are active at 
lipid/water interfaces, thereby allowing them to catalyse the hydrolysis of water-insoluble 
substrates. There is great potential for the use of lipases for organic synthesis, since they 
are environmentally friendly, recyclable biocatalysts that operate under mild reaction 
conditions.  Lipases make up a significant part of commercial enzyme sales as part of an 
industry that is valued at over $2 billion/year.3  They are chiefly used in the detergent 
industry, paper manufacturing and food production.  In organic synthesis they have 
demonstrated efficacy as catalysts for the selective hydrolysis of esters,4 regioselective 
esterification and transesterification,5 and even catalyse some unexpected reactions such 
as the aldol and Michael reactions.6 
Lipase B from Candida antarctica (CalB) is a commercially available lipase that has 
received particular interest in recent years.  It was originally isolated from a strain of 
basidomycetous yeast found in Antarctica, as its name suggests.  C. antarctica produces 
two lipases, named A and B.  Lipase A is a calcium dependant enzyme that is highly 
thermostable and active towards triglycerides, but has low activity for the hydrolysis of 
simple esters.7  Contrastingly, CalB requires no co-factors, has lower thermostability and 
boasts a broad specificity profile towards esters, amides and thiols.8  CalB is composed of 
317 amino acids with a molecular weight of 33 kD and a pI of 6.0.  It is a robust protein 
with optimum activity at pH 7.0, but is stable in the range of pH 3.5-9.5.  Depending on the 
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pH of the reaction media it denatures in the range of 50-60 °C and is available as a pure 
protein, or immobilised onto a solid support as Novozym 435 (Nov 435) that is comprised 
of recombinant CalB supported on a macroporous acrylic resin.  Immobilized CalB 
exhibits similar activity to that of the free recombinant enzyme, but with an increased 
thermal stability that enables it to be used at temperatures as high as 60-80 °C.9  The 
tertiary structure of CalB has an α/β hydrolase fold and its mode of action, like other 
lipases, is comparable to that of a serine protease.10  The active site is comprised of a flat 
hydrophobic region with a Ser-His-Asp “catalytic triad” playing a key role in the catalytic 
cycle (Scheme 63).  Initially, the histamine residue helps to remove a proton from the 
serine alcohol, allowing the serine oxygen anion to attack the ester carbonyl bond.  The 
tetrahedral intermediate is stabilised by hydrogen bonding to the negatively charged 
oxygen atom as it sits in an ‘oxyanion’ hole.11  Expulsion of the alcohol group leaves an 
acylated enzyme intermediate, which is then attacked by a water molecule to give a new 
enzyme tetrahedral intermediate stabilised by hydrogen bonding to the histamine residue.  
Re-formation of the carbonyl bond gives the acid product and restores the catalytically 
active serine nucleophile of the lipase to its free state. 




Initially CalB was added to 223 in a solution of toluene-d8 1:20 D2O (v/v) buffered with 
potassium phosphate to pH 7.5 (Scheme 64).  After 24 hours, in-process 1H NMR 
spectroscopic analysis revealed the presence of ethanol and acetone, the absence of 
starting material and formation of D-KDX with only minor amounts of elimination by-
products.  It was apparent that as the ester group of 223 was hydrolysed to afford its 
corresponding acid, the resulting drop in pH from 7.5 to 1.0 was also sufficient to result in 
concomitant acetonide deprotection to afford D-KDX. 
Next, Nov 435 was used in place of CalB to allow for ease of removal of the enzyme by 
filtration, with analysis revealing a crude product composition that was identical to the 
previous trial using soluble CalB.  Although the enzyme was successful in achieving both 
transformations in one pot on a trial scale, it was thought that the low reaction pH might 
cause the enzyme to denature and lose activity on a larger scale.  Therefore, the method 
was further developed into a one pot, two step procedure suitable for scale-up.  Firstly, 
223 was stirred for 16 hours in a dilute hydrochloric acid solution (pH 1.9).  After that time, 
in-process 1H NMR showed complete removal of the acetonide protecting group to afford 
diol 224, with no elimination by-products having been formed.  The reaction mixture was 
then neutralised (pH 7.0) with 1.0 M NaOH(aq) and warmed to 40 °C. Following the 
addition of Nov 435, the pH was maintained between 6.0-7.5 via dropwise addition of 0.1 
M NaOH(aq).  The reaction was monitored by in-process 1H NMR spectroscopy that 
revealed clean hydrolysis after just three hours, with no elimination by-products present.  
Scheme 64 Successful two-step deprotection and hydrolysis of α-keto ester 223 to afford 
D-KDX 
 
Attention was then turned towards the purification of D-KDX, since D-KDX of >98% purity 
was required for subsequent kinetic studies using KDG aldolase.  Earlier attempts to 
purify D-KDX and L-KDA had not been successful, presumably due to the sugars’ 
propensity to eliminate and polymerise under acidic conditions.12  Initially, purification by 
ion-exchange chromatography using Dowex 1x8 resin in its acidic form and eluting with 
water/formic acid 0.05-1.0 M was trialed.  HPLC analysis of the column fractions showed 
that pure product came off at eluent concentrations of 0.5-0.6 M formic acid. However, 
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concentration of these fractions gave impure oils that were contaminated with the 
elimination products previously observed.  Elimination occurred despite addition of excess 
water to the column fractions in an attempt to azeotrope off the formic acid.  After a 
meticulous search of the literature, it was found that 2-keto-3-deoxy-D-manno-octulosonic 
acid 16 had been chromatographed on silica gel TLC plates using the very polar eluent 
system of CH2Cl2-MeOH-H2O, 5:5:1.
13  It was very pleasing to find that purification of 
crude D-KDX by silica gel chromatography using this solvent system afforded a sample of 
pure product, without the formation of elimination products upon concentration of the 
fractions in vacuo. 
3.2.4 Impurities arising from acid- and base-catalysed decomposition of D-KDX 
In order to more fully understand why ester hydrolysis had proven unsuccessful using 
BrØnsted acids and bases, the stability of D-KDX under acidic conditions was investigated.  
D-KDX was stirred at room temperature in a D2O solution carefully acidified with conc. HCl 
to pH 1 and monitored at regular intervals by 1H NMR spectroscopic analysis (Scheme 
65).  In-process analysis after 14 hours showed that most of the D-KDX had decomposed, 
with the main constituent of the mixture being the mono-dehydration product 226.  After 
48 hours, all of the D-KDX had been consumed, with the major constituent of the product 
mixture still being the mono-dehydration product 226.  However, a smaller quantity of 
furan-2-carboxylic acid 225 was present, as well as multiple products with proton 
resonances in the range of 1.5-4.0 ppm, which are likely to be due to condensation 
products arising from competing intermolecular reactions between D-KDX, 226 and 225. 
Scheme 65 Products arising from acid treatment of D-KDX 
 
When D-KDX was treated with LiOH in D2O (0.2 M solution), it went on to form a complex 
mixture of products within 1.5 hours.  The structures of these products could not be fully 
assigned, although it could be concluded that D-KDX was definitely unstable under these 
basic aqueous conditions, perhaps decomposing via base-catalysed retro-aldol reactions.  
The 1H NMR spectra from these reactions were compared to the earlier acid- and base-
catalysed acetonide deprotection and ester hydrolysis trials on α-keto ester 223.  There 
was a close correlation between the 1H NMR spectra of both sets of experiments, which 
confirms that the instability of D-KDX under these acidic and basic reaction conditions was 
the reason for their failure to furnish D-KDX. 
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3.3 Synthesis of L-KDA  
The HWE method developed for the synthesis of D-KDX was then applied to the synthesis 
of its enantiomer L-KDA.  The correct configuration for L-KDA could be achieved using L-
glyceraldehyde acetonide 234 as a substrate for the HWE reaction.  
 
3.3.1 Synthesis of L-glyceraldehyde acetonide 234 
L-Glyceraldehyde acetonide 234 was not commercially available and so it was necessary 
to synthesise it from a suitable chiral pool starting material.  The literature synthesis of 223 
in three steps from L-ascorbic acid 230 was chosen for its efficiency and the ready 
availability of cheap starting materials and reagents.14 
L-Ascorbic acid 230 was first hydrogenated in an autoclave, using 150 psi of H2 pressure 
and a catalytic quantity of 10% Pd/C.  After recrystallisation from EtOAc/MeOH, lactone 
231 was isolated as a white crystalline solid in good yield (Scheme 66).  Lactone 231 was 
then treated with 1.3 equivalents of 2-methoxypropene 232 and a catalytic quantity of p-
TSA in anhydrous DMF.  This resulted in selective derivatisation of the terminal diol of 
231, rather than the internal diol fragment.  The resultant acetonide 233 was allowed to 
react directly, without further purification, with sodium metaperiodate in water to give L-
glyceraldehyde acetonide 234 in good yield with     
   -50 (c 0.5, CDCl3) (lit.
15     
   -54.9 
(c 3.4, CHCl3)).  The percentage enantiomeric excess was confirmed by reductive 
amination with (R)-α-methylbenzylamine, whereupon analysis of the product by 1H NMR 
spectroscopy revealed the presence of a single diastereomer (>97% d.e.). 





3.3.2 Synthesis and spectroscopic anaylsis of L-KDA 
Aldehyde 234 was then used as a substrate to prepare L-KDA using the 
HWE/deprotection methodology previously developed for D-KDX (Scheme 67).  L-KDX 
was synthesised and purified in good overall yield, with analytical data (MS, IR, 1H and 13C 
NMR spectra) identical to those previously obtained for D-KDX. 





3.4 Isomeric Composition of D-KDX/L-KDA in Solution 
The matching 1H and 13C NMR spectra of D-KDX and L-KDA revealed that these sugars 
exist as a mixture of three isomers in solution (Figure 19).  The COSY spectrum of D-KDX 
made it possible to assign the peaks belonging to each isomer and confirmed that three 
rapidly interconverting isomers existed in solution (Figure 20).  By comparing the 1H 
integrals of the CH2 peaks, which were clearly resolved in the 500 MHz NMR spectrum, it 
was possible to measure the relative proportions of these three isomers in D2O.  They 
existed in a ratio of 30:33:37 (acyclic:α-furanose:β-furanose) at 25 °C and pH 7.  The 
acyclic isomer was clearly confirmed to be the α-keto form from the 13C NMR spectrum, 
exhibiting a peak at 203 ppm due to the ketone carbon, with two peaks for α- and β-









Figure 20 COSY spectrum of D-KDX revealing interactions of resonances corresponding 













Resonances were assigned as the α- and β-furanose isomers by comparison with the 
chemical shifts previously observed for the α- and β-furanose isomers of D-KDG.  
Therefore, 1H NMR spectroscopic resonances at 2.39 ppm and 1.97 ppm were assigned 
to the C(3)H2 of the α-furanose isomer since they closely matched the C(3)H2 α-furanose 
resonances of the sodium salt of D-KDG (2.48 ppm and 1.93 ppm).  Conversely, the 
overlapping resonance centred at 2.23 ppm matched the chemical shift of the C(3)H2 
resonances of the β-furanose isomer of the sodium salt of D-KDG (2.29 ppm and 2.24 
ppm).  For D-KDX and L-KDA it appears that the carboxylate substituent must help 
stabilise the acyclic form, since its ethyl ester derivative 232 (Section 3.2.2) exhibited 
none of the acyclic isomer.  The relatively large quantity of acyclic isomer also contrasts 
with the low quantities of acyclic isomer found for D-KDG (0%) and D-KDGal (3%) 
(Sections 2.6.1 and 2.6.2), which is probably due to the Thorpe-Ingold effect, where the 
extra ring substituent of the C6-sugars favours ring closure.  However, D-KDX and L-KDA 
are not anomalous in having significant quantities of their acyclic isomers present in 
solution, as similar mixtures of cyclic and acyclic isomers have been seen previously for 
the 2-pentuloses D-ribulose 238 and D-xylulose 239,16-17 whilst for D-threose 240,18 the 
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acyclic isomer was present mainly in its hydrated (gem diol) form (Figure 21).  Indeed, for 
most aldose sugars it is known that in solution the more reactive aldehyde group of the 
acyclic form exists mostly in its hydrated form, but for ketose sugars the keto form 
dominates with no substantial quantities of hydrate.19-20   










 composition at 20 °C; 
b
 composition at 26 °C. 
 
3.5 Variation of the Isomeric Composition of D-KDX and L-KDA with Temperature 
Increasing the temperature resulted in an increase in the percentage of acyclic keto 
isomers of D-KDX/L-KDA, as previously observed for the hexose sugars D-KDG and D-
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KDGal (Section 2.7).  Specifically, 1H NMR spectroscopic analysis revealed that the 
percentage of acyclic isomer in D2O increased from 33% at room temperature to 51% at 
60 °C at the expense of both furanose isomeric forms (Figure 22). 




Conditions: 0.35M sugar, D2O, pH 7.0 
 
3.6 Confirmation of Enantiopurity of D-KDX and L-KDA 
Samples of D-KDX and L-KDA which were prepared using the methods described above 
had analytical data that confirmed that their assigned structures were correct.  However, 
since they were going to be used as enantiomerically pure substrates to assay KDG 
aldolase activity, it was crucial that their enantiopurity was also confirmed.  Somewhat 
disturbingly, when their specific rotation was recorded for milligram quantities of each 
enantiomer in H2O, the      readings were 0.01 and 0.00 for D-KDX and L-KDA, 
respectively!  It was unclear whether this was due to the relatively low concentration (c) 
values used, or whether racemisation of the sugars’ stereocentres had occurred during 
their syntheses. 
The synthetic route was re-examined in order to identify any steps that could potentially 
cause racemisation of the C(4) stereocentres provided by D-mannitol and L-ascorbic acid.  
Chiral derivatisation using enantiomerically pure (R)-α-methyl-benzylamine had confirmed 
that both the D- and L-glyceraldehyde acetonide intermediates were enantiomerically pure, 
so any racemisation event must have occurred after this point.  LHMDS was used as the 
base for the HWE coupling reaction, which could potentially racemise the alpha 
stereocentre of each aldehyde.  This was unlikely, however since HWE reactions had 
previously been carried out successfully without racemisation with aldehydes bearing an 
acidic α-stereocentre (Scheme 68).21-23   
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Scheme 68 Literature examples of racemisation free HWE reactions with aldehydes 









Further assurance was given by the observation that no epimerisation had been observed 
in the HWE reaction used for the syntheses of D-KDG and D-KDGal, which would have 
led to diastereomeric products that would have been detectable in the 1H NMR spectra of 
their crude reaction products.  For the three subsequent deprotection steps, the relatively 
mild conditions should not have led to any racemisation, especially as the stereocentre 
was no longer acidic.  Indeed, the α-keto ester products 223 and 237 from CsF/AcOH-
mediated deprotection had approximately equal and opposite optical rotation values [223-
    
   +12 (c 1.25, CH2Cl2); 237-    
   -8.9 (c 0.45, CH2Cl2)] confirming that the 
enantiopurity was likely to have been preserved throughout that reaction.  However, it 
could not be discounted that racemisation of D-KDX and L-KDA had occurred in the 
subsequent acid-catalysed deprotection reaction via a reversible retro-aldol/aldol process. 
Once the pentose sugars had been re-synthesised on a larger scale, a screen of different 
solvent systems and the use of a higher concentration of sugar confirmed that D-KDX and 
L-KDA  were optically active, giving optical rotation values of:     
   +13.5 (c 4.75, H2O-
MeOH, 1:1) for D-KDX; and     
   -13.3 (c 4.95, H2O-MeOH, 1:1) for L-KDA.  The fact that 
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these values were essentially equal and opposite in magnitude, strongly suggests that 
both D-KDX and L-KDA had been prepared in enantiopure form. 
To gather further evidence for the enantiomeric purity of D-KDX and L-KDA, it was 
decided to record their optical rotatory dispersion (ORD) spectra (Figure 23).  ORD 
spectra are dependent on the refractive index and also the absorption index of each 
isomer and normally give a distinctive Cotton effect close to the wavelength that a 
functional group absorbs at in the UV-vis spectrum.  By far the most extensive studies of 
ORD spectra have been conducted on ketones, since the carbonyl chromophore normally 
absorbs at ca. 280-290 nm and the absorption is not usually strong enough to interfere 
with the ORD measurement.  These ORD measurements have been widely used to probe 
structural features such as absolute configuration, the conformation of cyclic ketones in 
solution, absolute stereochemistry and the extent of ketal formation in solution.24  The 
ORD spectra of α-keto carboxylic acids have also been studied by a number of groups 
with one or two bands in the range of 207-245 nm being observed and attributed to the 
n→* absorption of different conformers.25-26 
The key observation for the ORD spectra recorded for D-KDX and L-KDA were that the 
anomalous dispersion curves were equal and opposite in sign.  When considered 
alongside the      readings that were equal and opposite in sign, this strongly implies that 
D-KDX and L-KDA had been successfully synthesised as pure enantiomers. 













205 230 255 280 305 330 355 380









Looking at the dispersion curve of L-KDA, it can be seen that it exhibits a positive Cotton 
effect with a peak at 237 nm and a trough at 213 nm.  The interpretation of this ORD 
curve is not trivial since the three isomeric forms of L-KDA present in solution could all be 
making contributions.  However, previous work by the Redmond group, who managed to 
isolate pure anomers of the stable methylated of 3-deoxy-D-manno-oct-2-ulosonic acid, α-
247 and β-247 (Figure 24),27 were useful in helping with the interpretation.  They found 
that α-247 exhibited a positive Cotton effect at 210 nm, whilst β-247 exhibited a mixed 
Cotton effect with a trough at 203 nm and a peak at 226 nm.  Therefore, it can be 
speculated that the contribution of the signs of the ORD curves of the α-and β-furanose 
isomers of L-KDA at 215 nm are equal and opposite and therefore combine to cancel 
each other out, leaving a small positive contribution to the absorption spectrum from the β-
furanose isomer at 226 nm. This combination of absorptions is then superimposed onto 
the contribution to the ORD spectrum from the acyclic isomer that contributes strongly 
towards the strong negative absorption at 215 nm. 





3.7 Kinetic Studies of KDG aldolase towards D-KDX and L-KDA 
The kinetic parameters of KDG aldolase towards pure D-KDX and L-KDA for the retro-
aldol cleavage reaction were then determined by running an assay over a range of sugar 
concentrations with all other variables kept constant.  Two reactions were run for every 
concentration of sugar: one with KDG aldolase added at To; and a control that had no 
enzyme added.  Each pair of reactions were conducted at 50 °C and stopped after ten 
minutes by the addition of aqueous trichloroacetic acid solution (10 μl, 12% w/v). The 
quantity of sugar starting material was then determined by a modified thiobarbituric acid  
(TBA, 249) assay (Scheme 69), where the 1,2-diol C-C bond of D-KDX or L-KDA was 
cleaved by periodic acid, sodium arsenite added to quench the reaction, and then an aldol 
condensation reaction between TBA 249 and the aldehyde moiety of 2,4-dioxobutanoic 
acid 248 carried out to afford 250 that has a chromophore at 549 nm.28-29 
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Scheme 69 Thiobarbituric acid assay used for determination of the activity of KDG 
aldolase towards D-KDX or L-KDA 
 
 
The absorbance of 250 at 549 nm was recorded for each of the reactions, and the initial 
rate (V) was determined for each concentration by calculating the difference in the amount 
of 250 present with and without KDG aldolase.  The KDG aldolase reaction is a single 
substrate reaction (Equation 1) and therefore the Michaelis-Menten equation (Equation 2) 
is obeyed.  
Equation 1 Single substrate enzyme reaction 
  
 
Equation 2 Michaelis-Menten equation 
 
V   =   (Vmax.[S]) / (Km+[S]) 
 
To determine the Michaelis-Menten constant (Km) and the maximum rate (Vmax), the 
kinetic assay results were used to make a Direct Linear plot (Equation 3),30 which is 
derived from the Michaelis-Menten equation. 
Equation 3 Direct Linear plot equation 
 
V   =   ((V.Km) / [S]) + V 




Using equation 3, two points were plotted for each sugar concentration:    
    When     Km = 0  Vmax = V 
    When  Vmax = 0      Km = -[S] 
Plotting lines through these two points for each sugar concentration gave lines that 
dissected each other near to one point on the graph, with the x- and y-axis values for this 
dissection point corresponding to Km and Vmax, respectively (Figure 25).  The values for 
Km and Vmax may also be determined using other plots derived from the Michaelis-Menten 
equation, such as the Hanes-Wolfe plot, Lineweaver-Burk and the Eadie-Hofstee plots,31 
however the Direct Linear plot is thought to give a statistically more accurate value for 
these two kinetic parameters.30  A Direct Linear plot for determination of Km and Vmax for 
D-KDX/L-KDA is presented below (Table 7 and Figure 25).  In practice, the Direct Linear 
plot and analysis were calculated using the Enzpack programme (version 1.4, Elsevier 
Biosoft), which also reports the values for Km and Vmax found using the Eadie-Hofstee, 
Hanes-Wolfe and Lineweaver-Burk plots for comparison.    
Table 7 TBA assay results for D-KDX/L-KDA 
Entry 1 2 3 4 5 6 7 8 
[D-KDX/L-KDA] 
(mMol) 
2.6 5 7.4 10 20 30 50 70 
Absorbance 0.056 0.090 0.120 0.129 0.205 0.223 0.235 0.292 
 





The Michaelis-Menten parameters Vmax and Km derived from the Direct Linear plot define 
the catalytic power of an enzyme:  
 Vmax is the maximum velocity when all the enzyme active sites are saturated with 
substrate and the turnover number (kcat) can be determined from Vmax when the 
enzyme mass, concentration and active sites per enzyme are known (Equation 4).  
Equation 4 Rate equation for Vmax 
Vmax   =   kcat [Eo] 
 Km is made up of three constants (Equation 5) and is inversely proportional to the 
affinity of the substrate for the enzyme active site (Equations 1 and 6).  However, 
when k2 is low relative to k-1, Km is a direct measure of the inverse of the enzyme 
affinity for the substrate.  When Km is a high value the catalytic efficiency kcat is low 
(Equation 7). 
Equation 5 Rate constants making-up Km 
 
Km   =   (k-1 + k2) / k1 
Equation 6 Relationship of Km to enzyme/substrate affinity 
 
Km       k-1 / k1 
Equation 7 Catalytic efficiency (kcat) 
 
kcat   =   Vmax / Km 
 
Michaelis-Menten kinetics were obeyed at 50 °C for both D-KDX and L-KDA, with kinetic 
parameters determined using the Direct Linear plot (Table 8).  D-KDX has a higher Km 
value, but this generally lower affinity for the substrate contrasts with a higher turnover 
number.  Consequently, the catalytic efficiencies for both enantiomers are comparable 
suggesting that KDG aldolase will efficiently catabolise either enantiomer within S. 
solfataricus.  When compared to the kinetic parameters previously reported for D-KDG 
and D-KDGal, it can be seen that catabolism by KDG aldolase of these pentose sugars is 
similar in catalytic efficiency to these hexose sugars.  This is especially true considering 
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the fact that the assays for D-KDG and D-KDGal were originally run at 60 °C and would be 
expected to give lower values for the turnover number than an assay run at 50 °C [the 
kinetic parameters for D-KDX and L-KDA were not recorded at 60 °C as it was thought 
that the enzyme reaction would proceed at too fast a rate to record an accurate value for 
the initial rate (V)]. 
Table 8 Summary of kinetic parameters for KDG aldolase towards D-KDX, L-KDA, D-KDG 
and D-KDGal 






1 D-KDXa 33.3(±3.3) 15.0(±1.1) 0.45(±0.06) 
2 L-KDAa 17.6(±1.1) 9.3(±0.4) 0.53(±0.04) 
4 D-KDGb 25.7(±1.2) 28.2(±1.4) 1.10(±0.08) 
5 D-KDGalb 9.9(±0.4) 6.8(±0.2) 0.70(±0.04) 
a. Reactions were carried out at 50 °C in 50 mM sodium phosphate buffer, pH 6.0. 
b. Reactions were carried out at 60 °C in 50 mM sodium phosphate buffer, pH 6.0, containing 5 mM fructose-
1,6-bisphosphate, 0.2 mM NADH, and an excess of B. stearothermophilus L-lactic dehydrogenase (coupled 
enzyme assay showing the formation of 2-keto-3-deoxy ulosonic acid by the UV absorbance at 340 nm of 




Therefore, it can be concluded that KDG aldolase is able to not only catalyse catabolism 
of the diastereomeric C6-sugars D-KDG and D-KDGal, but also the enantiomeric C5-
sugars D-KDX and L-KDA that are the metabolic intermediates of the two most naturally 
abundant pentose sugars, D-xylose 8 and L-arabinose 9.  Most metabolic pathways for 
these sugars are highly conserved, and show excellent stereoselectivity and exclusive 
specificity profiles for a single sugar isomer.32  By demonstrating that KDG aldolase 
exhibits activity towards these enantiomeric sugars, it has been shown that KDG aldolase 
falls into the smaller category of unselective enzymes that have a broad specificity profile 
for their natural substrates.  When this is placed in context with previous studies on other 
organisms, it can be concluded that the central metabolic pathway of S. solfataricus is 
inherently “promiscuous” in nature.  At this stage it is unclear whether this promiscuity is a 
survival adaption that the archaeon has evolved to best survive in its extreme 





3.8 KDG Aldolase Synthesis of D-KDX/L-KDA 
Both D-KDX and L-KDA were catabolised by KDG aldolase with comparable kinetic 
parameters, therefore from consideration of the principle of microscopic reversibility it was 
expected that a forward aldol reaction of pyruvate 7 and glycolaldehyde 14 would produce 
an approximately racemic aldol product.  It was decided to test this hypothesis by 
conducting a KDG aldolase catalysed reaction between 7 and 14, and then comparing the 
optical rotation and CD readings between the enzyme product 251 and the enantiopure 
products D-KDX and L-KDA. 
Expression and purification of a batch of recombinant KDG aldolase was carried out, in 
collaboration with Dr. S. F. Royer of the CER at the University of Bath, as described 
previously using the pET-3a expression vector (Novagen, Nottingham, UK) to insert the 
KDG aldolase gene into E.coli BL21(DE3)(Novagen).1  After culturing the E.coli overnight 
the KDG aldolase produced was isolated and purified by ion exchange chromatography 
and gel filtration.  This gave KDG aldolase that was homogenous by SDS/PAGE and had 
a protein concentration of 2.1 mg/ml of water.   
This recombinant KDG aldolase was then used to catalyse the aldol reaction of pyruvate 7 
and glycolaldehyde 14, with an excess of pyruvate 7 used to drive the aldol reaction to 
completion (Scheme 70).  When in-process HPLC analysis showed the complete 
consumption of glycolaldehye 14, the reaction was quenched by acidification to pH 2 in 
order to denature the aldolase.  After neutralisation of the crude product solution, Bakers 
yeast expressing pyruvate decarboxylase was added to the reaction mixture to catalyse 
removal of pyruvate by removal via a selective decarboxylation reaction.33  Purification of 
the crude reaction product by silica gel chromatography (CH2Cl2-MeOH-H2O, 5:5:1) then 
furnished the desired product 251 as a yellow oil (363 mg, 54% yield).   
Scheme 70 KDG aldolase catalysed synthesis of 251 
 
 
The isolated product 251 had an optical rotation value of     
   +0.7 (c 4.95, H2O-MeOH, 
1:1), which when compared to the optical rotation values of the pure enantiomers (D-KDX 
    
   +13.5; L-KDA     
   = -13.3) corresponds to 5% e.e. in favour of D-KDX.  The ORD 
results matched the small      value, with the ORD line of the aldolase-produced product 
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251 showing only a slight positive curve for D-KDX.  Thus, it is clear that KDG aldolase 
exhibits no facial selectivity for the reaction of pyruvate 7 and glycolaldehyde 14, 
producing an almost racemic mixture of the two enantiomers D-KDX and L-KDA, similar to 
the previously observed unselective aldol reaction of pyruvate 7 with D-glyceraldehyde 6.1 
Figure 26 ORD spectrum of KDG aldolase produced 251, D-KDX and L-KDA 
 
 
The kinetic parameters for the retro-aldol cleavage reaction of 251 were also recorded, 
using the same method as described for the assay of the pure enantiomers D-KDX and L-
KDA (Table 9).  As expected, similar Km, kcat and catalytic efficiency values were 
recorded for 251. 
Table 9 Comparison of kinetic parameters of KDG aldolase for D-KDX, L-KDA and 
enzymatically produced product 251 






1 D-KDXa 33.3(±3.3) 15.0(±1.1) 0.45(±0.06) 
2 L-KDAa 17.6(±1.1) 9.3(±0.4) 0.53(±0.04) 
3 251a 14.6(±0.8) 11.6(±0.6) 0.79(±0.06) 






The first practical method for the synthesis of enantiopure D-KDX and L-KDA has been 
developed, using a route which is amenable to the synthesis of other 2-keto-3-deoxy-
ulosonic acids.  These sugar enantiomers were found to be relatively unstable to acidic, 
basic and reductive conditions, but can be accessed by treatment of acetonide protected 
ethyl ester precursors 223 (or 237) with an aqueous solution carefully acidified with 1 M 
HCl to pH 1.9, followed by lipase catalysed ester hydrolysis at pH 6.0-7.5.  The 1H and 13C 
NMR spectroscopic data for D-KDX and L-KDA are reported for the first time, with these 
sugars having been shown to exist as an essentially 1:1:1 mixture of acyclic, α-furanose 
and β-furanose isomers in solution.  Variable temperature 1H NMR experiments have 
shown that the isomeric ratio shifts to 51% in favour of the acyclic isomer as the solution 
temperature is increased from 25 °C to 60 °C; an analogous trend to that previously 
observed for the C6-2-keto-3-deoxy-ulosonic acid analogues D-KDG and D-KDGal.  
The kinetic parameters for D-KDX and L-KDA using KDG aldolase have been determined 
using a modified TBA assay, with good catalytic efficiencies being found for each 
enantiomer (0.45 and 0.53 s-1mM-1).  This confirms that S. solfataricus uses the same 
KDG aldolase for the catabolism of not only the diastereotopic C6-sugars D-KDG and D-
KDGal but also for the enantiomeric C5-sugars D-KDX and L-KDA.  Therefore, 
metabolism of the four most abundant sugars in nature by S. solfataricus is largely 
promiscuous in nature, in stark contrast to the majority of other bacterial and eukaryote 
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The second part of this research program was directed towards development of 
methodology for the total synthesis of Histrinicotoxin HTX whose retrosynthesis is shown 
in Scheme 71, and discussed more fully in the following chapter.  As part of this synthesis, 
an aza-Michael reaction was required to convert bis-α,β-unsaturated ester 4 into mono-β-
amino ester 252 in high enantiomeric excess.  For this synthesis to proceed it was 
necessary to develop methodology that would enable stereoselective monoaddition of a 
nitrogen nucleophile to 4, with subsequent nitrogen deprotection to afford the primary 
amine in the presence of a hydrogenolytically sensitive α,β-unsaturated ester group. 
 Scheme 71 Proposed aza-Michael addition and amine deprotection for the total synthesis 
of Histrionicotoxin HTX 
 
 
Consequently, recent advances in the asymmetric aza-Michael addition of nitrogen based 
nucleophiles to α,β-unsaturated acid derivatives will now be described highlighting the key 
synthetic strategies that have been employed, including: addition to a chiral Michael 
acceptor; addition of a chiral aza-nucleophile; chiral metal-complex catalysed addition; 
chiral BrØnsted acid organocatalytic addition; and chiral ligand mediated addition. 
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4.2 Review of the Asymmetric aza-Michael Addition to α,β-Unsaturated Acid 
Derivatives 
4.2.1 aza-Michael Addition of Achiral aza-Nucleophiles to Chiral Michael Acceptors 
There are numerous examples in the literature where researchers have reacted achiral 
aza-nucleophiles with chiral Michael acceptors to afford β-amino acid derivatives.1-7 
Various chiral auxiliaries have been employed to induce stereocontrol into the aza-
Michael reaction with some excellent diastereoselectivities having been achieved.  One of 
the first examples was reported by the d’Angelo group, where a menthol derived ester 
was shown to give excellent levels of diastereoselectivity (Scheme 72).2  They found that 
it was necessary to conduct the addition reaction under high pressure (>14 bar), which 
enabled the conjugate addition of diphenylmethanamine to proceed to give 258 in 98% 
d.e.  The authors proposed a π-stacking model 259 to account for the high levels of 
diastereoselectivity; with the most stable conformation arising from the naphthyl group 
shielding one face of the crotonate, leading to preferential attack by the amine nucleophile 
on the less hindered face of the alkene of 257.  





Cardillo and co-workers have demonstrated that the aza-Michael addition of O-
benzylhydroxylamine to chiral imides 260 mediated by a Lewis acid can also furnish β-
amino carboxylate derivatives in good diastereoselectivities (Scheme 73).7  After 
screening four Lewis acids they found that two equivalents of AlMe2Cl gave the best 




proposed to be the result of Lewis acid chelation to both carbonyls creating a rigid chiral 
unsaturated system 262, allowing preferential nucleophilic attack on the less hindered Re-
face of the alkene group. 
Scheme 73 Diastereoselective aza-Michael reaction of achiral O-benzylhydroxylamine to 




Highly stereoselective aza-Michael reactions have also been developed that proceed 
under substrate control.  Yamamoto found that stereogenic oxy-substituents in the γ-
position of Michael acceptors 263a-d exert syn-diastereocontrol for the conjugate addition 
of lithium amides (Scheme 74).6   Increasing the size of the γ-substituent led to higher 
diastereoselectivities, reaching a syn/anti ratio of 99:1 for a trityloxy γ-substituent, 
although the isolated yield was reduced to 77%.  They also found that whereas 
unsubstituted α,β-unsaturated ester 263a gave low diastereoselectivities, a methyl 
substituent at the α-position (263b) increased the levels of syn-selectivity to 100%. 
Scheme 74 Diastereoselective aza-Michael reaction of an achiral aza-anion to a chiral γ-





4.2.2 aza-Michael Reactions of Chiral Amide Nucleophiles 
As early as 1910, Fischer and Scheibler reported the conjugate addition of ammonia to 
crotonic acid, and since this initial discovery many amines have been shown to undergo 
conjugate addition reactions to Michael acceptors.8-9 The stereoselectivity of this reaction 
has been widely explored, with mixtures of thermodynamic products often being produced 
under thermal conditions making high stereocontrol difficult to achieve.10-11 In contrast the 
aza-Michael addition of metal amides generated by treatment of the corresponding 
amines with alkyl lithium or Grignard reagents, proceed with good levels of stereocontrol 
obtained under kinetic control.  Early work by Yamamoto and Hawkins revealed that the 
C2 symmetric lithium amide 266 underwent highly diastereoselective conjugate addition to 
tert-butyl crotonate (Scheme 75). 11-13 β-amino ester 267 was isolated in 83% yield and an 
impressive >97% d.e., although deprotection by hydrogenolysis of the nitrogen atom 
proved difficult, requiring the use of excess palladium hydroxide and hydrogen at elevated 
temperature.  The Furukawa and Davies groups have demonstrated that aza-Michael 
addition of primary amine nucleophiles to α,β-unsaturated ester acceptors gave low yields 
and poor levels of diastereoselectivity.10,14 However, Davies went on to demonstrate that 
the lithium anion of (R)-N-benzyl-N-α-methylbenzylamide 270 reacted with α,β-
unsaturated esters to give β-amino esters with very high levels of diastereoselectivity 
(Table 10).  They showed that tert-butyl esters gave far superior isolated yields than 
methyl and benzyl esters (entries 1-3), where competing 1,2-addition pathways reduce the 
yield of the desired 1,4-addition products.  The scope and limitation of this aza-Michael 
addition has been widely explored, with good levels of diastereocontrol observed for tert-
butyl acceptors containing various aromatic and aliphatic groups at their β-positions, 
giving β-amino esters with >95% d.e. in all cases (entries 3-6).  Use of lithium amides of 
secondary amines containing two chiral centres, such as (R)-bis((R)-1-phenyl-ethyl)-
amine, gave high levels of diastereocontrol (>97% d.e.), but attenuated reaction rates and 
yields. 
Scheme 75 Hawkins aza-Michael addition methodology of a chiral binaphthyl aza-anion to 




Table 10 Diastereoselective aza-Michael reaction of a chiral lithium amide to an α,β-
unsaturated ester 
 
Entry R1 R2 Yield 
(%) 
d.e. (%) 
1 Ph Me 68 94 
2 Ph Bn 39 91 
3 Ph t-Bu 96 >95 
4 2-MeOC6H4 t-Bu 95 >95 
5 Et t-Bu 92 >95 
6 n-Pent t-Bu 81 >95 
 
This methodology has been used in the synthesis of a large number of pharmaceutically 
active compounds and natural products.14-17 For example, (R)-3,4-dihydroxy-β-pheny-
lalanine 272, a naturally occurring β-amino acid was synthesised via aza-Michael addition 
of lithium amide 270 to α,β-unsaturated ester 269a, followed by global benzyl deprotection 
by hydrogenolysis and acid promoted hydrolysis to give 272 in >98% d.e. and in an overall 
82% yield (Scheme 76).14   




It is interesting to note that, unlike the other two benzylic bonds, the C(3)-N benzylic bond 
is not cleaved under the hydrogenolysis conditions used,  which has been found to be the 
general rule for hydrogenolysis of this type of β-amino acid.  It has been postulated that 
this selectivity arises from formation of a protonated ammonium intermediate 273 that 
holds the C(3)-β-aryl group in a conformation that disfavours hydrogenolysis and cleavage 
of the C(3)-N bond (Figure 27). 
Figure 27 Postulated protonated ammonium intermediate 
 
Although the aza-Michael addition of (R)-N-benzyl-N-α-methylbenzylamide 266 proceeds 
with excellent stereoselectivity, a drawback to this metholodogy is the necessity of using 
hydrogenolytic conditions to remove both benzyl protecting groups that is incompatible 
with other hydrogenolytically sensitive functional groups such as alkenes.  To overcome 
this drawback Davies and Fenwick demonstrated that the lithium ion of (S)-(α-
methylbenzyl)allylamine 274 also undergoes highly diastereoselective aza-Michael 
additions to α,β-unsaturated tert-butyl esters (Scheme 77).18 The β-amino ester products 
276a-d could then be efficiently deallylated with (PPh3)3RhCl (Wilkinson’s catalyst) and 
converted, after transesterification to methyl esters, to the corresponding azetidin-2-ones 
278a-d by treatment with methyl magnesium bromide. 
Scheme 77 aza-Michael addition of lithium (R)-N-benzyl-N-α-methylbenzylamide 274 to 




Of the other homochiral “ammonia equivalents” investigated, conjugate addition of the 
lithium anion of (S)-(-)-2-methoxymethyl-1-trimethylsilylaminopyrrolidine (TMS-SAMP) 279 
has given particularly impressive results.  The Enders group showed that 279 underwent 
highly diastereoselective addition to a range of β-alkyl substituted α,β-unsaturated tert-
butyl esters to give aza-Michael products with 93-98% d.e.19  They subsequently 
demonstrated this methodology for the synthesis of cyclic β-amino esters 281, where the 
intermediate ester enolates reacted intramolecularly with a ω-carbon-halide bond resulting 
in ring closure (Scheme 78).20  Desilylation using silica in ethyl acetate with trace amounts 
of HCl, followed by amine deprotection using H2/Raney Ni furnished the desired cyclic β-
amino esters 282 in high enantiomeric excess. 
Scheme 78 Diastereoselective aza-Michael addition of the lithium ion of TMS-SAMP 279 




4.2.3 Metal Catalysed Asymmetric aza-Michael Addition Reactions 
An early example of a metal-catalysed asymmetric aza-Michael reaction was reported by 
the Sibi group in 1998.21  They reacted O-benzylhydroxylamine with α,β-unsaturated 
pyrazole amides 283 using catalytic quantities of a chiral Lewis Acid prepared from 
MgBr2.OEt2 and bisoxazoline 284 (Scheme 79).  Good to excellent enantioselectivities 
were achieved for amidic acceptors containing aliphatic β-substituents, but aromatic 
groups in the β-position gave low yields and poor enantioselectivities.  When the catalyst 
loading was increased to 30% and then to 100%, a decrease in yield, and a contrasting 
increase in enantioselectivity was observed.  After noticing that there was a concomitant 
increase in by-product 286 over time, that is formed by amidolysis of product 285, Sibi 
suggested that kinetic resolution was occurring via preferential amidolysis of the opposite 
enantiomer of 285. 
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Scheme 79 Aza-Michael reaction of O-benzylhydroxylamine to α,β-unsaturated amides 
catalysed by a chiral magnesium catalyst 
 
 
As part of their work studying reactions catalysed by metal complexes of chiral salen 
ligands, the Jacobsen group screened the aza-Michael addition reactions of hydrazoic 
acid in the presence of (salen)Al(lII) complexes such as 287.22 They found that hydrazoic 
acid underwent highly enantioselective aza-Michael reactions with α,β-unsaturated imides 
288, affording β-aza-imides 289 in 95-97% e.e., except for a phenyl substituted derivative 
that gave an aza-Michael product of only 58% e.e. (Scheme 80). 




Sundararajan and Prabagaran have endeavoured to develop a polymer supported chiral 
catalyst for enantioselective aza-Michael reactions, with the aim of simplifying purification 
of reaction mixtures (Scheme 81).23  The chiral polymer was formed by free radical 
copolymerisation of divinylbenzene (DVB), styrene and the chiral amino-diol 290.  This 
polymer was then complexed with aluminium by simply stirring an excess of polymer with 
LiAlH4 in THF under an inert atmosphere.  Good levels of enantioselectivity were then 
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achieved for the reaction of benzylamine 292 and ethyl cinnamate 293, but when the 
catalyst was recycled between each run, reduced enantioselectivities were achieved and 
the polymer was found to deteriorate to a fine dust due to attrition by mechanical stirring.  
Despite these problems, this work demonstrates that polymer supported chiral catalysts 
have the potential to act as efficient catalysts, for stereoselective aza-Michael additions. 
Scheme 81 Catalysis of the aza-Michael reaction by chiral polymer aluminium catalyst 
 
 
4.2.4 BrØnsted Acid and Organocatalytic Approaches to the Asymmetric aza-
Michael Reaction 
Recently a few examples of BrØnsted acid catalysed aza-Michael reactions to Michael 
acceptors have been reported using phosphorous and thiourea based catalysts.  The Ooi  
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group reported the use of chiral arylaminophosphonium barfate catalysts for the aza-
Michael reaction of 2,4-dimethoxyaniline 295 to nitrostyrenes with high enantio-
selectivities.24  More recently they have extended this work to addition reactions of 2,4-
dimethoxyaniline to nitro-enynes 296 (Scheme 82).25  Initial trials using catalyst 297a at 
room temperature gave good yields with low enantioselectivites, but this was greatly 
improved by conducting the reaction at lower temperatures, and using the binaphthyl 
catalyst 297b.  Under these conditions a range of β-amino homopropargylic nitro 
compounds 298, with variance of the electronic and steric properties of the R-group, were 
synthesised in high yield and excellent regio- and enantioselectivities. 
Scheme 82 Chiral arylaminophosphonium barfate 297a catalysed aza-Michael reaction of 




The use of weakly acidic chiral thioureas has been explored by Sibi and co-workers 
affording good results for the aza-Michael reaction of O-substituted hydroxylamines 300 to 
pyrazole crotonates 283 (Scheme 83).26  The optimised conditions yielded the desired 
product in mostly good yields with good to excellent levels of enantioselectivity.  The 
reaction proceeds using 0.3 molar equivalents of catalyst 301, but the authors preferred to 
use one equivalent to increase the rate of reaction.  By varying the substrate and catalyst 
structure and observing how the yields and enantioselectivities of product were affected, it 
was concluded that the chiral thiourea 301 was acting as a bifunctional catalyst to 
facilitate addition (Figure 28). 
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Scheme 83 Thiourea catalysed aza-Michael reaction of O-substituted hydroxylamines 300 









4.2.5 Chiral Ligand Mediated Asymmetric aza-Michael Reactions 
Tomioka and co-workers have demonstrated that chiral diether ligand 303 can induce high 
levels of stereocontrol into the aza-Michael reaction of lithium amides to α,β-unsaturated 
ester derivatives (Scheme 84).27  The silyl-amine 304 was first deprotonated using n-butyl 
lithium at -78 °C before addition of chiral diether ligand 303, and stirring at -78 °C for 30 
minutes to allow for complexation to occur.  A toluene solution of tert-butyl crotonate 305 
and TMSCl was then added dropwise and the reaction was stirred at low temperature for 
five hours.  The N-protected-β-amino ester 306 was obtained in an impressive 97% e.e. 
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and 97% yield.  This methodology was shown to work equally well using methyl, iso-
propyl, alkenyl and naphthyl β-substituents in place of the phenyl group. 
Scheme 84 Chiral diether ligand 303 mediated aza-Michael reaction 
 
The Tomioka group has gone on to show that other silyl amines could be successfully 
employed as aza-nucleophiles in this type of asymmetric aza-Michael addition reaction 
(Scheme 86i-iii).28-30 They tested these alternatives primarily to find an ammonia equiv-
alent that could be deprotected using conditions other than hydrogenolysis, since whilst 
being incompatible with the presence of some functional groups, hydrogenolysis was 
shown to sometimes lead to the undesired cleavage of the C(3)-N to give 3-
phenylpropanoate 309 type products (Scheme 85).  Anthraceny-9-ylmethyl amine 410 
gave improved yields for deprotection under milder hydrogenolytic conditions, but it still 
required 24 hours using 10% Pd/C (cf. 41 hours for deprotection of benzyl amine 306 
under these conditions) (Scheme 86i).30  Allylic amine 314 could be deprotected by 
rhodium catalysed isomerisation (Scheme 86ii),28 whilst the mesitylmethylamine 317 could 
be deprotected by a protracted three step chlorination/regioselective 
dehydrochlorination/transoximation strategy (Scheme 86iii).29  Unsuccessful attempts 
were made to use an ammonia equivalent that could be deprotected under oxidative 
conditions, with N-silyl protected para-methoxybenzylamine 325 being reported to be 
unsuccessful in the aza-Michael reaction in their hands, vide infra.30 





Scheme 86 Alternative silyl amides employed as aza-nucleophiles for the chiral ligand 









Tomioka went on to develop tandem enolate alkylation reactions using this methodology 
(Scheme 87),31 with chiral diether ligand 303 controlling the enantioselectivity of addition 
of 322 to Michael acceptor 323, followed by in situ alkylation at the α-position with a range 
of electrophiles, to give quaternary carbon β-amino esters 324 in high enantiopurity. 




4.3 Investigation of the Asymmetric Aza-Michael Reaction of N-(4-methoxybenzyl)-
1,1,1-trimethylsilanamide 
It was decided to explore aza-Michael reaction mediated by Tomioka’s chiral diether 
ligand 303 as a means of stereoselectively introducing nitrogen functionality into C(3) of 
bis-α,β-unsaturated ester 4 for the total synthesis of Histrionicotoxin HTX (Scheme 88).   




Because Tomioka’s chiral ligand methodology had been shown to add N-trimethyl-
silylbenzylamine 304 to simple α,β-unsaturated esters in good yield and excellent 
enantioselectivity, this was chosen as the starting point for synthetic investigations.27  
However, the main drawback to using Tomioka’s methodology was that deprotection of 
the N-benzyl protecting group required hydrogenolysis, which would also reduce the 
remaining conjugated alkene bond of 5.  As described, Tomioka and co-workers screened 
the aza-Michael reactions of various other ammonia equivalents, whose adducts would be 
deprotected by methods other than hydrogenolysis.28-30 As part of these studies, the 
lithium ion of N-(4-methoxybenzyl)-1,1,1-trimethylsilanamine 325 was explored as a 
nucleophile, whose aza-Michael addition products could potentially be deprotected using 
oxidants such as DDQ and CAN.  However, it was reported that attempts to employ this 
nucleophile resulted in none of the desired aza-Michael product using tert-butyl cinnamate 
305 as the Michael acceptor (Scheme 89).  The authors speculated that the lack of 
addition product formed in these reactions was due to “too much bulkiness or poor 
nucleophilicity” of the nitrogen nucleophile 325.  However, the “bulkiness” of 325 was 
certainly no greater than mesitylmethylamine 316 that they reported as a good nitrogen 
nucleophile for this type of aza-Michael reaction,29 whilst the presence of the para-
methoxy substituent would not have been expected to decrease the nucleophilicity of the 
lithium amide significantly.   
Scheme 89 Tomioka attempted aza-Michael addition of N-(4-methoxybenzyl)-1,1,1-




Significantly, in the course of investigation into the aza-Michael addition of chiral 2
◦
 
amines to α,β-unsaturated esters (Section 4.2.1), Davies and co-workers reported the 
aza-Michael addition of the lithium anion of (S)-N-benzyl-1-(4-methoxyphenyl)ethanamine 
to tert-butyl cinnamate 305, giving excellent levels of stereoselectivity and good yields of 
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β-amino acid product 329 after subsequent treatment with CAN and HCl(aq). (Scheme 
91).32 Close inspection of the unsuccessful aza-Michael protocol employed by Tomioka for 
the aza-Michael addition of amine 325 revealed that the reaction conditions employed 
were not the optimised protocol reported previously for the successful aza-Michael 
reaction of amine 304, with differences in the number of equivalents of amine base 
employed, length of reaction time, reaction temperature, and most importantly the 
absence/presence of TMSCl (Scheme 90i and ii).   
Scheme 90 Comparison of the reaction protocol employed by Tomioka for: (i) the 
unsuccessful aza-Michael reaction of aza-nucleophile 325 with tert-butyl cinnamate 305; 
(ii) the successful aza-Michael reaction of aza-nucleophile 304 with tert-butyl cinnamate 







Therefore, it was proposed that carrying out the aza-Michael reaction of amine 325 with 
bis-α,β-unsaturated ester 4 under more optimal conditions might afford the desired mono-




Scheme 91 Davies successful aza-Michael addition of chiral 2
◦







4.4 Investigation of the Asymmetric aza-Michael Reaction of N-(4-Methoxybenzyl)-
1,1,1-trimethylsilanamide to a bis-α,β-Unsaturated Ester 
Initially, the aza-Michael reaction of the lithium anion of amine 325 with bis-α,β-
unsaturated ester 4 mediated by chiral diether ligand 303 was investigated using the 
same conditions and molar equivalents of TMSCl additive that Tomiaka had used for the 
successful aza-Michael reaction of 304 shown in Scheme 90ii.  The detailed mechanism 
for the chiral diether ligand 303 mediated reactions of lithium amides has yet to be fully 
established, but it is thought to proceed via formation of a monomeric lithium amide 
complex 331 in situ (Scheme 92).33  An α,β-unsaturated ester 305 then coordinates to the 
lithium atom of complex 331 minimising steric repulsion with the two methyl groups of the 
ligand, resulting in enantioselective intramolecular nucleophilic attack of 325 to afford a 
lithium enolate 332, which reacts in turn with the excess TMSCl to give (Z)-silylketene 
acetal 333.  The use of TMSCl to trap the enolate prevents the enolate interfering with 
formation of complex 331, which has previously been blamed for lowered 
enantioselectivites and yields of aza-Michael products.27  Furthermore, it may also 
function to prevent the retro-aza-Michael reaction of 332 that would result in starting 
materials being regenerated.  Treatment with saturated aqueous ammonium chloride 









Therefore, a dry solution n-butyllithium (2.6 M in hexanes) in toluene was cooled to -78 °C 
and a dry solution of amine 325 in toluene was added dropwise and the reaction mixture 
stirred for 30 minutes.  Then chiral ligand 303 dissolved in dry toluene was added 
dropwise and the reaction mixture stirred for a further 30 minutes.  The reaction mixture 
was then transferred via an insulated cannula to a solution of bis-α,β-unsaturated ester 4 
and TMSCl in dry toluene and stirred at reduced temperature for five hours.  After 
quenching the reaction mixture with a saturated aqueous solution of ammonium chloride, 
a standard work-up procedure furnished a yellow oil that was purified by silica gel 
chromatography to afford the mono-addition product in an isolated yield of 40%, with the 
major impurities isolated in separate fractions and identified as unreacted starting material 
4 (15%) and bis-addition product 334 (5%) (Scheme 93).  
Since the chiral ligand 303 mediated aza-Michael reaction of silylamines generally 
proceed with excellent enantioselectivities of >97% e.e., it was hoped that the aza-Michael 
reaction of 325 would be equally enantioselective.  To determine the enantiomeric excess 
of the reaction, the aza-Michael reaction of amine 325 with 4 was repeated in the absence 








In order to distinguish between the two enantiomers of rac-5, a number of chiral HPLC 
columns were screened for their ability to resolve its enantiomers: Hichrom C18; Lux 
Cellulose 1; Regis Whelk-O 1; and Kromasil AmyCoat.  Excellent results were obtained 
with the Kromasil 5 μm AmyCoat stationary phase eluting with an isocratic gradient of 
isohexane/IPA (95/5) + 0.15% DEA at 1ml/min, which gave baseline separation of the two 
enantiomers of rac-5 (Figure 29).  A sample of 5 prepared in the presence of chiral ligand 
303 was then run using this method (Figure 30), which revealed that 5 had been formed 
with an enantiopurity >97% e.e., indicating that the aza-Michael reaction had proceeded 
with excellent levels of enantiocontrol.  The absolute configuration of 5, inferred from 
Tomioka’s previous reports of the aza-Michael reaction of lithium amides mediated by 













Having succeeded in the synthesis of 5 via a highly stereoselective aza-Michael reaction, 
this mono-addition reaction was subsequently utilised to prepare gram quantities of 5 for 
the total synthesis of Histrionicotoxin HTX that will be discussed more fully in Chapter 5 of 
this thesis.  Meanwhile, the initial successful enantioselective aza-Michael result was 
deemed worthy of further investigation for reaction of the lithium ion of amine 325 to a 
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4.5 Investigation of the Asymmetric Aza-Michael Reaction of N-(4-Methoxybenzyl)-
1,1,1-trimethylsilanamide to α,β-Unsaturated tert-Butyl Ester Analogues 
 
4.5.1 Synthesis of α,β-Unsaturated tert-Butyl Ester Analogues 
It was first necessary to prepare a range of aliphatic, aromatic and heteroaromatic (E)-α,β-
unsaturated tert-butyl esters containing various functional groups.  The desired 
compounds were either not available commercially or prohibitively expensive, so a reliable 
synthetic method using inexpensive reagents was sought.  Many methods have been 
reported to give (E)-unsaturated alkenes such as the Julia olefination,34-35 Peterson 
reaction,36 and the Wittig reaction.37-38 Recently lithium and magnesium in combination 
with nitrogen bases have been used for the HWE reaction of chiral aldehydes with 
phosphonate esters, giving good yields and (E)-selectivity.39-40 Davies and co-workers 
have improved on this methodology by developing a simple protocol using MeMgBr as 
both a base and source of chelating metal for the HWE reaction of tert-butyl phophonate 
ester 335 with a range of aliphatic and aromatic aldehydes (Scheme 94).41  The desired 
(E)-α,β-unsaturated tert-butyl esters 336 were reported to be isolated in excellent yields 
and with very high diastereoisomeric purities [(E):(Z) >98:2]. 
 




This protocol seemed particularly suitable since phosphonate ester 335 was commercially 
available and a number of aldehyde substrates were available in the laboratory.  Initially 4-
bromobenzaldehyde was reacted with the anion of phosphonate ester 335 using the 
Davies protocol, giving the desired (E)-α,β-unsaturated tert-butyl ester in a yield of 72% 
(Table 11 entry 1).  Therefore, five further aldehydes were reacted with 335 and the 
corresponding (E)-α,β-unsaturated tert-butyl esters isolated in acceptable yields (69-82%) 
and with excellent levels of diastereoselectivity (>97% E-isomer) (Table 11 entries 2-6). 
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Table 11 HWE synthesis of (E)-α,β-unsaturated esters 
 
Entry Ar-substituent E:Z Yield (%) 
1 
 
>97 : 3 72 
2 
 
>97 : 3 78 
3 
 
>97 : 3 82 
4 
 
>97 : 3 69 
5 
 
>97 : 3 67 
6 
 
>97 : 3 65 
 
An alternative Suzuki-coupling methodology was used for the synthesis of tert-butyl 
cinnamate 305 involving treatment of iodobenzene 337 and tert-butyl acrylate 338 with 
Pd(OH)2, P(o-tolyl)3 and DIPEA in MeCN at reflux.  Purification of the crude product by 
silica gel column chromatography gave a good yield of E-tert-butyl cinnamate 305 
(Scheme 95).   





α,β-Unsaturated ester 341 was efficiently synthesised by Grubbs olefin metathesis of  
hex-1-ene 339 and tert-butyl acrylate 340 that furnished its E-isomer in 55% yield after 
purification by silica gel chromatography (Scheme 96). 
Scheme 96 Grubbs olefin metathesis for the synthesis of 341 
 
 
4.5.2 Asymmetric aza-Michael Addition of the Lithium Anion of aza-Nucleophile 325 
to a Range of α,β-Unsaturated tert-Butyl Esters 
The aza-Michael reaction of N-(4-methoxybenzyl)-1,1,1-trimethylsilanamine 325 was first 
trialed with tert-butyl cinnamate 305 using the same methodology employed for bis-α,β-
unsaturated ester 4, except for increased equivalents of amine 325, n-BuLi and ligand 303 
since bis-addition was not a problem with mono-α,β-unsaturated ester 305 (Scheme 97).  
Therefore a solution of amine 327 (1.5 eq) in toluene was added dropwise to a solution of 
n-BuLi in hexane/THF at -78 °C and the reaction was stirred for 30 minutes.  Chiral ligand 
303 (1.8 eq) was then dissolved in toluene and added dropwise and stirred for a further 30 
minutes.  A solution of α,β-unsaturated ester 305 (1 eq) and TMSCl (5 eq) in toluene was 
then added dropwise and the reaction mixture stirred for five hours before being quenched 
by the careful addition of saturated aqueous ammonium chloride.  Purification of the crude 
reaction product by silica gel chromatography yielded the desired N-benzyl-β-amino ester 
326a in 77% yield and >97% e.e. (proved by chiral derivitisation and 1H NMR 
spectroscopic analysis vide infra). 




Delighted by this result, the scope of this aza-Michael methodology was further 
investigated by reacting the lithium anion of amine 325 with a range of β-substituted α,β-
unsaturated ester analogues (Table 12).  Entry 2 shows that the reaction was highly 
successful for aliphatic R-substituents, whilst entries 3-6 show a variety of aryl groups 
containing halo and electron withdrawing substituents were tolerated, giving good to 
excellent yields, except for the para-nitro derivative (entry 6) that gave a poorer yield of 
40%.  Entries 7 and 8 demonstrate that when heterocyclic rings were present in the β-
position, good yields of the aza-Michael products could also be achieved.  The generally 
high positive      values recorded for the N-benzyl-β-amino ester products suggested 
that these adducts had been formed with good enantiomeric excess. 
Table 12 Results of chiral ligand mediated aza-Michael reaction 
 


























4.5.3 Oxidative CAN Deprotection of aza-Michael Addition Products 
The oxidative deprotection of amine 326a was trialed using standard CAN methodology 
previously reported by Davies and co-workers for the N-debenzylation of tertiary amines 
(Scheme 98),42-43 as this would allow for the efficient orthogonal deprotection of amine 
functionality in the presence of functional groups sensitive to hydrogenolytic conditions.  
The mechanism of this oxidative debenzylation involves a Ce (IV) cation abstracting an 
electron from the lone-pair of the nitrogen to give radical cation 347.  The benzylic protons 
of 347 are acidic, and therefore one of them is removed by water to afford zwitterion 348.  
Tautomerisation of anion 348 affords benzylic radical 349 that undergoes further Ce (IV) 
cation mediated oxidation to afford carbocation 350, which tautomerises to iminium 
species 351.  Iminium cation 351 is then hydrolysed by water to afford para-
methoxybenzaldehyde 345 and the deprotected amine 352 (Scheme 99).  
Scheme 98 Example of CAN oxidative N-debenzylation of tertiary amine 
 
 





When four molecular equivalents of CAN were added to a MeCN/H2O (5:1) solution of 
protected amine 326a, TLC showed that all of the starting material was consumed after 
just two hours, so the reaction was worked-up to afford a quantitative yield of imine 353 
(Scheme 100).  Imines are easily hydrolysed under acidic aqueous conditions, but tert-
butyl esters are also susceptible to cleavage under mild acidic conditions.  A number of 
trials were conducted varying the acid, solvent and reaction time to find conditions that 
would exclusively hydrolyse the imine functionality, thus maximising the yield of β-amino 
ester 354a.  It was found that stirring imine intermediate 353 in MeCN/H2O (5:1) with 15 
equivalents of acetic acid at room temperature for 48 hours gave the best results 
furnishing β-amino-tert-butyl ester 354a in 83% yield. 
 
Scheme 100 CAN oxidation followed by acidic hydrolysis for the deprotection of PMB 





This oxidative deprotection methodology was then applied to the deprotection of the other 
aza-Michael products to give their corresponding β-amino ester products in average to 
good yields (Table 13).  The lower yields reported in entries 3, 5 and 7 were due to 
competing hydrolysis of the tert-butyl ester in the imine cleavage step to afford their 
corresponding acids, which were found to be present in the aqueous washings by mass 
spectroscopic analysis.  The enantiomeric excess of the resultant β-amino esters 354a-h 
were confirmed as >97% e.e. via derivatisation with 2-formylphenyl boronic acid and 
enantiopure BINOL, followed by 1H NMR spectroscopic analysis of the resultant 




Table 13 CAN deprotection results for N-benzyl-β-amino ester 354a-h 
 























a. % e.e. determined by Bull and James chiral derivitisation NMR methodology vide 
infra44-45 
 
4.5.4 Chiral Derivatisation of β-Amino Esters 354a-h to Determine their 
Enantiomeric Excess by 1H NMR Spectroscopic Analysis 
The enantiomeric excess of the β-amino esters 354a-h were determined using a three-
component NMR methodology developed by Bull, James and co-workers.44-50 This 
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approach involves treatment of a chiral amine with an enantiopure BINOL, such as (S)-
355, and 2-formylphenyl boronic acid 356 to afford a mixture of diastereomeric imino-
boronate esters 357 and 358 (Scheme 101).45,48 It has been found that the enantiomers of 
primary amines generally afford diastereomeric imino-boronate esters whose resonances 
are normally well resolved in their 1H NMR spectra.45 Since no kinetic resolution occurs in 
the derivatisation process, comparison of the integrals of multiple diastereomeric 
resonances allowed simple accurate determination of the enantiomeric excess of the 
parent amine. 
Scheme 101 Three-component derivatisation of chiral amines to afford mixtures of 
diastereoisomeric imino-boronate esters 
 
The scope of this chiral derivatisation methodology has been extended to determine the 
enantiomeric excess of C2-symmetric diamines and O-silyl-1,2-amino alcohols.
46,49 It has 
also been demonstrated that other 1,2-, 1,3- and 1,4-chiral diols can be used as chiral 
auxiliaries for imino-boronate ester formation,47 permitting the optimisation of the three-
component derivitisation protocol for specific amines.49 The enantiomeric excess of chiral 
diols can also be determined by using an enantiopure amine in the three-component 
reaction.44,47,50 
Therefore, the enantiomeric excesses of β-amino ester products 354a-h were determined 
using this three-component methodology.  For example, β-amino-ester 354a was reacted 
with enantiopure (R)-BINOL (R)-355 and 2-formylphenyl boronic acid 356 to afford imino-
boronate complex A (Scheme 102) and its 1H NMR spectrum acquired (Figure 31i).  This 
derivatisation reaction was then repeated using (S)-BINOL (S)-355, to afford the 
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diastereomeric imino-boronate complex B (Scheme 102) whose 1H NMR spectrum was 
also acquired (Figure 31ii).   
On comparison of the 1H NMR spectra of complexes A and B, the resonances for the HA, 
HB, HC, HC’ and the tert-butyl protons of each diastereomer showed significant chemical 
shift differences (0.1-0.4 ppm).  Thus showing clearly that one diastereomer is present in 
each spectrum.  Integration of the tert-butyl proton resonances at 0.85 ppm and 1.15 ppm 
for complexes A and B easily allowed the diastereomeric excess of the  parent β-amino 
ester 354a to be determined as >97% e.e.  The enantiomeric excess of the other β-amino 
ester products 354b-h were all determined in the same manner, revealing that they had all 
been synthesised in >97% e.e. 




4.5.5 Assignment of the Absolute Configuration of β-Amino Ester Products 
The absolute configuration of 354a was assigned by comparison of the 1H NMR spectra of 
the imino-boronate complexes A and B with the 1H NMR spectrum reported previously for 
diastereomeric imino-boronate complexes of known configuration (Figure 31iii).45 
Therefore, the chiral ligand 303 mediated aza-Michael reaction was shown to afford the 
(R)-N-benzyl-β-amino ester product 326a, which on deprotection by treatment with CAN 
and AcOH/H2O furnished (R)-β-amino ester 354a in >97% e.e.  This conclusion was 
confirmed by comparison of the sign and magnitude of the specific rotation of (R)-N-
benzyl-β-amino ester 326a      +20.0 (c 1.2, CHCl3), with the literature value for (R)-N-
benzyl-β-amino ester 326a that has been reported as     




This is the same sense of asymmetric induction found by Tomioka and co-workers when 
they used the same chiral diether ligand 303 for the aza-Michael reaction of N-benzyl-
1,1,1-trimethylsilanamine 304 to α,β-unsaturated tert-butyl esters (Section 4.2.5).27 
Figure 31 1H NMR spectra of imino-boronate complexes A, B and literature spectrum of 
rac-complex for comparison 





























A key β-amino ester intermediate 5 for the synthesis of Histrionicotoxin HTX has been 
synthesised via highly stereoselective aza-Michael addition of the chiral lithium anion of N-
trimethylsilyl-para-methoxybenzylamine 325 to bis-α,β-unsaturated tert-butyl ester 4 
mediated by an enantiopure chiral diether ligand 303.  This methodology has then been 
applied to a range of α,β-unsaturated tert-butyl esters.  Contrary to earlier reports, amide 
325 was found to be a good nucleophile for this aza-Michael reaction, when Tomioka’s 
optimised aza-Michael methodology was used.  These aza-anion conjugate addition 
reactions proved to be highly stereoselective, affording N-benzyl-β-amino ester products 
326a-h in >97% e.e. with a variety of aliphatic, aromatic and heteroaromatic α,β-
unsaturated tert-butyl esters.  Each N-benzyl-β-amino ester product was oxidatively 
deprotected with CAN to yield β-amino ester products 354a-h, after treatment of their 
imine intermediates with AcOH.  Since these CAN oxidative conditions enable the 
deprotection of PMB amines, this methodology provides a useful alternative for preparing 
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With efficient aza-Michael addition methodology having been developed for the 
asymmetric synthesis of β-amino esters, the research focus turned towards the synthesis 
of Histrionicotoxin HTX (Figure 32).  HTX has an impressive spiro[5.5]undecane ring 
system with four stereocentres and two cis-enyne side-chains that has been shown to be 
a potent non-competitive nicotinic acetylcholine receptor (nAChR) antagonist.1  Previously 
a number of syntheses of HTX have been reported that suffer from low overall yields and 
involve many steps.  The approach investigated proposed to rapidly construct the carbon 
backbone of HTX and introduce the nitrogen functionality enantioselectivity using the aza-
Michael methodology described in Chapter 4.  Attempts would then be carried out to 
achieve spirocyclisation applying ester enolate-imine methodology recently developed by 
Bull and co-workers.2 




5.2 Biological Activity of Histrionicotoxin 
HTX was first isolated by Daly in 1971 from skin extractions of the Columbian poison 
arrow frog Dendrobates histrionicus.3  Over the following years a further 14 spirocyclic 
alkaloids have been isolated from frogs of the family Dendrobatidae.  The compounds of 
this family share the unique core spiropiperidine structure and, with the exception of the 
three deoxygenated members, vary only in the length and degree of saturation present in 
their two side chains.  HTX and other spirocyclic alkaloids have been found to be potent 
non-competitive nAChR antagonists.  nAChRs are a class of cholinergic receptors 
activated by acetylcholine (ACh) as well as other neurotransmitters that were originally 
characterised by the agonistic effect that nicotine exerts on them.  When ACh binds to a 




Figure 33 The sequence of events at a typical cholinergic synapse4 
 
Step 1 
An arriving action potential depolarises the synaptic knob. 
Step 2 
Calcium ions enter the cytoplasm of the synaptic knob. 
ACh is released through exocytosis of neurotransmitter vesicles. 
Step 3 
ACh diffuses across the synaptic 
cleft and binds to receptors on 
postsynaptic membrane. 
Chemically regulated sodium 
channels on the postsynaptic 
surface are activated, producing a 
graded depolarization. 
ACh release ceases as calcium 
ions are removed from the 
cytoplasm of synaptic knob. 
 
Step 4 
The depolarisation ends as ACh is hydrolysed into acetate and choline by 
acetylcholinesterase. 
The synaptic knob reabsorbs choline from the synaptic cleft and uses it to  
resynthesize ACh. 
 
These nAChRs are found at the nerve-nerve synapses and nerve-muscle synapses of the 
peripheral nervous system, the ganglion and in the central nervous system where, except 
for a few exceptions, they appear at the post-synaptic membrane.  The structure of the 
nAChR of the Torpedo californica electic ray has been successfully characterised.5  It is a 
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protein complex made up of five subunits.  The five subunits (β, γ, δ and two α units) form 
a cylindrical shape which traverses the cell membrane with the centre of the cylinder 
acting as a gated ion channel for Na+, K+ or Ca2+ (Figure 34).  The nAChRs found in the 
human body differ according to the structure of their α- and β-subunits and show specific 
binding affinities, which can be probed by small molecule ligand binding studies.6 





Results of ligand binding studies on Torpedo californica electroplax, rat 
pheochromocytoma PC12 cells and frog nerve-muscle preperations have demonstrated 
the potent antagonistic effects of HTX.1,8-10  The Torpedo californica electroplax contain a 
high density of nAChRs that are analogous to the muscular nAChRs of other vertebrates.  
HTX does not inhibit the binding of acetyl choline, but instead augments its affinity for the 
receptor site at HTX concentrations of 2 μM and 8 μM.8  Contrastingly, HTX has a binding 
constant1 of 0.63 μM for the binding inhibition of radio labelled perhydrohistrionicotoxin 
361 (a compound that is known to bind at an allosteric site on the nAChR).9  Therefore, it 
can be concluded that, for muscular nAChRs, HTX acts as a non-competitive antagonist.  
                                                          
1
 The binding constant (Ki)            




For the rat pheochromocytoma PC12 cells that have nAChRs representative of a ganglion 
nAChRs, HTX also has a strong non-competitive antagonistic effect with an IC50 of 4.3 μM 
recorded for an assay where the 22Na+ influx was measured with a 2 mM concentration of 
the nAChR agonist carbamylcholine.1  Daly and co-workers used frog nerve-muscle 
preparations to test the effect of spirocyclic alkaloids on nerve-muscle preparations.9  
They showed that a HTX concentration of 5 μM blocked the normal nerve evoked muscle 
twitch, with repetitive stimulation resulting in the decreased rate and strength of muscle 
action potentials.  From these results they concluded that HTX was not only behaving as a 
non-competitive nAChR antagonist, but also acting on the sodium and potassium ion 
channels.  They speculated that the site of HTX binding could in fact be at the lipid-protein 
interface since HTX was found to have a high affinity for an intrinsic membrane protein. 
 
Central nervous system research opportunity 
It is known that there are a number of subtypes of neuronal nAChRs, these nAChRs are 
associated with Ca2+ transfer as well as Na+ and K+ permeability. Changing the 
concentration of Ca2+ in the cell affects a diverse range of signalling pathways.  
Modulation of the neurotransmitter release by nAChRs has been well documented and in 
some cases particular subtypes of nAChRs have been connected to the release of 
particular neurotransmitters.11  There is a pressing need for small molecules that have a 
high affinity and selectivity for these receptors that can be used as biological tools to 
selectively interrogate these complex systems.  It was hoped that in collaboration with the 
Wonnacott group, testing HTX and other synthetic analogues for selective antagonistic 
behaviour with neuronal nAChRs would enable new selective antagonists to be identified 
that could further the understanding of this important class of receptor. 
 
5.3 Previous Syntheses of Histrionicotoxin and Related [5.5] Spiro-2-Piperidines 
Over the last four decades a considerable amount of synthetic interest has focused on the 
HTX family of alkaloids.  The first synthesis of rac-HTX was reported by Kishi and co-
workers in 1985 and since then seven further total syntheses have been reported, as well 
as a number of formal syntheses.12-19  This mini review will be divided into four sections, 
each one focusing on selected ring disconnections illustrated below (Scheme 103), and 
will include syntheses of HTX and other members of the HTX family of alkaloids to 








5.3.1 Disconnection 1: Conjugate addition and the intramolecular ene reaction of 
amines 
In 1976, Corey and co-workers attempted to employ an aza-Michael reaction, to convert 
α,β-unsaturated ketone intermediate 359 to rac-361 (Scheme 104).20  They initially 
attempted the reaction in a saturated aqueous ammonia solution, but could only isolate 
amine 362 in 85% yield despite some spectroscopic data indicating the presence of the 
target cyclised product 360.  By adding sodium borohydride to the reaction they managed 
to generate a complex mixture of products, from which it was possible to isolate a 5% 
yield of rac-361. 




Almost a decade later the Carruthers and Godleski groups simultaneously published 
syntheses of rac-depentyl-perhydrohistrionicotoxin 366 (Scheme 105).  The Carruthers 
group prepared the protected amine 364 in good yield that underwent spirocyclisation in 
the presence of a catalytic amount of Pd(PPh3)4 in good yield.
21  To complete their 
synthesis they hoped to perform stereoselective hydroboration/oxidation reactions whose 
regioselectivity would be controlled by the proximal nitrogen.  Unfortunately, they could 
only achieve an epimeric mixture of alcohols, but after isolation of the required 
diastereomer it was deprotected to give 366 in an overall yield of 13%.  The Godleski 
group began their synthesis from the same starting material 363, but then chose to install 
benzylamine and spirocyclise via an intramolecular aza-Michael reaction, before reduction 
of the ketone functionality.22  The key spirocyclisation reaction gave a 13:1 ratio of 
diastereomers in favour of the desired product 368, which was reduced to rac-366 to 
complete the synthesis in a good overall 33% yield.   




Kishi and co-workers built on these results to develop the first total synthesis of rac-HTX 
(Scheme 106).12  The precursor 370 was first synthesised in 45% yield over four steps 
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and then an intramolecular aza-Michael reaction carried out to afford diastereomers 371 
and 372 in a 1:2 d.r.  Fortunately, this epimeric mixture could be equilibrated with sodium 
methoxide to give a 4:1 d.r. in favour of the desired diastereomer 371.  The diastereomers 
were then separated by chromatography and 371 was elaborated to rac-HTX over an 
interminable 25 steps, with an overall yield of 0.02%! 
Scheme 106 Kishi first total synthesis of rac-HTX 
 
Keck and co-workers developed a novel synthesis involving an intramolecular ene 
reaction to generate the spiro-2-piperidine core for their synthesis of rac-361 (Scheme 
107).23  Compound 373 was initially alkylated with 1-(2-iodoethyl)cyclohex-1-ene 374.  
Thermolysis of product 375 triggered a retro-Diels-Alder reaction, and the resulting N-
acylnitroso compound spontaneously underwent an intramolecular ene reaction to give N-
hydroxy-lactam 376.  The N-hydroxy group was then used to install the C(8) hydroxyl 
group stereoselectively by intramolecular attack on a bromonium species giving 377, 
which could be elaborated to rac-361 over 14 steps. 




Tanner subsequently developed iodine promoted spirocyclisation methodology (Scheme 
108).24-25  The primary hydroxyl group of 378 was converted into a benzylamine, with 
addition of iodine to forming an iodonium ion that reacted intramolecularly with the amino 
group to afford spirocycle 381 that was debenzylated and dehalogenated via 
hydrogenolysis to the target spirocycle rac-382. 
Scheme 108 Tanner iodine promoted spirocyclisation methodology rac-382 
 
 
5.3.2 Disconnection 2: 1,3-Dipolar Cycloaddition Approach 
In 1999 the Holmes group published an enantioselective route to (-)-HTX with an 
intramolecular [3+2] nitrone cycloaddition reaction as the key spirocyclisation step 
(Scheme 109).14 Earlier work by other groups had shown that this reaction could be used 
to prepare spiropiperidines,26-28 but only if the alkene substituents were not too sterically 
demanding.  By employing 388 as the substrate that contains an alkene substituted with 
an electron withdrawing nitrile group, Holmes overcame these steric demands, allowing 
further elaboration of the nitrile functionality to form the target compound.  (-)-HTX was 
synthesised by this method in an extended 20 steps, but in an acceptable overall yield of 
16%.  The stereochemistry was introduced during the [3+2] cylisation reaction using a 
chiral auxiliary to mediate reaction with 1-chloro-1-nitrosocyclohexane to form 
hydroxylamine 386 as a single isomer. They went on to apply the methodology to the 
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synthesis of the other enantiomer of the alkaloid, (+)-HTX, by using an alternative chiral 
auxiliary and protecting group strategy.16   




Soon after Holmes’ first total synthesis, Stockman and co-workers published a formal 
synthesis of rac-HTX that involved the synthesis of a C2-symmetric acyclic precursor 393 
(Scheme 110).15  393 was then reacted with hydroxylamine and heated in toluene in a 
sealed tube to give the spirocyclic structure 396.  This method was an improvement on 









Stockman later published a total synthesis of rac-HTX in collaboration with the Fuchs 
group.17  This used the spirocyclic ring forming methodology, but built the precursor via a 
more efficient route, elaborating 396 using alternative Wittig-based chemistry. 
 
 
5.3.3 Disconnection 3: Mannich-type Reactions of Imines and Acyliminium Ions 
The potential of the Mannich reaction for spirocyclisation was first explored by Corey in his 
total synthesis of the unnatural HTX analogue rac-epi-2,7-perhydrohistrionicotoxin rac-402 
(Scheme 111).29  Starting from bromocyclopentene they constructed the carbon backbone 
to give 397.  Condensation with liquid ammonia in a sealed tube with concomitant aza-
Michael addition gave imine 398.  The key enamine-Mannich reaction was promoted by p-
TsOH and the crude product was immediately reduced to yield 399 as a complex mixture 
of diastereomers.  The required epimer was isolated from this mixture of diastereomers by 
reaction with phosgene to form a cyclic carbamate 400 and then elaborated over four 




Scheme 111 Corey synthesis of unnatural HTX analogue rac-402 
 
The Mannich reaction of of N-acyliminium ions was developed by both the Evans and 
Speckamp groups working on glutarimide 403 (Scheme 112).30-31 Both groups began with 
a Grignard addition to glutarimide 403 forming an N-acyliminium ion intermediate 404 that 
underwent olefin cyclisation in the presence of formic acid.  Spirocycle 405 was then 
elaborated to the desired product by different methods to arrive at the target molecule.  
Speckamp later rationalised the stereoselectivity of the cyclisation reaction by postulating 
a chair-like transition state 408 in which the butyl group preferentially adopts an equatorial 
position.32 




A similar strategy was adopted by the Tanis group to realise the formal synthesis of rac-
361 (Scheme 113).33 A Grignard reaction with glutarimide provided 403, contains a furan 
moiety that underwent an intramolecular cyclisation onto an N-acyliminium ion 
intermediate to give 410 with an impressive 72% yield over the two steps.  The furan ring 
was then oxidatively cleaved to 411 using m-CPBA and the unstable ene-dione product 
was immediately reduced by using a Noyori kinetic ketalisation reaction followed by 
Raney nickel reduction to afford diketone 412, which had been previously elaborated by 
Keck and Corey to the target compound rac-361.23,34 
Scheme 113 Tanis formal synthesis of rac-361 
 
 
5.3.4 Disconnection 4: Intramolecular Nucleophilic Substitution Reactions 
The Stork group have reported a novel synthesis of (-)-HTX where an intramolecular 
nucleophilic substitution reaction gave the key spirocyclic structure 417 (Scheme 114).13,35  
They initially synthesised intermediate 413 from enantiomerically pure starting materials 
and then subjected this molecule to ozonolysis and Z-selective Wittig methodology to yield 
the bis-(Z)-1-iodo-alkene 414.  The side-chains were subsequently elaborated to afford 
415 and the amine functionality was then introduced by treating with trimethylaluminium-
ammonium chloride followed by acetyl protection of the alcohol functionality giving an 
acetoxy amide, which underwent a Hoffman-like rearrangement on the addition of 
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phenyliodonium bistrifluoroacetate to give 416.  Nucleophilic spirocyclisation then required 
heating of a 1,2-dichloroethane solution of bromide 417 and triethylamine at 55 °C.  
Coupling with (trimethylsilyl)-acetylene and deprotection of the spirocycle then gave (-)-
HTX in an overall 1% yield over 14 steps. 




The Fukuyama group recently reported another synthesis of (-)-HTX using a nucleophilic 
substitution reaction to form the spirocyclic structure after an impressive range of 
chemistry to construct the precursor 422 (Scheme 115).19 They subjected enantio-
merically pure dienyne 418 to metathesis conditions to afford bicyclic structure 419 in high 
yield and enantioselectivity.  The acetate group was then deprotected and used as a 
“chiral handle” to direct selective functionalisation of the alkene bonds.  Primary alcohol 
420 was oxidised and rearranged under Hoffman conditions to afford Boc-amide 421 that 
could be further elaborated to 422 before spirocyclisation by using a simple intramolecular 
nucleophilic substitution reaction.  Functionalisation of the Z-alkene side-chains using the 








5.3.5 Summary of Synthesis of HTX and Analogues 
The synthesis of HTX and analogues has proved a testing challenge to a number of 
talented synthetic groups and a fertile ground for the development of methodology over 
the past four decades.  Synthetic organic chemistry is an ever evolving discipline, so there 
is undoubtedly scope for new concise and novel strategies for the synthesis of HTX and 
analogues.  If successful, this would enable libraries of spirocyclic compounds to be 
tested for selective antagonistic behaviour against specific subtypes of neuronal nAChRs 
that could lead to dramatic discoveries in the field of neurochemistry. 
 
 
5.4 Synthetic Plan for the Total Synthesis of Histrionicotoxin 
The initial plan for the synthesis of HTX can be simplified into five stages: 
 A. Construction of the acyclic bifunctional carbon backbone using standard organic 
chemistry (2 to 424). 
B. Stereoselective introduction of amine functionality (424 to 425). 
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C. Cyclisation and novel aza-Baylis Hillman spirocyclisation (425 to 428). 
D. Stereoselective introduction of the alcohol functionality (428 to 429). 
E. Elaboration of the cis-enyne side-chains (429 to HTX). 
 
Scheme 116 Retrosynthetic analysis of HTX 
 
 
5.5 Synthesis of Acyclic Carbon Backbone 
Synthesis of the HTX carbon backbone required high yielding robust methodology since 
these early steps would have to be carried out reliably on a multigram scale.  If the 
methodology was either low yielding or insufficiently reliable, the total synthesis of HTX 
would be doomed to failure as later steps would require considerable amounts of material 
to trial various strategies and optimise of reaction conditions. 
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At the outset, a Grignard reaction of 5-bromo-pent-1-ene 2 with ethyl formate 3 was used 
to prepare alcohol 430 in 89% yield requiring no further purification (Scheme 117).36 It was 
then necessary to protect the alcohol group before further functionalisation of the 
molecule.  The TBS protecting group was chosen as it was known to be stable to Grubb’s 
olefin metathesis and strongly basic conditions, but could be selectively removed by 
fluoride reagents.37 Accordingly alcohol 430 was reacted with TBSCl under standard 
conditions to give protected diene 431 in 90% yield and purity after silica gel 
chromatography (Scheme 117).38 




Diene 431 was then coupled with tert-butyl acrylate using Grubbs’ 2nd generation catalyst, 
which has previously been employed to effectively couple terminal alkenes to make α,β-
unsaturated esters.39 Grubbs has observed that coupling acrylates with terminal alkenes 
proceeded with particularly good product selectivity.40 He attributed this to the marked 
difference in reactivity between the “Type I” terminal alkene and less reactive “Type II” 
acrylate donors.  Initially the reactive Type I alkene 431 homodimerises, which releases 
ethylene that escapes as a gas from the system.  The Type II acrylate 432 homodimerises 
very slowly and before this occurs it undergoes cross-metathesis with the more reactive 
Type I dimer giving product 433 that is stable under the reaction conditions.  It was found 
that after stirring the two reactants for 24 hours under ambient conditions, the desired 
hetero coupled product was obtained in 89% yield, only requiring a silica gel plug to 
remove the ruthenium impurities (Scheme 118). 




Bis-α,β-unsaturated tert-butyl ester 433 had therefore been synthesised in just three steps 
in an excellent overall 71% yield.  In the proposed synthesis this thirteen carbon backbone 
would be used to construct the spiropiperidine ring system containing two side-chains that 
are suitable for homologation.  To realise this synthetic approach, a nitrogen atom had to 
be introduced stereoselectively into the β-position to just one of the esters.   
This work was achieved using the aza-Michael methodology described in the previous 
chapter, PMB amine 325 being added stereselectively and in a satisfactory yield of 47% 
after silica gel chromatography.  The remainder of the yield was accounted for by bis-aza-
Michael addition 435 product (5%) and unreacted 433 (18%), which could be recovered 
during the purification of 434 and then recycled. 
Scheme 119 Asymmetric aza-Michael reaction to introduce amine functionality 
 
5.6 Alcohol Deprotection 
Initially removal of the silyl protecting group was attempted using tetrabutylammonium 
fluoride (TBAF), which is often used as a water-soluble fluoride ion source for removal of 
silyl ether protecting groups (Scheme 120).  However, the desired product 436 was 
isolated in just 3% yield after flash chromatography.  Instead a much larger quantity of 
157 
 
disubstituted pyran 437 was isolated (43% yield).  Formation of side-product 437 was 
rationalised via intramolecular conjugate addition of the deprotected oxygen anion of 
intermediate 438 onto its α,β-unsaturated ester group. 
Scheme 120 Attempted TBAF deprotection of alcohol moiety of 434 
 
 
A recent review of the oxa-Michael reaction by Bräse and Nising highlighted that although 
the reaction is often reversible and suffers from low reactivity, a number of examples have 
been published in the literature, using various nucleophiles, where the reaction has been 
successfully used for the synthesis of complex molecules.41 Indeed, examples such as the 
synthesis of bis-pyran 440 by Palmisano and co-workers (Scheme 121),42 prompted the 
authors to state that this type of oxa-Michael reaction could be a “key tool” for the 
synthesis of tetrahydropyran ring systems.   




Whilst the cyclisation of anion intermediate 439 to tetrahydropyran 440 was a neat 
example of the intramolecular oxa-Michael reaction leading to a complex heterocyclic 
molecule, it was of no use for the synthesis of HTX, so alternative conditions for the silyl 
deprotection were sought.  A careful literature search revealed that the Kibayashi group 
had encountered a similar problem during their synthesis of the natural product (-)-
Vermiculine (Scheme 122).43  When desilylation of 441 was carried out with TBAF in THF 
at 60 °C they also isolated the oxa-Michael product.  However, by using a benzoic acid 
buffered THF solution of TBAF, the de-protected product 442 could be obtained in 65% 
yield. 




Kibiyashi’s method was then successfully applied to the deprotection of 434 (Scheme 
123).  The yield of alcohol 436 after purification by silica gel flash chromatography was 
low at 40%, but subsequent trials proved it to be a reliable protocol. 




5.7 Oxidation attempts 
A great range of reagents and conditions are available to the organic chemist for the 
oxidation of secondary alcohols such as 436 to ketones: chromium reagents (Jones’s 
reagent,44 Collins’s reagent,45 Corey’s reagent46-47); potassium permanganate;48 tetra-
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propylammonium perruthenate (TPAP);49 hypervalent iodine reagents;50 manganese 
dioxide;51 and metal transfer hydrogenation catalysts52-53 to name but a few.  Initially the 
Swern oxidation conditions were trialed as a mild oxidant for the oxidation of secondary 
alcohol 436.  Disappointingly, the standard methodology gave a complex mixture of 
products after complete consumption of the starting material.  Silica gel chromatography 
failed to isolate any of the desired product, but the isolation of para-methoxybenzaldehyde 
345 suggested that the oxidative conditions had resulted in oxidation of the PMB 
protected amine functionality.  Although not anticipated, this additional oxidation is not 
wholly surprising since the oxidative deprotection of PMB amines by oxidants such as 
CAN and DDQ is well-known in the literature.54 In fact, Overton and co-workers have 
previously shown that standard Swern oxidation conditions convert phenyl benzylamine 
443 to methylthiomethyl amine 444 and imine 445 (Scheme 124).55 
Scheme 124 Swern oxidation of phenyl benzylamine 443 
 
 
The oxidation of alcohol 436 was next trialed with the Dess-Martin periodinane reagent 
446 (DMP), since DMP has been found to be a mild oxidant that shows good 
chemoselectivity.56 1.1 equivalents of DMP were used for oxidation of alcohol 436 for one 
hour, before quenching and extraction gave a crude product that was a mixture of starting 
material 436, imine 447 and benzaldehyde 345 in a ratio of 1:1.75:1 (Scheme 125).   




2-Iodoxybenzoic acid (IBX) was then trialed as an oxidant of alcohol 436 since this 
alternative hypervalent iodine reagent has been reported to be even milder than DMP for 
some reactions (e.g. the cleavage of 1,2-diols).57 After stirring the reaction mixture, 
consisting of a DMSO solution of starting material and 1.4 molecular equivalents of IBX, 
for 1 hour only unreacted starting material was recovered.  The reaction was then put 
back on with excess IBX (five equivalents) and heated incrementally whilst following the 
reaction progress by TLC.  Despite heating the reaction at 150 °C for six hours, the 
starting material 436 remained unreacted, with oxidant degradation preventing any further 
reaction. 
 
5.8 Alternative Protecting Group Strategy 
After these oxidation trials, the reserves of alcohol 436 had run out and it seemed an 
opportune time to review the synthetic strategy.  After just five synthetic steps, the thirteen 
carbon backbone had been synthesised and the amine functionality had been introduced 
stereoselectively.  Synthetic efforts could now be focused on the re-synthesis of advanced 
alcohol intermediate 436 and screening for a chemoselective oxidation methodology.  
Alternatively, the synthetic strategy could be modified to overcome the lack of 
chemoselectivity encountered in the alcohol oxidation step in the presence of the PMB 
protected amine functionality.  The latter option was favoured and a strategy was 
designed that incorporated earlier alcohol oxidation followed by protection of the ketone 
functional group as an acetonide, followed by olefin-metathesis and aza-Michael 
methodologies for rapid carbon chain amplification and desymmetrisation (Scheme 126). 




Accordingly alcohol 430 was re-synthesised using Grignard methodology as described 
previously, and then oxidised under Swern oxidation conditions, which furnished ketone 
448 in 97% yield.  Both the 1,3-dioxane 449 (73%) and 1,3-dioxalane 450 (56%) 
acetonides were synthesised via treatment with the corresponding diol in the presence of 
p-TSA in toluene.  Acetonides 449 and 450 were coupled with tert-butyl acrylate 432 using 
Grubb’s 2nd generation ruthenium catalyst in CH2Cl2 to afford bis-α,β-unsaturated esters 4 
(70%) and 451 (62%).  The synthesis of 1,3 dioxane acetal 449 and subsequent alkene 
metathesis proceeded in higher yield, so considering this protecting group is also more 
labile to acid promoted deprotection, it became the acetal protecting group of choice.  
Therefore 4 was then reacted with amine 325 using the previously described chiral ligand 
mediated 303 aza-Michael methodology to afford amine 5 in 40% yield and >97% e.e. 
(Scheme 127).   







5.9 Investigation into Acetal Deprotection 
Two initial attempts at acetal deprotection of aza-Michael product 5, using AcOH/water 
and p-TSA/acetone conditions respectively, yielded complicated poorly resolved 1H NMR 
spectra.  These same conditions were then tested on bis-aza-Michael product 452 in the 
hope that this symmetrical system could clarify what was occurring under these acidic 
conditions (Scheme 128).  Frustratingly, the 1H NMR spectrum of the crude product was 
poorly resolved and very complicated.  However, analysis of the crude products of these 
reactions by mass spectrometry, revealed disappearance of starting material 452 and 
emergence of a new peak with a m/z ratio of 623.4095 - a mass loss of 61.5 that suggests 
acetal deprotection and accompanying dehydration.  This result suggested that not only 
had the acetal group been removed, but that the amino group had reacted 
intramolecularly with the resultant ketone group to afford a cyclic structure.  Further 
analysis of the products by 1H, 13C and 2D experiments in CDCl3 was hampered by the 
poor quality of the resultant spectra, however screening alternative deuterated solvents 
revealed that toluene-d8 gave much cleaner 
1H and 13C NMR spectra that could be 
properly analysed.  This spectral data indicated that the structure of the major product was 
enamine 453.   




The p-TSA/acetone deprotection method was repeated on aza-Michael product 5 and the 
isolated product was analysed in toluene-d8 (Scheme 129).  Now it was apparent that the 
acetal singlet peak had disappeared from both the 1H and 13C spectra, clearly showing 
successful acetal deprotection had occurred.  The structure of the product could be 
assigned as cyclic enamine 454 with the aid of key diagnostic peaks.  In the 13C NMR 
spectrum resonances at 140.5 ppm and 99.6 ppm are due to the enamine carbons C(5) 
and C(10) (Figure 35), a conclusion that is confirmed by a broad resonance at 4.51 ppm in 
the 1H spectrum that is characteristic of the enamine HA.  Careful analysis of cross-peaks 
in the COSY spectrum (Figure 36) suggested that the enamine double bond was 
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endocyclic, since the resonance at 2.39 ppm, which is due to HE, interacts with a 
resonance centred at 1.82 ppm and 1.50 ppm.  If the double bond was exocyclic HE would 
interact with resonances further downfield than 1.50 ppm as the adjacent protons would 
be alkenyl and allylic protons.  This conclusion  agrees with previously reported 
assignments for related 6-alkyl-1,2,3,4-tetrahydropyridines that were found to be 
endocyclic enamines.58-61 








Figure 36 COSY spectrum showing key interactions for cyclic enamine 454 
 
5.10 Amine Deprotection 
Initially, deprotection of the PMB group of amine 5 was trialed using standard oxidative 
CAN methodology.54 The reaction yielded a complex mixture of products in low yield that 
could not be fully characterised, although  para-methoxybenzyaldehyde could be clearly 
seen in the 1H NMR spectrum, showing that some PMB deprotection had occurred.  
However, it was also clear that the acetal resonance at 3.8 ppm was no longer present, 
whilst a resonance at 4.8 ppm that was characteristic of cyclic enamine formation was 
visible.  DDQ oxidative deprotection was also trialed, but did not yield the desired product.  
Instead it gave mixtures of starting material 5, benzaldehyde 345 and imine 455.  As an 
alternative to oxidative deprotection, some other deprotection methods were investigated.  
Strong acid has been used to deprotect 2,4-dimethoxybenzylamines and these conditions 
have been employed to deprotect PMB amines.62  Therefore, 5 was heated in a TFA 
solution or in a (1.25 M) methanolic HCl solution, and in both cases acetal deprotection 
and ester hydrolysis occurred. However, the PMB group was not deprotected.  α-
Chloroethyl choroformate has been shown to deprotect the PMB group from 2o amines.63-
64 This reagent was first trialed for the deprotection of 5, with just acetal deprotection 
observed, and then on enamine 454, which yielded unreacted starting material despite the 
use of dichloroethane in place of CH2Cl2 and forcing reflux conditions. 
The PMB protecting group can be removed, in an analogous fashion to benzyl protected 
amines, under reductive conditions.65 Unfortunately, these conditions also reduce alkene 
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bonds.  However, it was reasoned that amine deprotection with concomitant alkene 
reduction would allow the advanced structure 457 to be synthesised that could then be 
used to trial spirocyclisation conditions.  Accordingly the alkene bond of 5 was first 
reduced in near quantitative yield by cobalt chloride hexahydrate mediated sodium 
borohydride reduction,66 and then the PMB group reduced by hydrogenolysis using one 
atmosphere of hydrogen and Pearlman’s catalyst (Scheme 131).65 Compound 456 was 
then subjected to the p-TSA acetal deprotection and cyclisation methodology developed 
previously for 452, which to our delight gave cyclic imine 457 in good yield.  The 1H NMR 
spectrum of 457 shows that the aromatic and acetal resonances are absent and CHA 
resonance has shifted downfield to 3.83 ppm (Figure 37).  It is clear that 457 exists solely 
as an imine in toluene-d8, since there is no broad enamine resonance centred around 4.5 
ppm in the 1H NMR spectrum (as seen for compounds 453 and 454) and the 13C NMR 
spectrum has no enamine peaks (Figure 38), but instead imine carbon C(3) resonance at 
168.1 ppm adjacent to the carbonyl carbon resonances of C(1) and C(2) at 172.0 ppm 
and 170.8 ppm. 



















5.11 Attempted Spirocyclisation via Ester Enolate-Imine Reactions 
Recently, the Bull group has reported the first diastereoselective intramolecular ester-
enolate imine cyclisation reaction to afford cyclic β-lactams in high d.e. (Scheme 132).2  
This cyclisation reaction was shown to be highly diastereoselective for cyclisation of a 
range of: (i) substituted aryl ω-imino esters (n = 1), giving 90-97% d.e.; (ii) aliphatic ω-
imino esters (n = 1), giving their corresponding β-lactams in 92-94% d.e.; and for an aryl 
ω-imino ester containing an increased chain length (n = 2), affording 464 in a reduced 
yield (57%) and diastereoselectivity (84% d.e.). 
In order to achieve spirocyclisation, this base promoted ester-enolate imine cyclisation 
methodology was investigated using imine 458 as the substrate (Scheme 133).  Initially 
458 was subjected to the optimised ester-enolate imine cyclisation conditions.67  
Therefore, a THF solution of 458 was treated with NHMDS (1.1 meq) and 15-crown-5 (1.1 
meq)  and stirred at -40 °C for 24 hours. Then a standard work-up procedure was followed 
and yielded unreacted starting material 458.  Unperturbed by this negative result, the 
reaction was repeated at room temperature and then at 40 °C, but again only unreacted 
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Scheme 132 Intramolecular stereoselective ester-enolate imine cyclisation reaction, 





starting material was recovered.  The reaction at room temperature was repeated and 
quenched with D2O after one hour to ensure that deprotonation was occurring.  In-process 
LC/MS analysis and the 1H NMR spectrum of the crude product clearly showed that 
inclusion of deuterium was occurring.  The reaction was then repeated at room 
temperature using fresh NHMDS without the crown ether additive without any change in 
the result.  The influence of the base was further investigated by using LHMDS and LDA 
in place of NHMDS, and then by increasing the equivalents of NHMDS to 2.2.  In all cases 
only unreacted starting material 458 was recovered. 





A careful search of the literature showed that although the first example of the asymmetric 
intramolecular ester-enolate imine condensation had only recently been reported by Bull 
and co-workers, there were many reports and comprehensive reviews that describe the 
intermolecular version of this type of enolate-imine cyclisation reaction.68-69 A review of 
these reports revealed that almost all of these reports descibed the reaction of ester-
enolates with aldimines, with only three examples reported of the reaction of ester-
enolates with ketimines (Scheme 134),70-72 and only a few examples of ketimines reacting 
with other nucleophiles.73-78 Researchers have highlighted two major difficulties for the 
reaction of nucleophiles with ketimines: the steric hindrance around the ketimine bond that 
makes new bond formation to a ketimine sp2-carbon unfavourable; and the fact that the 
ketimine group has acidic alpha protons that are rapidly isomerized under basic conditions 
to afford an unreactive enamine anion.  In each of the three examples shown in Scheme 
134 an electron withdrawing group was required to be bound to the ketimine nitrogen for 
the ketimine bond to undergo nucleophilic attack.  




It was reasoned that the main reason for the lack of cyclisation of the enolate of imine 458 
was due to the relatively low reactivity of the ketimine bond.  Therefore, three activation 
strategies were considered for the potential activation of the ketimine bond nucleophilic 
attack (Scheme 135): BrØnsted acid catalysis; Lewis acid catalysis; and derivatisation of 
imine 458 to afford an N-acyliminium ion. 
Scheme 135 Potential ketimine activation strategies 
 
 
5.12 Attempted BrØnsted Acid Catalysed Spirocyclisation 
Canet and co-workers have shown that p-TSA could be used as a BrØnsted acid to 
catalyse the Mannich reaction of ketones to aldimines for the formation of 2,6-
disubstituted piperidines (Scheme 136).79-80 This BrØnsted acid activation has 
subsequently been used by a number of other groups for the Mannich reactions of 
ketimines for the synthesis of ring fused polycyclic alkaloids,81-84 and the Corey group 
have used this activation strategy for a spirocyclisation route to an unnatural HTX 
analogue (Section 5.3.3).20 These reports use a variety of acids, solvents and conditions 
to achieve intramolecular cyclisation by nucleophilic attack of an enol species at a 
charged iminium ion centre.  Interestingly many of these intramolecular cyclisation 
reactions are highly stereoselective due to their transition states adopting well-defined 
conformations that exhibit a pronounced influence on the stereochemical outcome. 
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Scheme 136 Example of intramolecular BrØnsted acid catalysed Mannich-type reaction for 
the synthesis of tetracyclic fused-ring natural product rac-Porantherine 47582  
 
Therefore, the spirocyclisation of 458 was attempted using a series of BrØnsted acid 
conditions.  Four BrØnsted acids in various solvents at room temperature, 50 °C and 100 
°C were screened for their ability to catalyse the spirocyclisation of enamine 458 (Table 
14).  Treatment of 458 with (1.25 M) methanolic HCl led to partial transesterification to the 
corresponding methyl esters at room temperature and full transesterification at 50 °C 
(Entry 1).  H2SO4 in MeCN (or DMSO) resulted in hydrolysis of the ester groups of 458, 
with no evidence of any spirocyclisation having occurred (Entry 2 and 3).  Treating with 
TFA in DMSO gave no reaction (Entry 4), whilst TFA in toluene gave a intractable sticky 
brown solid as did p-TSA in toluene (Entry 5 and 6).   
Table 14 Attempted BrØnsted acid catalysed spirocyclisation of enamine 458 
 
Entry Acid Solvent Result 
1 aHCl Methanol 
Partial-complete 
transesterification 
2 bH2SO4 MeCN Ester hydrolysis 
3 bH2SO4 Dioxane Ester hydrolysis 
4 cTFA DMSO No reaction 
5 cTFA Toluene 
Insoluble brown 
solid 
6 dp-TSA Toluene 
Insoluble brown 
solid 
Reactions run on a 0.02 mmol scale at rt, 50 °C and 100 °C for 24 hours under N2. (a) 1.25M solution; (b) 
0.05M solution; (c) 30 eq.; (d) 1 eq. 
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5.13 Attempted Spirocyclisation of N-Acyliminium Ions 
N-acyliminium ions 479 have been shown to be versatile reactive electrophiles and have 
been the subject of a number of reviews in recent years.89-93  Because of their high 
reactivity they are nearly always generated in situ from more stable precursors of the 
general structure 478, with acid or heat employed to break a C-X bond (Scheme 137).  
When X is an alkoxy substituent, the precursor is generally a stable molecule requiring the 
addition of a BrØnsted or Lewis acid to break the C-O bond and generate the N-
acyliminium ion (Scheme 138 and 139).  
Scheme 137 Standard in situ generation of N-acyliminium ion 
 
 
For example, Aggarwal and co-workers have shown that N,O-aminal amide 481 can be 
used to generate an N-acyliminium ion by treatment with BF3.OEt2, which then undergoes 
a Baylis-Hillman reaction mediated by dimethyl sulfide to afford a [4.4] spirocycle (Scheme 
138).94 This suggests that if a similar N,O-aminal amide of imine 458 could be synthesised 
then it might undergo an intramolecular Mannich-type reaction to from a spirocycle, and 
also that this methodology could potentially be applied to the Baylis-Hillman reaction 
required for the synthesis of HTX. 
Scheme 138 Intramolecular Baylis-Hillman reaction of N-acyliminium ion generated in situ 
from N,O-aminal amide 488 
 
 
N,O-acylaminals can be synthesised in a number of ways: by the intramolecular reaction 
of amides with aldehydes to generate a five- or six-membered ring;95 the partial reduction 
of imides by DIBAL or NaBH4;
96 the addition of one equivalent of a Grignard reagent to an 
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imide;97 or the electrochemical oxidation of amides, carbamates and N-acylated amino 
acids.98-99 Unfortunately the synthesis of 4° N,O-acylaminals, much like the reaction of 
nucleophiles with ketimines rather than aldimines, is not so trivial due to both the 
increased steric strain and the presence of enolisable acidic alpha protons.  In fact there 
are only a handful of examples where the synthesis of 4° N,O-acylaminals has been 
reported.100-106 Of these the synthesis of N,O-aminal 484 by the treatment of imines with 
diethyl pyrocarbonate 483 reported by Speckamp appeared to be most relevant (Scheme 
139).107 
 
Scheme 139 Speckamp synthesis of N,O-acylaminal 492 
 
When this methodology was applied to imine 458, the desired N,O-acylaminal was not 
isolated. Instead enolisation of intermediate N-acyliminium ion occurred before the 
intermediate iminium species could be trapped by an ethoxide anion, yielding N-acyl 
enamine 485 in good yield and purity (Scheme 140). More recently Le Grognec and co-
workers have developed the original Speckamp methodology by the use of microwave 
heating to generate N,O-acylaminals in faster times and in some cases bearing enolisable 
protons.108 Therefore the Le Grognec methodology was trialed with imine 458 (Scheme 
140). Frustratingly this methodology again afforded N-acyl enamine product 485, with 
longer reaction times resulting in hydrolysis to afford the open chain ketone 486. 






This chapter has described attempts towards the total synthesis of HTX and, whilst the 
synthesis is frustratingly incomplete, it is the author’s belief that this chemistry is now well 
positioned to achieve a successful spirocyclisation reaction and elaboration of the 
resultant spiropiperidine intermediate to HTX. 
 
A number of objectives have been achieved on the way to synthesising HTX: the acyclic 
carbon backbone of HTX has been synthesised; oxidation problems have been overcome 
by altering the protecting group strategy; the first chiral centre and amine functionality 
have been introduced with high enantioselectivity; and initial cyclisation of the piperidine 
ring of HTX has been realised. A positive outcome of these synthetic efforts is the 
discovery that N-trimethylsilyl-para-methoxybenzylamide 325 gives excellent levels of 
enantioselectivity for the chiral ligand 303 mediated aza-Michael reaction, which can be 
applied to the aza-Michael addition for a wide range of α,β-unsaturated tert-butyl esters.  
By conducting unsuccessful spirocyclisation trials using basic and BrØnsted acid catalysts, 
the relatively low reactivity of the ketimine bond to an intramolecular nucleophilic reaction 
has been highlighted. 
 
No doubt the oxidative deprotection of the nitrogen functionality can be optimised after 
more trials. This would give good quantities of 427 that could be used for an intra-
molecular aza-Baylis Hillman reaction-a reaction that Aggarwal and co-workers have 
previously demonstrated can be used for the spirocyclisation of N-acyliminium ions to 
synthesise [4.4] spirocycles.  If methodology could be developed for the synthesis of an 4° 
N,O aminal, it would serve as an excellent precursor for the aza-Baylis Hillman reaction 
and this methodology would undoubtedly be of great interest to the wider synthetic 
chemistry community (Scheme 141). Alternatively, the investigation of Lewis acid catalysis 
for the intramolecular Mannich reaction and the aza-Baylis Hillman reaction would be 
worthwhile and if successful would represent the first Lewis acid catalysed aza-Baylis 
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Chapter 6 Experimental Procedures and Data 
 
6.1 General Conditions 
 
Reactions that required the use of dry solvents were conducted in oven dried glassware 
under an atmosphere of nitrogen using inert atmosphere techniques.  Dry solvents were 
obtained by passing through anhydrous alumina columns using an Innovative Technology 
Inc. PS-400-7 solvent purification system.  Petrol refers to the fraction of petroleum ether 
boiling at 40-60 °C.  Hexanes refers to the hexane fraction of petroleum.  Solvents were 
evaporated on a Büchi Rotorvapor. 
1H and 13C NMR were run in CDCl3, toluene-d8, DMSO-d6, methanol-d4 and D2O using 
Bruker Avance 250/300/400/500 MHz spectrometers.  Chemical shifts (δ) are quoted in 
parts per million and are referenced to the residual solvent peak.  The multiplicities and 
general assignments of spectroscopic data are denoted as: singlet (s), doublet (d), triplet 
(t), quartet (q), quintet (quint), doublet of doublets (dd), triplet of doublets (td), triplet of 
triplets (tt), multiplet (m), aromatic (Ph), obscured (obs.) and apparent (app.).  Coupling 
constants (J) are quoted to the nearest 0.1 Hz.  All structural assignments of both 1H and 
13C NMR spectra were achieved with the aid of COSY, HMQC, HMBC and TOCSY 
experiments wherever possible and with comparisons from analogous previously reported 
compounds. 
Infra red spectra were recorded on a Perkin Elmer Spectrum 100 FT-IR spectrometer, 
using a Universal ATR accessory for sampling, with only selected absorbances quoted as 
ν  in cm-1. 
Mass spectra were recorded on a micrOTOF electrospray time-of-flight (ESI-TOF) mass 
spectrometer (Bruker Daltonik GmbH, Bremen, Germany), using acetonitrile or water to 
dissolve the sample. 
TLC was carried out using commercially available polyethylene backed plates coated with 
Merck Kieselgel 60 GF254.  Plates were visualised under UV light (at  254 nm) or by 
staining with potassium permanganate, ninhydrin or phosphomolybdic acid followed by 
heating.  Flash chromatography was performed under manually generated medium 
pressure using Merck 60 H silica gel (35-75 μm) unless otherwise stated stated.  Samples 
were loaded as saturated solutions in an appropriate solvent or adsorbed onto 2 mass 
equivalents of the column solid phase material.  
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ORD measurements were recorded on a Jasco J-600 spectrometer scanning from 400 
nm to 204 nm using a cell with a cell length of 0.2 cm.  The samples were dissolved in 
D2O-MeOH (1:1) at a concentration of 6.6 mM. 




6.2 Procedures and Data for Chapter 2 
 




ZnCl2 (125 g, 0.918 mol) was dissolved in dry acetone (770 mL) and cooled to 20 °C.  D-
Mannitol 179 (80 g, 0.439 mol) was added and the solution stirred at room temperature for 
22 hours.  K2CO3 (127 g, 0.919 mol) dissolved in water (130 mL) was then added to the 
vigorously stirred reaction mixture, which was cooled with ice/water to maintain a 
temperature of <5 °C.  The precipitate was removed by filtration and washed with CH2Cl2 
(2 x 200 mL).  The aqueous filtrate was made basic by the addition of concentrated 
NH4OH(aq) (1 mL), before concentration in vacuo.  The resulting solid was dissolved in 
CH2Cl2 (500 mL), washed once with water (100 mL), dried over anhydrous MgSO4, filtered 
and concentrated in vacuo to a cream solid.  Recrystallisation from boiling CCl4 afforded 
the title compound as white crystalline needles (61 g, 53% yield).      
   +1.9 (c 1.6, 
MeOH) (lit.2      
   +2.0 (c 2.0, MeOH)); mp. 119.5-121 °C (lit.2 mp. 118-120 °C); 1H NMR 
(300 MHz, CDCl3) δH = 4.16-4.08 (2H, m, CHCHOH), 4.06 (2H, dd, J = 8.5 and 6.4 Hz, 
CHAHBCH), 3.90 (2H, dd, J = 8.5 and 5.8 Hz, CHAHBCH), 3.68 (2H, d, J = 6.2 Hz, CHOH), 
1.35 (6H, s, C(CAH3)2), 1.29 (6H, s, C(C
BH3)2); 
13C NMR (75 MHz, CDCl3) δC = 109.4, 75.5, 
71.3, 66.8, 26.7, 25.2; IR (thin film)  υmax (cm
-1): 3310 (br., OH); HRMS (ESI): m/z 
263.1473, C12H23O6 [M+H]









To a suspension of 180 (5.20 g, 19.8 mmol) in CH2Cl2 (17 mL) was added saturated 
NaHCO3(aq) (1.9 mL).  NaIO4 (8.50 g, 39.6 mmol) was then added slowly, maintaining the 
temperature below 25 °C.  The reaction mixture was stirred at room temperature and 
monitored by TLC (Et2O-hexane, 2:1, Rf = 0.24).  After 2 hours the suspension was 
filtered and the filtrate concentrated at 55 °C under atmospheric pressure.  Distillation of 
the residue afforded the title compound as a colourless oil (3.30 g, 65% yield).      
   
+60.4 (c 2.25, EtOAc) (lit.4     
   +59.7 (c 4.1, CHCl3)); bp. 74-76 °C @ 35 Torr (lit.
5 bp. 
67-73 °C @ 30 Torr); 1H NMR (300 MHz, CDCl3) δH = 9.74 (1H, d, J = 1.9 Hz, CHO), 4.41 
(1H, ddd, J = 7.5, 4.8 and 1.8 Hz, CHCHO), 4.20 (1H, dd, J = 8.8 and 7.4 Hz, CHAHB), 
4.12 (1H, dd, J = 8.8 and 4.8 Hz,  CHAHB), 1.51 (3H, s, CAH3), 1.44 (3H, s, C
BH3); 
13C 
NMR (75 MHz, CDCl3) δC = 201.8, 111.3, 79.8, 65.6, 26.2, 25.1; IR (thin film)  υmax (cm
-1): 
1734 (m, C=O); HRMS (ESI): m/z 131.0681, C6H11O3 [M+H]






Under an inert atmosphere (S)-(−)-α-methylbenzylamine (0.041 ml, 0.325 mmol) was 
added to a solution of aldehyde 181 (21 mg, 0.163 mmol) in dry MeOH (0.2 mL) and 
stirred over 3Å MS for 12 h.  The reaction mixture was then cooled to 0 °C before the 
careful addition of sodium borohydride (3 mg, 0.082 mmol).  The reaction was monitored 
by TLC and upon complete consumption of the intermediate (CH2Cl2-MeOH, 20:1, Rf = 
0.41) the reaction was concentrated in vacuo.  The residue was partioned between 
CH2Cl2 and water, and the organic layer washed twice more before being dried over 
anhydrous MgSO4 and concentrated in vacuo to afford the title compound as a white solid 
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(37 mg, 96% yield).      
   −45.1 (c 1.2, CDCl3); Rf = 0.11 (CH2Cl2-MeOH, 20:1); 
1H NMR 
(300 MHz, CDCl3) δH = 7.30-7.20 (5H, m, Ph), 4.26 (1H, qd, J = 6.5 and 4.1 Hz, 
CHCH2NH), 4.05 (1H, dd, J = 8.0 and 6.4 Hz, CH
AHBCH), 3.81 (1H, q, J =6.6 Hz,  
CHCH3), 3.72 (1H, dd, J = 7.9 and 6.6 Hz, CH
AHBCH), 2.71 (1H, dd, J = 12.1 and 4.1 Hz, 
CHAHBNH), 2.58 (1H, dd, J = 12.1 and 6.8 Hz, CHACHBNH), 1.53 (1H, br. s, NH), 1.32 
(3H, s, CCAH3C




(75 MHz, CDCl3) δC = 145.5, 128.5, 126.9, 126.8, 109.1, 75.3, 67.4, 58.3, 50.1, 26.9, 25.5, 
24.6; IR (thin film)  υmax (cm
-1): 3026 (w, Csp2-H), 2986 (w, Csp3-H); HRMS (ESI): m/z 
258.1448, C14H21NNaO2 [M+Na]






To a solution of aldehyde 181 (1.00 g, 7.74 mmol) in dry THF (5 mL), cooled to 0 °C, were 
added zinc dust (1.01 g, 15.5 mmol) and allyl bromide (1.87 g, 15.5 mmol).  Saturated 
NH4Cl(aq) (3 mL) was then added to the reaction mixture over 10 minutes, maintaining the 
temperature between 0-5 °C. The reaction mixture was then allowed to warm to room 
temperature and monitored by TLC (EtOAc-petrol, 1:1, Rf = 0.22).  After 24 hours no 
starting material was detected, therefore the reaction mixture was filtered through celite 
and the THF removed in vacuo.  The residue was partitioned between water and CH2Cl2 
and the aqueous layer further extracted with CH2Cl2 (2 x 20 mL). The combined organic 
extracts were then dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
afford the title compound as a colourless oil (0.87 g, 65% yield), which required no further 
purification.  
Major diastereomer6 182 
 
 
1H NMR (300 MHz, CDCl3) δH = 5.94-5.72 (1H, m, CH=CH2), 5.20-5.05 (2H, m, CH=CH2), 
4.07-3.84 (3H, m, OCH2-CH), 3.80-3.66 (1H, m, CHOH), 2.44-2.32 (1H, br. s, OH), 2.32-
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2.08 (2H, m, CH2CH=CH2), 1.40 (3H, s, CC
AH3C




(75 MHz, CDCl3) δC = 133.2, 117.1, 108.1, 77.2, 69.6, 64.4, 36.7, 25.6, 24.3.  
Minor diastereomer7 189 
 
 
1H NMR (300 MHz, CDCl3) δH = 5.94-5.72 (1H, m, CH=CH2), 5.20-5.05 (2H, m, CH=CH2), 
4.07-3.84 (3H, m, CH2-CH), 3.63-3.51 (1H, m, CHOH), 2.57-2.46 (1H, br. s, OH), 2.32-
2.08 (2H, m, CH2CH=CH2), 1.40 (3H, s, CC
AH3C




(75 MHz, CDCl3) δC = 133.1, 116.7, 108.4, 77.6, 70.6, 65.0, 37.2, 25.6, 24.3. 
Mixture of the 2 diastereomers (ratio 6 : 1): 
    
   +11.8 (c 2.5, CH2Cl2); IR (thin film) υmax (cm
-1): 3467 (br., OH); HRMS (ESI): m/z 
195.0984, C9H16NaO3 [M+Na]






To a solution of alcohols 182 and 189 (0.50 g, 2.90 mmol) in dry THF (3.8 mL) at 0 °C was 
added potassium tert-butoxide (0.46 g, 4.06 mmol) and the mixture stirred for 5 minutes.  
Benzyl bromide (0.60 g, 3.48 mmol) was then added dropwise, whilst maintaining the low 
temperature. When the addition was complete, the cooling bath was removed and the 
reaction mixture was stirred at room temperature.  After 5 hours TLC analysis showed that 
the reaction had gone to completion, so the reaction mixture was quenched by the 
addition of saturated NH4Cl(aq) (21 mL) and extracted with EtOAc (3 x 20 mL).  The 
combined organic extracts were washed with water and brine, then dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to give a yellow oil, which was purified by silica 
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gel chromatography (petrol-EtOAc, 50:1, Rf = 0.2) to afford the title compound as a 
colourless oil (0.41 g, 54% yield). 
Major diastereomer8 183 
 
 
    
   +61.48 (c 3.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3) δH = 7.32-7.15 (5H, m, Ph), 5.92-
5.73 (1H, m, CH=CH2), 5.13-4.98 (2H, m, CH=CH2), 4.59 (1H, d, J = 11.4 Hz, PhCH
AHB), 
4.54 (1H, d, J = 11.4 Hz, PhCHAHB), 4.08-3.92 (2H, m, OCH2CH), 3.82 (1H, dd, J = 7.7 
and 6.1 Hz, CH-CH-OBn), 3.50 (1H, app. q, J = 5.7 Hz, CHOBn), 2.44-2.19 (2H, m, 
CH2CH=CH2), 1.35 (3H, s, CC
AH3C
BH3), 1.28 (3H, s, CC
AH3C
BH3); 
13C NMR (75 MHz, 
CDCl3) δC = 138.4, 134.2, 128.4, 127.8, 127.7, 117.5, 109.1, 78.9, 77.2, 72.5, 66.4, 35.6, 
26.7, 25.4; IR (thin film) υmax (cm
-1): 1641 (w, C=C); HRMS (ESI): m/z 285.1442, 
C16H22NaO3 [M+Na]
+ requires 285.1467. 
 
Minor diastereomer9 190 
 
 
    
   +4.0 (c 3.1, CH2Cl2); 
1H NMR (300 MHz, CDCl3) δH = 7.41-7.32 (5H, m, Ph), 5.94-
5.83 (1H, m, CH=CH2), 5.21-5.06 (2H, m, CH=CH2), 4.73 (1H, d, J = 11.9 Hz, PhCH
AHB), 
4.68 (1H, d, J = 11.9 Hz, PhCHAHB), 4.23 (1H, app. q, J = 6.8 Hz, CH-CH-OBn), 4.00 (1H, 
dd, J = 8.2 and 6.7 Hz, CHAHBO), 3.73 (1H, dd, J = 8.2 and 7.4 Hz, CHAHBO), 3.53 (1H, 
dt, J = 6.8 and 4.4 Hz, CHOBn), 2.29-2.20 (2H, m, CH2CH=CH2), 1.45 (3H, s, 
CCAH3C
BH3), 1.39 (3H, s, CC
AH3C
BH3);  
13C NMR (75 MHz, CDCl3) δC = 138.7, 134.6, 
128.3, 127.8, 127.6, 117.2, 109.3, 79.3, 77.9, 72.6, 65.8, 35.3, 26.6, 25.5; IR (thin film) 
υmax (cm









Under an inert atmosphere, OsO4 (0.01 g, 0.0381 mmol) was added to a solution of the 
alkene 183 (0.10 g, 0.381 mmol) in acetone/water (8:1, 2.9 mL).  After 5 minutes 4-methyl 
morpholine N-oxide (50 wt% aq. soln., 49 mg, 0.419 mmol) was added and the reaction 
mixture stirred for a further 48 hours.  The reaction mixture was then concentrated in 
vacuo and the residue purified by silica gel chromatography (EtOAc, Rf = 0.47) to afford 
the title compound as a colourless oil (0.08 g, 71% yield).  Major diastereomer8: 1H NMR 
(300 MHz, CDCl3) δH = 7.30-7.22 (5H, m, Ph), 4.69 (1H, d, J = 11.3 Hz, CH
AHBPh), 4.54 
(1H, d, J = 11.3 Hz, CHAHBPh), 4.17-3.96 (2H, m, CH2O), 3.91-3.77 (2H, m, CH2OH), 
3.77-3.65 (1H, m, CHO), 3.57-3.46 (1H, m, CHOH), 3.41-3.32 (1H, m, CHOBn), 2.71 (1H, 
br. s, OH), 1.73-1.64 (2H, m, CH2CHOBn), 1.38 (3H, s, CC
AH3C
BH3), 1.29 (3H, s, 
CCAH3C
BH3); 
13C NMR (75 MHz, CDCl3) δC = 137.7, 128.6, 128.1, 127.9, 109.3, 77.9, 
77.0, 72.9, 70.2, 66.6, 66.1, 34.5, 26.4, 25.1. Minor diastereomer8: 1H NMR (300 MHz, 
CDCl3) δH = 7.30-7.22 (5H, m, Ph), 4.59 (2H, s, CH2Ph), 4.17-3.96 (2H, m, CH2O), 3.91-
3.77 (2H, m, CH2OH), 3.77-3.65 (1H, m, CHO), 3.57-3.46 (1H, m, CHOH), 3.41-3.32 (1H, 
m, CHOBn), 2.71 (1H, br. s, OH), 1.65-1.55 (2H, m, CH2CHOBn), 1.35 (3H, s, 
CCAH3C
BH3), 1.29 (3H, s, CC
AH3C
BH3); 
13C NMR (75 MHz, CDCl3) δC = 138.0, 128.5, 
128.1, 128.0, 109.4, 78.0, 77.7, 73.0, 68.9, 67.0, 66.5, 34.3, 26.5, 25.2. Mixture of the 2 
diastereomers (ratio 1:0.9):     
   −1.7 (c 1.1, CH2Cl2); IR (thin film) υmax (cm
-1): 3382 (br., 
OH); HRMS (ESI): m/z 295.1541, C16H23O5 [M-H]
- requires 295.1545. 
 






Method 111:  
To a solution of IBX (2.30 g, 8.20 mmol) in DMSO (25 mL) was added diol 191 (0.30 g, 
2.05 mmol) and the reaction was stirred at room temperature for 5 hours, whereupon TLC 
analysis showed that the reaction had gone to completion. The reaction mixture was 
diluted with water (30 mL) and extracted with Et2O (3 x 50 mL).  The combined organic 
extracts were dried over anhydrous MgSO4, filtered and concentrated in vacuo to afford 
the title compound as a white solid (0.21 g, 65% yield). 
Method 212:  
To a solution of octan-1,2-diol 191 (0.10 g, 0.684 mmol) in acetone (10.5 mL) was added 
5%  NaHCO3(aq) (3.6 mL).  After cooling the reaction mixture to 0 °C it was treated with 
KBr (0.013 g, 0.137 mmol) and TEMPO (0.23 g, 1.50 mmol), followed by the dropwise 
addition of 0.63 M NaClO(aq) (2.73 ml, 1.78 mmol).  After 1 hour a further portion of 0.63 
M  NaClO(aq) (1.05 ml, 0.684 mmol) was added dropwise and the solution was stirred at 0 
°C for 2 hours.  The reaction was then quenched by the addition of 5% NaHCO3(aq) (5.5 
mL) and concentrated in vacuo to reduced volume.  The basic aqueous residue was 
washed with Et2O (2 x 20 mL), acidified to pH 3 by the careful addition of 2 M HCl and 
then extracted with EtOAc (3 x 50 mL). The combined organic extracts were washed with 
water and brine, then dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
afford the title compound as a white solid (97 mg, 90% yield). 
Mp. 48-50 °C (lit.10 mp. 50-55 °C); 1H NMR (300 MHz, CDCl3) δH = 9.76 (1H, br. s, 
COOH), 2.86 (2H, t, J = 7.3 Hz, CH2C=O), 1.58 (2H, qn(is, J = 7.3 Hz, CH2CH2C=O), 
1.34-1.18 (6H, m, CH2CH2CH2), 0.82 (3H, t, J = 6.8 Hz, CH3CH2); 
13C NMR (75 MHz, 
CDCl3) δC = 195.8, 160.7, 37.7, 31.4, 28.6, 23.0, 22.4, 14.0; IR (thin film) υmax (cm
-1): 3066 
(br., OH), 1702 (s, C=O); HRMS (ESI): m/z 157.0871, C8H13O3 [M-H]
- requires 157.0865. 
 




To a solution of octan-1,2-diol 191 (0.30 g, 2.05 mmol) in acetonitrile/water (2:1 v/v, 27 
mL) was added 2-iodobenzoic acid (0.102 g, 0.41 mmol) and oxone (2.27 g, 3.69 mmol).  
The mixture was stirred at 70 °C for 6 hours and then cooled in an ice bath. The 
suspension was filtered and the solid residue washed with EtOAc (50 mL).  The combined 
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filtrates were extracted with EtOAc (100 mL)  and the organic phase was washed with 
water (2 x 50 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
afford the title compound as a yellow oil (0.23 g, 71% yield). 1H NMR (300 MHz, CDCl3) δH 
= 11.2 (1H, br. s, COOH), 2.28 (2H, t, J = 7.5 Hz, CH2C=O), 1.58 (2H, quintet, J = 7.5 Hz, 
CH2CH2C=O), 1.35-1.16 (6H, m, CH2CH2CH2), 0.82 (3H, t, J = 6.8 Hz, CH3CH2); 
13C NMR 
(75 MHz, CDCl3) δC = 180.5, 34.1, 31.4, 28.7, 24.6, 22.5, 14.0; IR (thin film) υmax (cm
-1): 








To a solution of (-)-2,3-O-isopropylidine-D-erythronolactone 197 (4.73 g, 29.9 mmol) in dry 
CH2Cl2 (85 mL) at -78 °C and under inert atmosphere, a solution of DIBAL (1.0 M in 
hexane, 34.3 ml, 34.4 mmol) was added dropwise.  After stirring the mixture at reduced 
temperature for 2 hours, TLC (EtOAc-toluene, 1:1) showed the reaction had gone to 
completion.  MeOH (5 mL) was added dropwise and the mixture was then poured, with 
care, into a rapidly stirred ice/water mixture (75 mL).  The suspension was filtered through 
celite and the filtered solids washed well with Et2O.  The combined filtrates were dried 
over anhydrous MgSO4, filtered and concentrated in vacuo to afford the title compound as 
a colourless oil which required no further purification (3.11 g, 65% yield).      
   +75.0 (c 
1.12, CHCl3);  Rf = 0.47 (EtOAc-toluene, 1:1); 
1H NMR (300 MHz, CDCl3) δH = 5.35 (1H, b, 
CHOH), 4.77 (1H, dd, J = 5.8 and 3.2 Hz, CHCH2), 4.51 (1H, d, J = 5.8 Hz, CHCHOH), 
4.01 (1H, dd, J = 10.4 and 3.4 Hz, CHAHB), 3.95 (1H, d, J = 10.4 Hz, CHAHB), 2.74 (1H, br. 
s, OH), 1.40 (3H, s, CCAH3C
BH3), 1.25 (3H, s, CC
AH3C
BH3); 
13C NMR (75 MHz, CDCl3) δC 
= 112.3, 101.7, 85.2, 79.9, 71.8, 26.2, 24.7; IR (thin film) υmax (cm
-1): 3421 (br., OH); 
HRMS (ESI): m/z 183.0629, C7H12NaO4 [M+Na]










Ethyl glyoxalate (48 ml of a ~50 wt% toluene solution, 0.230 moles) was cracked at reflux 
for 1 hour.  On cooling to room temperature, toluene (260 mL), dimethyl phosphate (26.4 
ml, 0.200 moles) and para-toluenesulfonic acid monohydrate (0.140 g, 0.740 mmol) were 
added sequentially and the reaction mixture was heated at reflux for 16 hours.  After 
cooling, the solution was concentrated in vacuo to a yellow oil, which was purified by silica 
gel chromatography (CH2Cl2-MeOH, 50:1, Rf = 0.2) to afford the title compound as a 
colourless oil (28.3 g, 71% yield).  1H NMR (300 MHz, CDCl3) δH = 4.56 (1H, d, J = 16.2 
Hz, CHOH), 4.36-4.24 (2H, m, CH2CH3), 3.84 (3H, d, J = 3.9 Hz, OC
AH3), 3.80 (3H, d, J = 
3.9 Hz, OCBH3), 1.29 (3H, t, J = 7.2 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 169.2 
(d, J = 1.8 Hz), 68.7 (d, J = 155.1 Hz), 62.7, 54.3 (d, J = 6.3 Hz), 54.0 (d, J = 6.3 Hz), 
14.0; 31P (122 MHz, CDCl3) δP = 19.0; IR (thin film) υmax (cm
-1): 3229 (br., OH), 1752 (s, 
C=O); HRMS (ESI): m/z 213.0531, C6H14O6P [M+H]
+ requires 213.0528. 
 




To a stirred solution of 204 (19.1 g, 0.09 moles) in CH2Cl2 (1.4 L) was added imidazole 
(18.4 g, 0.271 moles), DMAP (1.65 g, 0.014 moles) and tert-butyldimethylsilyl chloride 
(27.2 g, 0.181 moles). The mixture was stirred at room temperature for 18 hours when 
TLC analysis (EtOAc-petrol, 1:1) showed that the reaction had gone to completion.  The 
reaction mixture was washed with saturated NaHCO3(aq), dried over anhydrous MgSO4, 
filtered and concentrated in vacuo.  The residue was purified by silica gel chromatography 
(EtOAc-petrol, 1:2-1:1), to afford the title compound as a colourless oil (24 g, 81% yield). 
Rf = 0.35 (EtOAc-petrol, 1:1); 
1H NMR (300 MHz, CDCl3) δH = 4.51 (1H, d, J = 18.6 Hz, 
CHOSi), 4.23-4.11 (2H, m, CH2CH3), 3.75 (3H, d, J = 4.9 Hz, OC
AH3), 3.71 (3H, d, J = 4.9 




13C NMR (75 MHz, CDCl3) δC = 168.4 (d, J = 2.5 Hz), 70.6 (d, J = 161 Hz), 61.9, 
54.2 (d, J = 4.4 Hz), 54.1 (d, J = 4.5 Hz), 25.5, 18.4, 14.1, -5.4 (d, J = 12.2 Hz); 31P (122 
MHz, CDCl3) δP = 18.9; IR (thin film) υmax (cm
-1): 1753 (m, C=O); HRMS (ESI): m/z 
327.1376, C12H28O6PSi [M+H]







A dry THF (24 mL) solution of LHMDS (1.0 M in THF, 21.5 ml, 21.5 mmol) was cooled to -
78 °C. Ethyl 2-((tert-butyldimethy-lsilyl)oxy)-2-(dimethoxyphosphoryl)acetate 1 (6.20 g, 
19.0 mmol) was dissolved in dry THF (24 mL) and the solution added dropwise. The 
reaction mixture was stirred for a further 10 minutes following the addition.  A THF (24 mL) 
solution of (3aS,6aR)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol 198 (3.04 g, 19.0 
mmol) was then added dropwise.  The reaction mixture was then stirred for another 5 
minutes before being allowed to warm to 0 °C.  Once TLC (EtOAc-toluene, 1:1) confirmed 
the reaction had gone to completion, the suspension was poured into Et2O (290 mL), 
washed sequentially with 1 M HCl(aq) and saturated NaHCO3(aq), dried over anhydrous 
MgSO4, filtered and concentrated in vacuo.  The residue was purified by silica gel 
chromatography (EtOAc-petrol, 1:20 to 1:1) to give the title compound as a colourless oil 
(4.58 g, 67% yield).      
   +31.3 (c 1.5, CHCl3); 
1H NMR (300 MHz, CDCl3) δH = 5.57 (1H, 
d, J = 7.8 Hz, C=CH), 5.48-5.43 (1H, m, CHCH=C), 4.50 (1H, td, J = 6.4 and 4.2 Hz, 
CHCH2OH), 4.32-4.23 (2H, m, OCH2CH3), 3.65 (1H, dd, J = 11.2 and 4.3 Hz, HOCH
AHB), 
3.57 (1H, dd, J = 11.2 and 6.2 Hz, HOCHAHB),  2.08 (1H, br. s, OH), 1.56 (3H, s, 
CCAH3C
BH3), 1.44 (3H, s, CC
AH3C
BH3), 1.37 (3H, t, J = 7.2 Hz, OCH2CH3), 0.99 (9H, s, 
C(CH3)3, 0.21 (6H, s, Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 164.5, 142.2, 121.2, 
115.6, 109.0, 108.6, 78.71, 73.8, 62.2, 61.4, 27.7, 25.8, 25.5, 25.0, 18.2, 4.2, -4.8, -4.9; IR 
(thin film) υmax (cm
-1): 3492 (br., OH), 1726 (m, C=O), 1641 (w, C=C); HRMS (ESI): m/z 
383.1877, C17H32NaO6Si [M+Na]









In oven-dried glassware under inert atmosphere CsF (0.819 g, 5.39 mmol) and AcOH 
(0.770 ml, 13.5 mmol) were added to a solution of 199 (0.970 g, 2.69 mmol) in dry MeCN 
(97 mL) at 0 °C.  The resulting mixture was stirred at 0 °C for a further 30 minutes and 
then at room temperature.  After 30 minutes TLC analysis (EtOAc-petrol, 1:2) showed 
complete consumption of starting material 199, so the reaction mixture was diluted with 
EtOAc (300 mL) and petrol (300 mL), washed with saturated NaHCO3(aq), dried over  
anhydrous MgSO4, filtered and concentrated in vacuo to afford the title compound as a 
yellow oil (0.603 g, 91% yield).   
Major isomer β-200 
 
1H NMR (300 MHz, CDCl3) δH = 4.42-4.33 (1H, m, CHCH2COH), 4.22-4.12 (2H, m, 
OCH2CH3), 4.09-4.05 (1H, m, CHCHCH2COH), 4.03 (1H, dd, J = 12.5 and 2.9 Hz, 
OCHAHB), 3.94 (1H, br. s, OH), 3.90 (1H, dd, J = 12.5 and 2.0 Hz, OCHAHB), 2.21 (1H, dd, 
J = 13.6 and 8.2 Hz, CHAHBCOH), 1.93 (1H, dd, J = 13.6 and 6.1 Hz, CHAHBCOH), 1.40 
(3H, s, CCAH3C
BH3), 1.24 (3H, s, CC
AH3C
BH3), 1.22 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C 
NMR (75 MHz, CDCl3) δC = 169.9, 108.8, 94.3, 71.2, 69.2, 62.5, 61.6, 33.2, 27.6, 25.8, 
14.0.  
Minor isomer α-200  
 
1H NMR (300 MHz, CDCl3) δH = 4.50-4.41 (1H, m, CHCH2COH), 4.24-4.11 (3H, m, 
CHCHCH2COH, OCH2CH3), 3.80 (1H, dd, J = 12.4 and 5.9 Hz, OCH
AHB), 3.72 (1H, dd, J 
= 12.4 and 4.9 Hz, OCHAHB), 2.33 (1H, dd, J = 15.1 and 4.4 Hz, CHAHBCOH), 2.08 (1H, 
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dd, J = 15.1 and 5.4 Hz, CHAHBCOH), 1.44 (3H, s, CCAH3C
BH3), 1.26 (3H, s, CC
AH3C
BH3), 
1.23 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 169.5, 109.4, 94.2, 
70.9, 70.6, 62.6, 62.3, 32.2, 27.2, 25.0, 14.0. 
Mixture of the 2 isomers (ratio 3:1): 
    
   +38.8 (c 1.60, CH2Cl2); Rf = 0.32 (EtOAc-petrol, 1:2); IR (thin film) υmax (cm
-1): 3429 
(br., OH), 1743 (m, C=O); HRMS (ESI): m/z 269.0996, C11H18NaO6 [M+Na]
+ requires  
269.1001. 
 




Preparation from 200 employing method 2 used for the synthesis of D-KDX afforded the 
title compound as a yellow viscous oil (0.59 g, 85% yield). 
β-pyranose (45%)  
 
1H NMR (500 MHz, CDCl3) δH = 4.04-3.98 (1H, m, CHOHCH2COC), 3.93 (1H, d, J = 12.7 
Hz, CHAHBOC), 3.79-3.77 (1H, m, CHOHCH2OC), 3.72 (1H, dd, J = 12.7 and 2.4 Hz, 
CHAHBOC), 1.95 (1H, dd, J = 13.2 and 12.2 Hz, CHAHBCOC), 1.82 (1H, dd, J = 13.5 and 
5.0 Hz, CHAHBCOC).  
α-furanose (22%)  
 
1H NMR (500 MHz, CDCl3) δH = 4.32-4.27 (1H, m, CHOH), 4.14-4.11 (1H, q, J = 4.1 Hz, 
CHCH2OH), 3.70-3.67 (1H, m, CH
AHBOH), 3.61-3.57 (1H, m, CHAHBOH), 2.48 (1H, dd, J 




β-furanose  (20%)  
 
1H NMR (500 MHz, CDCl3) δH = 4.32-4.27 (1H, m, CHOH), 4.00-3.95 (1H, m, CHCH2OH), 
3.69-3.65 (1H, m, CHAHBOH), 3.60-3.56 (1H, m, CHAHBOH), 2.29 (1H, dd, J = 13.3 and 
6.7 Hz, CHAHB), 2.24 (1H, dd, J = 13.1 and 6.5 Hz, CHAHB).  
α-pyranose (12%)  
 
1H NMR (500 MHz, CDCl3) δH = 3.86-3.81 (1H, m, CHOHCH2COC), 2.11-2.05 (1H, m, 
CHAHBCOC), 1.74-1.67 (CHAHBCOC).  
Equilibrium mixture of 4 isomers:     
   -16.8 (c 0.24, D2O at pH 6); 
13C NMR (126 MHz, 
CDCl3) δC = 176.5, 176.3, 176.2, 103.7, 103.1, 96.3, 86.7, 86.6, 71.4, 71.0, 67.3, 64.9, 
64.8, 64.4, 62.2, 61.6, 44.0, 43.3, 33.8; I.R. (thin film) υmax (cm
-1): 1740 (m, C=O); HRMS 
(ESI): m/z 177.0402, C6H9O6 [M-H]
- requires 177.0399. 
 




Under inert atmosphere a solution of D-tartaric acid (5.20 g, 34.6 mmol), 2,2-
dimethoxypropane (9.80 ml, 79.6 mmol), MeOH (2.1 mL) and p-TSA (0.02 g, 0.107 mmol) 
were heated at 100 °C for 2.5 hours.  Additional 2,2-dimethoxypropane (4.9 ml, 39.4 
mmol) and cyclohexane (23 mL) were added, a distillation head was attached to the flask 
and  ca. 30 ml of liquid was removed by distillation.  After cooling to room temperature, 
K2CO3 (41 mg, 0.37 mmol) was added and the mixture stirred until the reddish colour 
abated.  The reaction mixture was then concentrated in vacuo and purified by silica gel 
chromatography (EtOAc-petrol, 3:10, Rf = 0.28) to give the title compound as a colourless 
oil (4.98 g, 66% yield).      
   = +41.4 (c = 1.62 in CDCl3); 
1H NMR (300 MHz, CDCl3) δH = 
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4.66 (2H, s, CHCH), 3.68 (6H, s, CO2CH3), 1.35 (6H, s, C(CH3)2); 
13C NMR (75 MHz, 
CDCl3) δC = 170.1, 113.9, 112.2, 77.0, 52.8, 26.7; I.R. (thin film) υmax (cm
-1): 1740 (m, 
C=O); HRMS (ESI): m/z 219.0872, C9H15O6 [M+H]







To a solution of 212 (0.930 g, 4.25 mmol) in dry toluene (17 mL), under an inert 
atmosphere, was added DIBAL (1.0 M in toluene, 8.50 ml, 8.50 mmol) dropwise over 2 
hours, maintaining the temperature at -5 – 0 °C throughout.  The mixture was then stirred 
at 0 °C for 1 hour before being cooled to -78 °C and a further portion of DIBAL (1 M in 
toluene, 4.25 ml, 4.25 mmol) was then added dropwise over 1 hour.  In a separate vessel, 
under an inert atmosphere, LHMDS (1 M in THF, 6.37 ml, 6.37 mmol) was added 
dropwise to a dry THF (19 mL) solution of ethyl 2-((tert-butyldimethylsilyl)oxy)-2-
(dimethoxyphosphoryl)acetate 1 (2.08 g, 6.37 mmol) at -78 °C.  After stirring this solution 
for 10 minutes it was added via cannular to the reduced mixture of 212.  The reaction 
mixture was stir-warmed to room temperature and stirred for a further 5 hours before 
being quenched with a saturated aq. soln. of potassium sodium tartrate (8.6 mL).  The 
suspension was stirred vigorously for 2 hours, diluted with water (9 mL) and then filtered 
through celite.  The filtrate was extracted with Et2O (3 x 50 mL), the combined organic 
extracts dried over anhydrous MgSO4, filtered and concentrated in vacuo.  Purification of 
the residue by silica gel chromatography (EtOAc-petrol, 1:20 to 1:10) afforded the title 
compound as a colourless oil (0.552 g, 36% yield).  Major isomer:     
   +20.0 (c 0.6, 
CDCl3); Rf = 0.41 (EtOAc-petrol 3:10); 
1H NMR (300 MHz, CDCl3) δH = 5.26 (1H, d, J = 9.0 
Hz, C=CH), 4.99 (1H, t, J = 8.1 Hz, CHCH=C), 4.08 (2H, q, J = 7.2 Hz, OCH2CH3), 3.72-




BH3), 1.16 (3H, t, J = 7.2 Hz, OCH2CH3), 0.78 (9H, s, C(CH3)3), 0.00 (6H, s, 
Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 165.0, 143.4, 121.2, 109.1, 81.4, 73.2, 61.7, 
61.4, 27.1, 27.0, 25.5, 18.2, 14.1, -4.7, -4.9; IR (thin film) υmax (cm
-1): 3512 (br., OH), 1722 
(m, C=O); HRMS (ESI): m/z 383.1872, C17H32O6NaSi [M+Na]
+ requires 383.1866. Minor 
Isomer:     
   -8.0 (c 0.25, CDCl3); Rf = 0.48 (EtOAc-petrol, 3:10); 
1H NMR (300 MHz, 
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CDCl3) δH = 5.77 (1H, d, J = 8.7 Hz, C=CH), 4.69 (1H, t, J = 8.7 Hz, CHCH=C), 4.11-3.98 
(2H, m, OCH2CH3), 3.70-3.65 (1H, m, CHCH2OH), 3.62 (1H, dd, J = 11.7 and 3.4, 
CHAHBOH), 3.62 (1H, dd, J = 11.7 and 4.1, CHAHBOH), 2.45 (1H, br. s, OH), 1.28 (3H, s, 
CCAH3C
BH3), 1.26 (3H, s, CC
AH3C
BH3), 1.14 (3H, t, J = 7.2 Hz, OCH2CH3), 0.79 (9H, s, 
C(CH3)3, 0.05 (6H, s, Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 165.1, 144.5, 116.7, 
109.6, 81.3, 71.7, 61.5, 61.4, 27.1, 26.9, 25.8, 18.6, 14.2, -4.2, -4.4; IR (thin film) υmax (cm
-









Preparation from 218 using the same method as that used for 200 afforded the title 
compound as a colourless oil (0.82 g, 85% yield).      
   +10.5 (c 2.00, CDCl3); 
1H NMR 
(300 MHz, CDCl3) δH = 4.36-4.22 (3H, m, CHOHCH2CO, OCH2CH3), 3.82-3.77 (1H, m, 
CHOHCH2OH), 3.74 (1H, dd, J = 11.7 and 4.0 Hz, CH
AHBOH), 3.64 (1H, dd, J = 11.7 and 
4.4 Hz, CHAHBOH), 3.17  (1H, dd, J = 17.2 and 6.9 Hz, CHAHBCO), 3.06 (1H, dd, J = 17.2 
and 5.1 Hz, CHAHBCO), 2.35 (1H, br. s, OH), 1.34 (3H, s, CCAH3C
BH3), 1.33 (3H, s, 
CCAH3C
BH3), 1.30 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 191.6, 
160.6, 109.5, 81.0, 72.6, 62.7, 61.8, 42.7, 27.03, 26.96, 13.9; IR (thin film) υmax (cm
-1): 










Preparation from 219 employing method 2 used for the synthesis of D-KDX afforded the 
title compound as a yellow viscous oil (0.32 g, 80% yield). 
α-Pyranose (72%) 
  
1H NMR (500 MHz, CDCl3) δH = 3.81-3.74 (1H, m, CH2CHOH), 3.73-3.70 (1H, m, 
OCHAHB), 3.54-3.50 (2H, m, OCHAHBCHOH), 2.08 (1H, dd, J = 13.1, 5.2 Hz, CHAHB), 1.71 
(1H, dd, J = 11.5, 13.1 Hz,  CHAHB); 13C NMR (126 MHz, CDCl3) δC = 176.2, 98.5, 70.6, 
68.9, 62.9, 38.9. 
β-furanose (11%) 
 
1H NMR (500 MHz, CDCl3) δH = 3.98 (1H, dd, J = 12.3, 3.8 Hz, HOCH
AHB), 3.78-3.73 (1H, 
m, CH2CHOH), 3.53-3.49 (1H, m, OCHCH2OH), 3.38 (1H, dd, J = 12.2, 6.9 Hz, 
HOCHAHB), 2.38 (1H, dd, J = 13.6, 4.3 Hz, CHAHB), 1.59 (1H, dd, J = 13.6, 8.0 Hz, 
CHAHB). 
 (9%) α-furanose 
 
1H NMR (500 MHz, CDCl3) δH = 4.40-4.37 (1H, m, CH2CHOH), 4.22-4.18 (1H, m, 
OCHCH2OH), 3.79-3.75 (1H, m, HOCH
AHB), 3.71-3.68 (1H, m, HOCHAHB), 2.28 (2H, d, J 
= 4.0 Hz, CH2). 
β-pyranose (5%) 
 
1H NMR (500 MHz, CDCl3) δH = 4.47-4.43 (1H, m, CH2CHOH), 4.13-4.09 (1H, m, 
OCHAHBCHOH), 3.70-3.65 (1H, m, OCHAHB), 3.57-3.53 (1H, m, OCHAHB), 2.47 (1H, dd, J 





1H NMR (500 MHz, CDCl3) δH = 4.46-4.31 (1H, m, CHCH2OH), 4,13-4.09 (1H, m, 
CH2CHOH), 3.83-3.73 (2H, m, CH2OH), 2.93 (2H, d, J = 6.7 Hz, CH2). 
 
Equilibrium mixture of 5 isomers:     
   -5.5 (c 3.6, MeOH-H2O 1:1); IR (thin film) υmax (cm
-
1): 1735 (m, C=O); HRMS (ESI): m/z 177.0405, C6H9O6 [M-H]
- requires 177.0399. 
 
 







Preparation from aldehyde 181 using the same method as that used for the synthesis of 
199 afforded, after purification by silica gel chromatography (EtOAc-petrol, 1:25), the title 
compound as a colourless oil (0.84 g, 73% yield).  Major isomer:     
   +15.8 (c 3.35, 
CDCl3); Rf = 0.42 (EtOAc-petrol, 1:20); 
1H NMR (300 MHz, CDCl3) δH = 5.39 (1H, d, J = 
7.5 Hz, CH=C), 5.17 (1H, app.q, J = 6.9 Hz, CHCH=C), 4.12 (1H, dd, J = 8.1 and 6.5 Hz, 
CHAHBCH), 4.07 (2H, q, J = 7.1 Hz, OCH2), 3.42 (1H, dd, J = 8.1 and 6.8 Hz, CH
AHBCH), 
1.29 (3H, s, CCAH3), 1.23 (3H, s, CC
BH3), 1.16 (3H, t, J = 7.2 Hz, CH2CH3), 0.79 (9H, s, 
C(CH3)3), 0.00 (6H, s, Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 164.2, 142.0, 123.8, 
109.3, 72.5, 70.0, 61.2, 26.7, 25.6, 18.2, 14.1, -4.8, -4.9.  Minor isomer: Rf = 0.51 (EtOAc-
petrol, 1:20); 1H NMR (300 MHz, CDCl3) δH = 5.81 (1H, d, J = 8.6 Hz, CH=C), 4.92-4.82 
(1H, m, CHCH=C), 4.06 (2H, q, J = 7.0 Hz, OCH2), 3.97 (1H, dd, J = 8.1 and 6.2 Hz, 
CHAHBCH) 3.42 (1H, dd, J = 8.1 and 6.7 Hz, CHAHBCH), 1.29 (3H, s, CCAH3), 1.24 (3H, s, 
CCBH3), 1.15 (3H, t, J = 7.2 Hz, CH2CH3), 0.80 (9H, s, C(CH3)3), 0.03 (6H, s, Si(CH3)2); IR 
197 
 
(thin film) υmax (cm
-1): 1720 (m, C=O); HRMS (ESI): m/z 353.1739, C16H30NaO5Si [M+Na]
+ 
requires 353.1760.   
 




Preparation from 222 using the same method as that used for 200 afforded the title 
compound as a yellow oil (0.54 g, 86% yield).      
   +12 (c 1.25, CH2Cl2); 
1H NMR (300 
MHz, CDCl3) δH = 4.45 (1H, quintet, J = 6.4 Hz, CH2CHCH2), 4.24 (2H, q, J = 7.2 Hz, 
OCH2CH3), 4.10 (1H, dd, J = 8.2 and 6.1 Hz, CH
AHBOC(CH3)2), 3.52 (1H, dd, J = 8.5 and 
6.3 Hz, CHAHBOC(CH3)2), 3.21 (1H, dd, J = 17.6 and 6.1 Hz, CH
AHBC=O), 2.92 (1H, dd, J 
= 17.6 and 6.8 Hz, CHAHBC=O), 1.32 (3H, s, CCAH3), 1.28 (3H, t, J = 7.2 Hz, OCH2CH3), 
1.26 (3H, s, CCBH3); 
13C NMR (75 MHz, CDCl3) δC = 192.0, 160.4, 109.3, 71.1, 69.1, 62.7, 
43.8, 26.8, 25.5, 14.0; IR (thin film) υmax (cm
-1): 1729 (m, C=O); HRMS (ESI): m/z 
239.0881, C10H16O5Na [M+Na]
+ requires 239.0895. 
 




Titanium tetraisopropoxide (0.58 ml, 1.90 mmol) was added to  a solution of 1 (1.80 g, 
5.52 g) in benzyl alcohol (36 mL) under inert atmosphere.  The reaction mixture was 
heated at 100 °C for 12 hours, at which point TLC analysis (EtOAc-petrol, 1:10) showed 
complete consumption of 1.  The reaction mixture was cooled to room temperature and 
quenched with 1 M HCl(aq) (90 mL).  The reaction mixture was filtered through celite and 
then extracted with a solution of pentane/Et2O (1:1) (3 x 100 mL).  The combined organic 
extracts were dried over anhydrous MgSO4, filtered and concentrated in vacuo.  The 
residue was purified by silica gel chromatography (EtOAc-petrol, 1:5, Rf = 0.32) affording 
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the title compound as a colourless oil (0.65 g, 30% yield).  1H NMR (300 MHz, CDCl3) δH = 
7.41-7.31 (5H, m, ArH), 5.25 (2H, dd, J = 16.9 and 12.1 Hz, OCH2Ph), 4.66 (1H, d, J = 7.9 
Hz, CHOSi), 3.79 (3H, d, J = 5.0 and 4.9 Hz, OCAH3), 3.74 (3H, d, J = 5.0 Hz, OC
BH3), 
0.90 (9H, s, C(CH3)3), 0.08 (6H, s, Si(CH3)2); NMR (75 MHz, CDCl3) δC = 168.4, 135.3, 
128.7, 128.6, 128.6, 70.8 (d, J = 163), 67.6, 54.2 (d, J = 6.9 Hz), 54.0 (d, J = 6.8 Hz), 25.5, 
18.4, -5.4 (d, J = 12.5 Hz); 31P (122 MHz, CDCl3) δP = 18.5; IR (thin film) υmax (cm
-1): 1753 
(C=O); HRMS (ESI): m/z 389.1576, C12H28O6PSi [M+H]







Preparation from 228 and 181 employing the same method as that used for 199 gave the 
title compound as a colourless oil (0.39 g, 85% yield).  Major isomer:     
   11.4 (c 2.01, 
CDCl3); 
1H NMR (300 MHz, CDCl3) δH = 7.37-7.28 (5H, m, Ph), 5.55 (1H, d, J = 7.4 Hz, 
CH=C), 5.30 (1H, q, J = 7.4 Hz, CHCH=C), 5.19 (2H, s, CH2Ph), 4.20 (1H, dd, J = 8.1 and 
6.8 Hz, CHAHBCH), 3.55 (1H, dd, J = 7.9 and 6.1 Hz, CHAHBCH), 1.32 ( 3H, s, CCAH3), 
1.28 (3H, s, CCBH3), 0.89 (9H, s, C(CH3)3), 0.09 (6H, s, Si(CH3)2); 
13C NMR (75 MHz, 
CDCl3) δC = 166.2, 142.0, 136.0, 128.9, 128.5, 128.3, 123.6, 109.3, 72.5, 74.5, 70.0, 26.7, 
25.6, 18.2, -5.8, -6.0.  IR. (thin film) υmax (cm
-1): 1726 (m, C=O); HRMS (ESI): m/z 
414.1900, C21H32O5SiNa [M+Na]
+ requires 414.1917. 
 




Preparation from 499 employing the same method as that used for 200 afforded the title 
compound as a colourless oil (0.20 g, 79% yield).      




(300 MHz, CDCl3) δH =7.67-7.28 (5H, m, Ph), 5.29 (2H, s, CH2Ph), 5.52 (1H, quintet, J = 
6.3 Hz, CH2CHCH2), 4.18 (1H, dd, J = 7.9 and 5.4 Hz, CH
AHBOC(CH3)2), 3.59 (1H, dd, J = 
8.5 and 6.3 Hz, CHAHBOC(CH3)2), 3.30 (1H, 1H, dd, J = 17.6 and 6.3 Hz, CH
AHBC=O), 
3.00 (1H, dd, J = 17.6 and 6.7 Hz, CHAHBC=O), 1.36 (3H, s, CCAH3), 1.30 (3H, s, CC
BH3); 
13C NMR (75 MHz, CDCl3) δC = 191.7, 160.3, 134.4, 129.0, 128.8, 128.7, 109.4, 71.2, 
69.2, 68.3, 44.0, 26.9, 25.5; IR (thin film) υmax (cm
-1): 1726 (m, C=O); HRMS (ESI): m/z 
301.1076, C15H18NaO5 [M+Na]
+ requires 301.1052. 
 




Method A: D2O (2 mL) was added to a toluene-d8 (0.1 mL) solution of 223 (0.02 g, 0.092 
mmol), followed by CalB (0.01 g) and the reaction was stirred at 40 °C and monitored by 
1H NMR.  After 6 hours the reaction was complete and the reaction mixture was 
concentrated in vacuo to afford the residue as a yellow oil (0.013 g, 95% yield). 
Method B: Water (5 mL) was added to a toluene (0.25 mL) solution of 223 (0.2 g, 0.92 
mmol) and the mixture was carefully acidifed to pH 1.9 by the dropwise addition of 1 M 
HCl(aq).  After stirring at room temperature for 24 hours, sufficient 1 M NaOH(aq) was 
added to neutralise the mixture.  Novozym 435 (0.2 g) was added and the reaction 
mixture was heated to 40 °C, with the pH mantained at 6-7.5 by the careful addition of 1 M 
NaOH(aq).  After 5 hours the mixture was filtered and concentrated in vacuo to give a 
yellow oil (0.128 g, 94% crude yield).  This product could be further purified by silica gel 
chromatography (CH2Cl2-MeOH-H2O, 5:5:1) to furnish the title compound as a yellow oil 
(0.065 g, 48% yield). 
α-Furanose isomer (33%) 
 
1H NMR (500 MHz, D2O) δH = 4.55-4.49 (1H, m, CHOHCH2), 4.05 (1H, dd, J = 9.8 and 4.7 
Hz, CHAHBCH), 3.95 (1H, dd, J = 9.8 and 2.5 Hz, CHAHBCH), 2.40 (1H, dd, J = 14.3 and 
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6.3 Hz, CHAHBC=O), 1.98 (1H, m, CHAHBC=O); 13C NMR (126 MHz, D2O) δC = 177.0, 
103.8, 75.7, 71.4, 43.9.   
β-Furanose isomer (37%) 
 
 
1H NMR (500 MHz, D2O) δH = 4.51-4.47 (1H, m, CHOHCH2), 4.09 (1H, dd, J = 9.7 and 4.3 
Hz, CHAHBCH), 3.84 (1H, dd, J = 9.7 and 2.1 Hz, CHAHBCH), 2.26-2.21 (2H, m, CH2C=O); 
13C NMR (126 MHz, D2O) δC = 176.9, 103.9, 75.0, 70.6, 44.2.   
Acyclic isomer (30%) 
 
 
1H NMR (500 MHz, D2O) δH = 4.18-4.11 (1H, m, CHOHCH2), 3.55 (1H, dd, J = 11.8 and 
4.2 Hz, CHAHBCH), 3.48 (1H, dd, J = 11.8 and 6.4 Hz, CHAHBCH), 2.92 (1H, dd, J = 17.1 
and 4.4 Hz, CHAHBC=O), 2.84 (1H, dd, J = 17.1 and 8.3 Hz, CHAHBC=O); 13C NMR (126 
MHz, D2O) δC = 203.8, 169.5, 67.5, 65.0, 42.8.   
Mixture of 3 isomers:     
   +13.5 (c 4.75, H2O-MeOH, 1:1); IR (thin film) υmax (cm
-1): 3359 
(br., OH); 2476 (br., CO2H), 1756 (m, C=O), 1710 (m, C=O), 1602 (s, C=O); HRMS (ESI): 
m/z 147.0328, C5H7O5 [M-H]






L-Ascorbic acid (9.50 g, 54 mmol) was dissolved in water (70 mL) and charged into a Parr 
autoclave.  After flushing with N2, 10% Pd/C (0.9 g) was added and the reaction heated at 
50 °C under a H2 pressure of 130 psi.  After 72 hours the reaction mixture was filtered 
through celite and the filtrate concentrated to a white solid.  This was further purified by 
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recrystallisation (EtOAc/MeOH) to give the title compound as white crystalline needles 
(8.00 g, 83% yield).      
   +54.0 (c 2.0, H2O) (lit.
22     
   +54.8 (c 4.0, H2O)); 
1H NMR (500 
MHz, DMSO-d6) δH = 5.81 (1H, d, J = 7.5 Hz, CHOHC=O), 5.34 (1H, d, J = 7.6 Hz, 
CHOHCHOH), 4.98 (1H, d, J = 5.3 Hz, CHOHCH2OH), 4.66 (1H, t, J = 5.7 Hz, CH2OH), 
4.44 (1H, dd, J = 7.6 and 4.6 Hz, CHOHC=O), 4.23 (1H, dd, J = 8.3 and 2.8 Hz, 
CHOC=O), 4.18 (1H, dd, J = 7.2 and 4.0 Hz, CHOHCHOH), 3.77-3.72 (1H, m, 
CHOHCH2OH), 3.55-3.50 (1H, m, CH
AHBOH), 3.50-3.44 (1H, m, CHAHBOH); 13C NMR (75 
MHz, DMSO-d6) δC = 176.6, 81.2, 71.1, 70.4, 69.8, 62.3; IR (thin film) υmax (cm
-1): 3547 (m, 
OH), 3467 (m, OH), 3214 (br., OH), 1779 (s, C=O); HRMS (ESI): m/z 201.0388, 
C6H10NaO6 [M+Na]







A DMF (33 mL) solution of 231 (3.67 g, 20.6 mmol) was cooled to 10 °C. para-
toluenesulfonic acid monohydrate (0.03 g, 0.16 mmol) was added, followed by dropwise 
addition of  isoprenyl methyl ether (2.57 ml, 26.8 mmol) and the solution was stirred at 
room temperature for 24 hours.  It was then treated with Na2CO3.10H2O (7.00 g, 24 mmol) 
and stirred vigirously for a further 2 hours.  After filtering through celite the filtrates were 
concentrated in vacuo to a yellow oil, which crystallized upon addition of toluene.  The title 
compound was removed by filtration, washed with petrol-ethanol (9:1) and dried in vacuo 
to a yellow crystalline solid (3.20 g, 72% yield).      
   +42.9 (c 1.4, DMSO) (lit.23     
   
+38.3 (c 0.7, MeOH)); mp. 154-158 °C (lit.23 mp. 167-168 °C); 1H NMR (300 MHz, DMSO-
d6) δH = 5.82 (1H, br. s, OH), 5.39 (1H, br. s, OH), 4.34 (1H, d, J = 4.0 Hz, CHOHC=O), 
4.24-4.08 (3H, m, CHOHCHOCHOH), 3.98 (1H, dd, J = 8.7 and 6.3 Hz, CHAHBCOH), 3.67 
(1H, dd, J = 8.3 and 6.1 Hz, CHAHBCOH), 1.26(3H, s, CCAH3), 1.20 (3H, s, CC
BH3); 
13C 
NMR (75 MHz, DMSO-d6) δC = 176.3, 109.3, 81.6, 75.4, 70.5, 69.5, 64.7, 26.9, 25.6; IR 
(thin film) υmax (cm
-1): 3451 (br., OH), 1759 (s, C=O); HRMS (ESI): m/z 241.0707, 
C9H14NaO6 [M+Na]








An aqueous (16 mL) suspension of 233 (3.47 g, 15.9 mmol) was cooled to 0 °C and the 
pH adjusted to 5.5 by the careful addition of 1 M NaOH(aq).  NaIO4 (6.8 g, 31.8 mmol) was 
added portion-wise over 5 minutes and a pH between 5–6 was maintained throughout the 
reaction.  The reaction was stirred at room temperature and monitored by TLC (Et2O-
petrol, 2:1).  After 2 hours 233 was fully consumed, so the solution was saturated with 
NaCl(s) and the resultant suspension filtered.  The pH of the filtrates was adjusted to 7 
before extraction with Et2O (5 x 20 mL).  The combined organic extracts were dried over 
anhydrous MgSO4, filtered and concentrated at 55 °C under atmospheric pressure.  
Distillation of the residue yielded the title compound as a colourless oil (1.42 g, 69% yield).  
    
   -50 (c 0.5, CDCl3) (lit.
24     
   -54.9 (c 3.4, CHCl3)); bpt. 67-72 °C @ 31 Torr (lit.
23 
bpt. 64-66 °C @ 35 Torr); Rf = 0.24 (Et2O-petrol, 2:1); 
1H NMR (300 MHz, CDCl3) δH = 
9.77 (1H, d, J = 2.02 Hz, CHO), 4.44 (1H, ddd, J = 7.3, 4.7 and 1.8 Hz, CHCHO), 4.22 
(1H, dd, J = 8.8 and 7.4 Hz, CHAHB), 4.15 (1H, dd, J = 8.8 and 4.8 Hz,  CHAHB), 1.54 (3H, 
s, CAH3), 1.47 (3H, s, C
BH3); 
13C NMR (75 MHz, CDCl3) δC = 201.9, 111.3, 79.9, 65.6, 
26.3, 25.2; IR (thin film)  υmax (cm
-1): 1732 (m, C=O); HRMS (ESI): m/z 131.0713, C6H11O3 






Preparation from 234 using the same method as that used for 187 afforded the title 
compound as a white solid (29 mg, 90% yield).      
   +46.0 (c 1.45, CDCl3); 
1H NMR (300 
MHz, CDCl3) δH = 7.29-7.19 (5H, m, Ph), 4.16-4.07 (1H, m, CHCH2NH), 3.91 (1H, dd, J = 
8.0 and 6.3 Hz, CHAHBCH), 3.70 (1H, q, J =6.6 Hz,  CHCH3), 3.48 (1H, dd, J = 8.1 and 6.9 
Hz, CHAHBCH), 2.55 (1H, dd, J = 11.9 and 7.4 Hz, CHAHBNH), 2.43 (1H, dd, J = 11.9 and 
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4.2 Hz, CHACHBNH), 1.58 (1H, br. s, NH), 1.33 (3H, s, CCAH3C
BH3), 1.32 (3H, d, J = 6.6 
Hz, CHCH3), 1.27 (3H, s, CC
AH3C
BH3); 
13C NMR (75 MHz, CDCl3) δC = 145.5, 128.5, 
127.0, 126.5, 109.1, 75.9, 67.7, 58.6, 50.8, 26.9, 25.5, 24.6; IR (thin film)  υmax (cm
-1): 
3027 (w, Csp2-H), 2986 (w, Csp3-H);; HRMS (ESI): m/z 258.1451, C14H21NNaO2 [M+Na]
+ 







Aldehyde 234 was reacted with phosphonate ester 1 in the same way described for 199 to 
give the title compound as a colourless oil (0.50 g, 70% yield).  Major isomer:     
   -12.9 
(c 0.62, CHCl3); 
1H NMR (300 MHz, CDCl3) δH = 5.33 (1H, d, J = 7.7 Hz, CH=C), 5.17 (1H, 
app. q, J = 6.6 Hz, CHCH=C), 4.12 (1H, dd, J = 8.0 and 6.6 Hz, CHAHBCH), 4.07 (2H, q, J 
= 7.1 Hz, OCH2), 3.41 (1H, dd, J = 8.2 and 6.9 Hz, CH
AHBCH), 1.28 (3H, s, CCAH3), 1.22 
(3H, s, CCBH3), 1.16 (3H, t, J = 7.2 Hz, CH2CH3), 0.79 (9H, s, C(CH3)3), 0.00 (6H, s, 
Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 164.2, 142.0, 123.7, 109.3, 72.5, 70.0, 61.1, 
26.7, 25.6, 18.2, 14.1, -4.8, -4.9.  Minor isomer: 1H NMR (300 MHz, CDCl3) δH = 5.81 (1H, 
d, J = 8.3 Hz, CH=C), 4.92-4.82 (1H, m, CHCH=C), 4.06 (2H, q, J = 7.0 Hz, OCH2), 3.97 
(1H, dd, J = 8.0 and 6.2 Hz, CHAHBCH) 3.42 (1H, dd, J = 8.1 and 6.7 Hz, CHAHBCH), 1.29 
(3H, s, CCAH3), 1.24 (3H, s, CC
BH3), 1.15 (3H, t, J = 7.2 Hz, CH2CH3), 0.80 (9H, s, 
C(CH3)3), 0.03 (6H, s, Si(CH3)2).  IR (thin film) υmax (cm
-1): 1718 (m, C=O); HRMS (ESI): 
m/z 353.1780, C16H30NaO5Si [M+Na]
+ requires 353.1760.   
 






Compound 236 was deprotected in the same way described for 200 to give the title 
compound as a yellow oil (0.28 g, 86% yield).      
   -8.9 (c 0.45, CH2Cl2); 
1H NMR (300 
MHz, CDCl3) δH = 4.47 (1H, qt, J = 6.3 Hz, CH2CHCH2), 4.27 (2H, q, J = 7.2 Hz, 
OCH2CH3), 4.14 (1H, dd, J = 8.4 and 6.0 Hz, CH
AHBOC(CH3)2), 3.54 (1H, J = 8.5 and 6.3 
Hz, CHAHBOC(CH3)2), 3.24 (1H, dd, J = 17.7 and 6.2 Hz, CH
AHBC=O), 2.95 (1H, dd, J = 
17.7 and 6.8 Hz, CHAHBC=O), 1.35 (3H, s, CCAH3 C
BH3), 1.31 (3H, t, J = 7.1 Hz, 
OCH2CH3), 1.29, (3H, s, C C
BAH3C
BH3); 
13C NMR (75 MHz, CDCl3) δC = 192.0, 160.5, 
109.3, 71.2, 69.1, 62.7, 43.8, 26.8, 25.5, 14.0; IR (thin film) υmax (cm
-1): 1726 (m, C=O); 
HRMS (ESI): m/z 239.0886, C10H16 Na O5 [M+Na]
+ requires 239.0895. 
 




Compound 237 was deprotected and hydrolysed using method 2 developed for the 
synthesis of D-KDX to give the title compound as a yellow oil (0.08 g, 87% yield). 
α-Furanose isomer (33%) 
 
1H NMR (500 MHz, CDCl3) δH = 4.52-4.48 (1H, m, CHOHCH2), 4.04 (1H, dd, J = 9.8 and 
4.7 Hz, CHAHBCH), 3.93 (1H, dd, J = 9.8 and 2.5 Hz, CHAHBCH), 2.39 (1H, dd, J = 14.3 
and 6.2 Hz, CHAHBCOH), 1.97 (1H, app.d, J = 14.6 Hz, CHAHBCOH); 13C NMR (126 MHz, 
CDCl3) δC = 177.0, 103.8, 75.6, 71.3, 43.9.   
β-Furanose isomer (37%) 
 
1H NMR (500 MHz, CDCl3) δH = 4.50-4.46 (1H, m, CHOHCH2), 4.07 (1H, dd, J = 9.7 and 
4.3 Hz, CHAHBCH), 3.83 (1H, dd, J = 9.7 and 2.1 Hz, CHAHBCH), 2.25-2.19 (2H, m, 
CH2COH); 




Acyclic isomer (30%) 
 
1H NMR (500 MHz, CDCl3) δH = 4.15-4.10 (1H, m, CHOHCH2), 3.54 (1H, dd, J = 11.8 and 
4.2 Hz, CHAHBCH), 3.46 (1H, dd, J = 11.8 and 6.4 Hz, CHAHBCH), 2.90 (1H, dd, J = 17.1 
and 4.3 Hz, CHAHBC=O), 2.83 (1H, dd, J = 17.1 and 8.4 Hz, CHAHBC=O); 13C NMR (126 
MHz, CDCl3) δC = 203.8, 169.5, 67.5, 65.0, 42.8;  
Equilibrium mixture of 3 isomers:     
   -13.3 (c 4.95, H2O-MeOH, 1:1); IR (thin film) υmax 
(cm-1): 3302 (br., OH); 2496 (br., CO2H), 1752 (m, C=O), 1710 (m, C=O), 1603 (s, C=O); 
HRMS (ESI): m/z 147.0212, C5H7O5 [M-H]
- requires 147.0299.  
 
Expression and Purification of KDG aldolase 
KDG aldolase was expressed using the pET-3a expression vector (Novagen, Nottingham, 
UK) with the gene cloned into the NdeI and BamHI restriction sites. One-litre cultures of E. 
coli BL21(DE3) (Novagen) containing the vector were grown overnight at 37 °C without 
induction. Cells were collected by centrifugation and re-suspended at 0.2 g/mL in water. 
These cells were lysed by two passes through a cell disruptor (one-shot model, Constant 
Systems, Warwick, UK) at 200MPa before heat precipitation at 95 °C for 30 min. Debris 
was removed by centrifugation at 18,000 x g for 30 min, and the resulting KDG-aldolase 
sample lyophilized.  The crude residue was first purified by gel filtration on a Sephacryl S-
300 HR column (5cm x 44cm) in 20 mM Tris/HCl buffer (pH 8.5).  Gel-filtration fractions 
showing KDG-aldolase activity were then applied to a HiTrap Q anion-exchange column 
(previously equilibriated in 20 mM Tris/HCl buffer (pH 8.5)) and eluted with 20 mM 
Tris/HCl buffer (pH 8.5) followed by a gradient of 0-2 M NaCl in 20 mM Tris/HCl buffer (pH 
8.5).  The fractions containing pure KDG aldolase by SDS/PAGE were lyophilised to 
afford a concentrated aqueous solution of KDG aldolase.  The concentration of enzyme 
was determined to be 2.07 g/ml using a NanoVue spectrophotometer.   
 
Kinetic Study Using Modified Thiobarbituric Acid Assay325 
Different concentrations of D-KDX (or L-KDA) (2.5-80 mM) in 50 mM sodium phosphate 
buffer (pH 6.0) were prepared with a total volume of 100 μl. These samples were then 
incubated with purified KDG aldolase (5 μl, 2.07g/mL) at 50 °C for 10 minutes before each 
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kinetic assay was terminated by the addition of trichloroacetic acid (10 μl, 12% w/v). 
Precipitated proteins were removed by centrifugation (9,000 x g for 5 minutes) and 50 μl 
of the supernatant oxidized by addition of periodic acid (125 μl, 25 mM in 0.125 M H2SO4 
solution) followed by incubation at room temperature for 20 minutes. This oxidation step 
was terminated by the addition of sodium arsenite (250 μl, 2% w/v in 0.5 M HCl). 
Thiobarbituric acid(aq) 249 (1 mL, 0.3% w/v) was then added and the chromophore 
developed by heating at 100 °C for 10 min. A 25 μl sample of this solution was then 
removed, diluted with 1400 μl of water, and the absorbance of the solution determined at 
549 nm. The absorption coefficient of the resultant chromophore was determined to be 
14519 M-1cm-1.   
 
Preparation of bakers yeast expressing pyruvate decarboxylase44  
Type II bakers yeast (7.0 g) was suspended in cold water (100 mL) and stirred for 18 
hours at <4 °C. The cells were harvested by centrifugation (18,000 x g for 30 minutes), 
washed twice with cold water (2x100 mL, <4 °C), before resuspension of the harvested 
cells in cold water (20 mL) and storage at <4 °C for future use in the KDG aldolase 






Glycolaldehyde 14 (0.270 g, 4.54 mmol) and sodium pyruvate 4 (0.800 g, 9.08mmol) were 
added to a solution of KDG aldolase (5 μl) in 20 mM Tris/HCl buffer (23 mL, pH 6.5). The 
reaction was heated at 50 °C using a shaking incubator, with reaction progress monitored 
in-process by analysis using an Agilent 1200 HPLC fitted with a Bio-Rad Aminex HPX-
87H column (300mm x 7.8mm) (0.6 mL/min, 1 M formic acid, 60 °C), using a refractive 
index detector for peak detection. Once all the glycolaldehyde 14 had been consumed, 
the reaction mixture was quenched by acidification to pH 2 with 1 M HCl(aq) and then 
neutralised to pH 7.0 after 2 hours using 2 M NaOH(aq). An air bubbler was attached to the 
reaction vessel and a suspension of yeast cells (20 mL) expressing pyruvate 
decarboxylase added. The resultant suspension was then stirred for 3 hours, with the pH 
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maintained above 6.5 via careful addition of 1 M NaOH(aq), until HPLC analysis revealed 
that all of the excess pyruvate had been consumed. The residual yeast cells were 
removed by centrifugation (18,000 x g for 3 x 30 minutes) and the mother liquors 
concentrated to afford a crude reaction product that was purified by flash chromatography 
on silica gel (CH2Cl2-MeOH-H2O, 5:5:1) to afford the title compound as a yellow oil (0.363 
g, 54%).     




6.4 Procedures and Data for Chapter 4 
 




To a solution of iodobenzene 337 (2.69 g, 13.2 mmol) in MeCN (80 mL) under an inert 
atmosphere were added successively DIPEA (6.90 ml, 39.6 mmol), tert-butyl acrylate 338 
(2.12 ml, 14.5 mL), tri(o-tolyl)phosphine (0.40g, 13.2 mmol) and palladium(II) acetate 
(0.15 g, 0.66 mmol).  The mixture was heated at reflux for 17 hours and monitored by TLC 
(EtOAc-petrol, 1:30).  The suspension was then cooled to room temperature, diluted with 
water (60 mL) and extracted with EtOAc (3 x 50 ml3).  The combined organic extracts 
were washed with brine and water, dried over anhydrous MgSO4 and concentrated in 
vacuo to a purple oil.  The residue was purified by flash chromatography (EtOAc-petrol, 
1:30) to afford the title compound as a yellow oil (1.94 g, 72% yield).  Rf = 0.39 (EtOAc-
petrol, 1:30); 1H NMR (300 MHz, CDCl3) δH = 7.51 (1H, d , J = 16.0 Hz, CH=CHCO2), 
7.47-7.25 (5H, m, Ph), 6.30 (1H, d, J = 16.0 Hz, CH=CHCO2), 1.46 (9H, s, C(CH3)3); 
13C 
NMR (75 MHz, CDCl3) δC = 166.3, 143.6, 134.7, 123.0, 128.8, 128.0, 120.2, 80.5, 28.2; IR 
(thin film) υmax (cm











To a solution of tert-butyl 2-(diethoxyphosphoryl)acetate 335 (0.50 g, 1.98 mmol) in dry 
THF (25 mL) at room temperature under an inert atmosphere, was added 
methylmagnesium bromide (0.66 ml, 1.98 mmol) and the mixture stirred for 15 minutes.  A 
dry THF (12.5 mL) solution of 4-bromobenzaldehyde  was then added dropwise and the 
reaction mixture heated at reflux for 18 hours.  After cooling to room temperature, 
saturated NH4Cl(aq) was added and the mixture was extracted with Et2O (3 x 30 mL).  The 
combined organic extracts were washed with brine and water, dried over anhydrous 
MgSO4, filtered and concentrated in vacuo.  The residue was purified by silica gel 
chromatography (EtOAc-petrol, 1:30) affording the title compound as a white solid (0.404 
g, 72% yield).  Mp. 53-55 °C (lit.27 mpt. 52-53 °C); 1H NMR (300 MHz, CDCl3) δH = 7.47 
(1H, d, J = 15.8 Hz, CH=CHCO2), 7.42 (2H, d, J = 6.8 Hz, BrCCHCH), 7.29 (2H, d, J = 6.8 
Hz, BrCCHCH), 6.31 (1H, d, J = 15.8 Hz, CH=CHCO2), 1.46 (9H, s, C(CH3)3); 
13C NMR 
(75 MHz, CDCl3) δC = 166.1, 142.2, 133.6, 132.1, 129.36, 124.2, 120.9, 80.8, 28.2; IR (thin 
film) υmax (cm








Preparation from 2,4-dichlorobenzaldehyde employing the same method as that used for 
336b afforded the title compound as a colourless oil (0.59 g, 78% yield).  Rf = 0.35 
(EtOAc-petrol, 1:50); 1H NMR (300 MHz, CDCl3) δH = 7.92 (1H, d, J = 16.0 Hz, 
CH=CHCO2), 7.54 (1H, d, J = 8.5 Hz, CHCCl), 7.43 (1H, d, J = 2.0 Hz, CClCHCCl), 7.25 
(1H, dd, J = 8.6 and 2.0 Hz, CCHCH), 6.35 (1H, d, J = 16.1 Hz, CH=CHCO2), 1.54 (9H, s, 
C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 165.6, 138.1, 136.0, 135.4, 131.5, 129.9, 128.3, 
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127.5, 123.2, 81.0, 28.2; IR (thin film) υmax (cm
-1): 1706 (s, C=O); HRMS (ESI): m/z 
295.0244, C13H14Cl2NaO2 [M+Na]
+ requires 295.0269. 
 




Preparation from 4-formylbenzonitrile employing the same method as that used for 336b 
afforded the title compound as a white solid (0.59 g, 82% yield).  Mp. 140-142 °C (lit.27 
mp. 136-138 °C); Rf = 0.49 (EtOAc-petrol, 1:10); 
1H NMR (300 MHz, CDCl3) δH = 7.67 
(2H, d, J = 7.6 Hz, NCCCH), 7.58 (2H, d, J = 7.6 Hz, NCCCHCH), 7.55 (1H, d, J = 16.1 
Hz, CH=CHCO2), 6.45 (1H, d, J = 16.1 Hz, CH=CHCO2), 1.54 (9H, s, C(CH3)3); 
13C NMR 
(75 MHz, CDCl3) δC = 165.4, 141.1, 139.0, 132.6, 128.3, 123.8, 118.4, 113.1, 81.2, 28.1; 
IR (thin film) υmax (cm
-1): 2226 (m, CN), 1702 (s, C=O); HRMS (ESI): m/z 252.0990, 
C14H15NNaO2 [M+Na]
+ requires 252.1000. 
 




Preparation from 4-nitrobenzaldehyde employing the same method as that used for 336b 
afforded the title compound as a colourless oil (0.35 g, 69% yield).  Rf 0.43 (EtOAc-petrol, 
1:15); 1H NMR (300 MHz, CDCl3) δH = 8.14 (2H, d, J = 8.7 Hz, O2NCCH), 7.57 (2H, d, J = 
8.7 Hz, O2NCCHCH), 7.53 (1H, d, J = 16.0 Hz, CH=CHCO2), 6.42 (1H, d, J = 15.9 Hz, 
CH=CHCO2), 1.46 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 165.3, 148.3, 140.9, 
140.6, 128.5, 124.5, 124.1, 81.5, 28.1; IR (thin film) υmax (cm
-1): 1708 (s, C=O); HRMS 
(ESI): m/z 272.0878, C13H15NNaO4 [M+Na]









Preparation from thiophene-2-carbaldehyde employing the same method as that used for 
336b afforded the title compound as a colourless oil (0.60 g, 67% yield).  Rf 0.41 (EtOAc-
petrol, 1:50); 1H NMR (300 MHz, CDCl3) δH = 7.67 (1H, d, J = 15.7 Hz, CH=CHCO2), 7.32 
(1H, d, J = 5.1 Hz, CHS), 7.20 (1H, d, J = 3.5 Hz, CHCS), 7.02 (1H, dd, J = 5.1 and 3.6 
Hz, CHCHCHS), 6.16 (1H, d, J = 15.7 Hz, CH=CHCO2), 1.51 (9H, s, C(CH3)3); 
13C NMR 
(75 MHz, CDCl3) δC = 166.2, 139.8, 136.1, 130.5, 128.0, 119.0, 80.5, 28.2; IR (thin film) 
υmax (cm








Preparation from furan-2-carbaldehyde employing the same method as that used for 336b 
afforded the title compound as a yellow oil (0.51 g, 65% yield).  Rf 0.13 (EtOAc-petrol, 
1:50); 1H NMR (300 MHz, CDCl3) δH = 7.38 (1H, d, J = 1.6 Hz, CHO), 7.26 (1H, d, J = 15.9 
Hz, CH=CHCO2), 6.50 (1H, d, J = 3.4 Hz, CHCO), 6.38 (1H, dd, J = 3.4 and 1.8 Hz, 
CHCHCHO), 6.18 (1H, d, J = 15.9 Hz, CH=CHCO2), 1.44 (9H, s, C(CH3)3); 
13C NMR (75 
MHz, CDCl3) δC = 166.4, 151.2, 144.4, 130.1, 118.0, 114.0, 112.1, 80.4, 28.2; IR (thin film) 
υmax (cm













To a solution of hex-1-ene 339 (2.89 ml, 13.6 mmol) in CH2Cl2 (29 mL) under inert 
atmosphere was added tert-butyl acrylate 340 (5.92 ml, 40.8 mmol) followed by Grubbs 
2nd generation catalyst (0.10 g).  The reaction mixture was stirred at room temperature for 
24 hours and then filtered through celite and concentrated in vacuo.  Distillation of the 
residue furnished the title compound as a colourless oil (1.42 g, 55% yield).  Bp. 90 °C @ 
0.8 Torr; 1H NMR (250 MHz, CDCl3) δH = 6.78 (1H, dt, J = 15.7 and 6.9 Hz, CH2CH=CH), 
5.66 (1H, dt, J = 15.7 and 1.5 Hz, CH2CH=CH), 2.10 (2H, qd, J = 7.1 and 1.5 Hz, CH2-
CH2-CH), 1.49 (9H, s, C(CH3)3), 1.37-1.18 (4H, m, CH3CH2CH2), 0.93 (3H, t, J = 7.1 Hz, 
CH3CH2); 
13C NMR (75 MHz, CDCl3) δC = 166.6, 148.5, 123.3, 80.3, 32.2, 30.6, 28.5, 22.6, 
14.2; IR (thin film) υmax (cm
-1): 1706 (s, C=O); HRMS (ESI): m/z 207.1343, C11H20NaO2 






The reaction was conducted under inert atmosphere in oven dried glassware.  To a stirred 
solution of para-methoxy-benzylamine (5.00 g, 36.4 mmol) in THF (140 mL) cooled to 0 
°C was added n-butyllithium solution (2.3 M in hexanes, 6.6 ml, 38.2 mmol) dropwise.  
The reaction was stirred at room temperature for 8 hours and then cooled to 0 °C prior to 
the dropwise addition of chlorotrimethylsilane (4.67 ml, 36.8 mmol) in THF (40 mL).  The 
reaction was heated at reflux for 12 hours, concentrated, triturated with pentane (2 x 100 
mL) and concentrated in vacuo to afford the title compound as a yellow oil (5.59 g, 73% 
yield).  1H NMR (300 MHz, CDCl3) δH = 7.16 (2H, d, J = 8.6 Hz, CH3OCCHCH), 6.82 (2H, 
d, J = 8.6 Hz, CH3OCCH), 3.77 (2H, d, J = 7.8 Hz, CH2N), 3.7 (3H, s, OCH3), 1.90 (1H, br. 
s, NH), 0.00 (9H, s, Si(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 158.2, 136.5, 129.1, 
113.85, 55.2, 45.3, 0.0; IR (thin film) υmax (cm
-1): 3305 (w, NH), 1505, 1499 (m, m, C=C). 
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To a solution of amine 325 (1.81 g, 8.66 mmol) in dry toluene (23.1 mL) at -78 °C, under 
an inert atmosphere, was added n-butyllithium (2.5 M in hexanes, 3.46 ml, 8.66 mmol) 
dropwise.  After stirring the mixture at -78 °C for 30 minutes, a dry toluene (11.4 mL) 
solution of chiral ligand 303 (2.62 g, 10.4 mmol) was added dropwise.  After stirring the 
mixture for a further 30 minutes at -78 °C, a dry toluene (11.4 mL) solution of 305 (1.18 g, 
5.78 mmol) and chlorotrimethylsilane (3.65 ml, 28.9 mmol) was added dropwise.  The 
reaction mixture was stirred for 5 hours at -78 °C and then quenched by the careful 
addition of saturated NH4Cl(aq).  After allowing the suspension to stir-warm to room 
temperature saturated NaHCO3(aq) was added carefully and then extracted with EtOAC (3 
x 100 mL).  The combined organic extracts were washed with brine and water, dried over 
anhydrous MgSO4, filtered and concentrated in vacuo.  The residue was purified by silica 
gel chromatography (EtOAc-petrol, 1:5), affording the title compoundas a yellow oil (1.52 
g, 77% yield).      
   +25.9 (c 3.2, CH2Cl2); Rf 0.18 (EtOAc-petrol, 1:5); 
1H NMR (300 MHz, 
CDCl3) δH = 7.43-7.26 (5H, m, Ph), 7.22 (2H, d, J = 8.6 Hz, CHCHCOCH3), 6.87 (2H, d, J 
= 8.6 Hz, CHCHCOCH3), 4.09 (1H, dd, J = 8.6 and 5.5 Hz, CHNH), 3.82 (3H, s, OCH3), 
3.61 (1H, d, J = 12.9 Hz, NHCHAHB), 3.51 (1H, d, J = 12.9 Hz, NHCHAHB), 2.68 (1H, dd, J 
= 15.3 and 8.7 Hz, CHACHBCO2), 2.56 (1H, dd, J = 15.3 and 5.6 Hz, CH
ACHBCO2), 2.20 
(1H, br. s, NH), 1.40 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 171.1, 158.6, 142.8, 
132.6, 129.3, 128.5, 127.4, 113.8, 80.6, 59.1, 55.3, 50.8, 44.3, 28.0; IR (thin film) υmax (cm
-
1): 1721 (s, C=O); HRMS (ESI): m/z 364.1911, C21H27NNaO3 [M+Na]












Preparation from 336b employing the same method as that used for 326a afforded the 
title compound as a white solid (0.64 g, 79% yield).      
   +38.6 (c 1.71, EtOAc); Rf 0.34 
(EtOAc-petrol, 1:6); 1H NMR (300 MHz, CDCl3) δH = 7.40 (2H, d, J = 8.3 Hz, CHCHCBr), 
7.18 (2H, d, J = 8.3 Hz, CHCHCBr), 7.09 (2H, d, J = 8.5 Hz, CHCHCOCH3), 6.77 (2H, d, J 
= 8.5 Hz, CHCHCOCH3), 3.95 (1H, dd, J = 8.4 and 5.4 Hz, CHNH), 3.72 (3H, s, OCH3), 
3.48 (1H, d, J = 12.5 Hz, NHCHAHB), 3.38 (1H, d, J = 12.5 Hz, NHCHAHB), 2.52 (1H, dd, J 
= 15.4 and 8.4 Hz, CHACHBCO2), 2.40 (1H, dd, J = 15.4 and 5.4 Hz, CH
ACHBCO2), 1.94 
(1H, br. s, NH), 1.30 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.8, 158.6, 141.8, 
132.2, 131.6, 129.3, 129.1, 121.1, 113.8, 80.9, 58.5, 55.3, 50.8, 44.1, 28.0; IR (thin film) 
υmax (cm








Preparation from 336c employing the same method as that used for 326a afforded the title 
compound as a white solid (0.52 g, 76% yield).      
   +24.1 (c 1.58, CH2Cl2); Rf 0.22 
(EtOAc-petrol, 1:10); 1H NMR (300 MHz, CDCl3) δH = 7.48 (1H, d, J = 8.5 Hz, CHCHCCl), 
7.29 (1H, d, J = 2.1 Hz, CClCHCCl), 7.19 (1H, dd, J = 8.4 and 2.1 Hz, CHCHCCl), 7.09 
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(2H, d, J = 8.6 Hz, CHCHCOCH3), 6.75 (2H, d, J = 8.6 Hz, CHCHCOCH3), 4.44 (1H, dd, J 
= 8.6 and 4.5 Hz, CHNH), 3.70 (3H, s, OCH3), 3.46 (1H, d, J = 12.5 Hz, NHCH
AHB), 3.41 
(1H, d, J = 12.8 Hz, NHCHAHB), 2.51 (1H, dd, J = 15.6 and 4.7 Hz, CHACHBCO2), 2.40 
(1H, dd, J = 15.5 and 8.8 Hz, CHACHBCO2), 1.31 (9H, s, C(CH3)3); 
13C NMR (75 MHz, 
CDCl3) δC = 170.6, 158.7, 138.5, 134.2, 133.3, 129.4, 129.3, 127.5, 113.8, 81.0, 55.3, 
55.1, 51.0, 42.2, 28.1; IR (thin film) υmax (cm
-1): 1723 (s, C=O); HRMS (ESI): m/z 
432.1128, C21H25Cl2NNaO3 [M+Na]
+ requires 432.1110. 
 




Preparation from 336d employing the same method as that used for 326a afforded the 
title compound as a yellow oil (0.23 g, 62% yield).      
   +42.7 (c 3.35, EtOAc); Rf = 0.19 
(EtOAc-petrol, 1:3); 1H NMR (300 MHz, CDCl3) δH = 7.56 (2H, d, J = 8.4 Hz, CHCHCCN), 
7.42 (2H, d, J = 8.4 Hz, CHCHCCN), 7.07 (2H, d, J = 8.6 Hz, CHCHCOCH3), 6.76 (2H, d, 
J = 8.6 Hz, CHCHCOCH3), 4.03 (1H, dd, J = 8.4 and 5.3 Hz, CHNH), 3.71 (3H, s, OCH3), 
3.46 (1H, d, J = 12.9 Hz, NHCHAHB), 3.38 (1H, d, J = 12.9 Hz, NHCHAHB), 2.53 (1H, dd, J 
= 15.4 and 8.3 Hz, CHACHBCO2), 2.41 (1H, dd, J = 15.4 and 5.4 Hz, CH
ACHBCO2), 2.09 
(1H, br. s, NH), 1.29 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.4, 158.7, 148.5, 
132.4, 131.8, 129.3, 128.2, 118.9, 113.8, 111.2, 81.2, 58.8, 55.3, 50.9, 43.8, 28.0; IR (thin 
film) υmax (cm
-1): 2226 (m, CN), 1703 (s, C=O); HRMS (ESI): m/z 389.1855, C22H26N2NaO3 












Preparation from 336e employing the same method as that used for 326a afforded the title 
compound as a yellow oil (0.33 g, 40% yield).      
   +35.7 (c 2.6, EtOAc); Rf 0.25 (EtOAc-
petrol, 1:3); 1H NMR (300 MHz, CDCl3) δH = 8.12 (2H, d, J = 8.7 Hz, CHCHCNO2), 7.47 
(2H, d, J = 8.7 Hz, CHCHCNO2), 7.06 (2H, d, J = 8.5 Hz, CHCHCOCH3), 6.75 (2H, d, J = 
8.5 Hz, CHCHCOCH3), 4.08 (1H, dd, J = 8.4 and 5.3 Hz, CHNH), 3.70 (3H, s, OCH3), 3.46 
(1H, d, J = 12.9 Hz, NHCHAHB), 3.38 (1H, d, J = 12.9 Hz, NHCHAHB), 2.53 (1H, dd, J = 
15.4 and 8.4 Hz, CHACHBCO2), 2.42 (1H, dd, J = 15.4 and 5.3 Hz, CH
ACHBCO2), 2.09 
(1H, br. s, NH), 1.28 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.4, 158.8, 150.7, 
147.3, 131.8, 129.3, 128.3, 123.8, 113.9, 81.3, 58.5, 55.3, 50.9, 43.7, 28.0; IR (thin film) 
υmax (cm








Preparation from 336f employing the same method as that used for 326a afforded the title 
compound as a colourless oil (0.78 g, 86% yield).      
   +23.5 (c 3.4, EtOAc); Rf = 0.33 
(EtOAc-petrol, 1:5); 1H NMR (300 MHz, CDCl3) δH = 7.19-7.12 (3H, m, CHCHCOCH3, 
CHS), 6.89-6.86 (2H, m, CHCHCS), 6.77 (2H, d, J = 8.6 Hz, CHCHCOCH3), 4.30 (1H, dd, 




(1H, d, J = 12.9 Hz, NHCHAHB), 2.64 (1H, dd, J = 15.5 Hz, 8.3, CHACHBCO2), 2.56 (1H, 
dd, J = 15.4 and 5.5 Hz, CHACHBCO2), 2.07 (1H, br. s, NH), 1.32 (9H, s, C(CH3)3); 
13C 
NMR (75 MHz, CDCl3) δC = 170.7, 158.6, 147.8, 132.2, 129.5, 126.5, 124.5, 124.4, 113.8, 
80.1, 55.3, 54.6, 50.6, 44.6, 28.1; IR (thin film) υmax (cm
-1): 1722 (s, C=O); HRMS (ESI): 
m/z 370.1450, C19H25NNaO3S [M+Na]
+ requires 370.1453. 
 
(R)-tert-Butyl 3-(furan-2-yl)-3-((4-methoxybenzyl)amino)propanoate 326g 
 
   
 
Preparation from 336g employing the same method as that used for 326g afforded the 
title compound as a yellow oil (0.62 g, 73% yield).      
   +57.3 (c 3.3, EtOAc); Rf 0.22 
(EtOAc-petrol, 1:5); 1H NMR (300 MHz, CDCl3) δH = 7.37 (1H, d, J = 1.9 Hz, CHO), 7.21 
(2H, d, J = 8.7 Hz, CHCHCOCH3), 6.84 (2H, d, J = 8.7 Hz, CHCHCOCH3), 6.32 (1H, dd, J 
= 3.1 and 1.9 Hz, CHCHO), 6.20 (1H, d, J = 3.1 Hz, CHCHCHCO), 4.14 (1H, dd, J = 7.7 
and 6.4 Hz, CHNH), 3.79 (3H, s, OCH3), 3.68 (1H, d, J = 12.6 Hz, NHCH
AHB), 3.54 (1H, d, 
J = 12.6 Hz, NHCHAHB), 2.18-2.01 (2H, m, CH2CO2), 1.96 (1H, br. s, NH), 1.40 (9H, s, 
C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.7, 158.6, 155.3, 141.7, 132.2, 129.4, 113.7, 
110.0, 106.8, 80.7, 55.3, 52.3, 50.5, 41.1, 28.0; IR (thin film) υmax (cm
-1): 1725 (s, C=O); 
HRMS (ESI): m/z 354.1691, C19H25NNaO4 [M+Na]
+ requires 354.1681. 
 





Preparation from 341 employing the same method as that used for 326a afforded the title 
compound as a yellow oil (1.2 g, 68% yield).      
   -3.5 (c 2.02, CH2Cl2); Rf = 0.50 
(EtOAc-petrol, 1:5); 1H NMR (300 MHz, CDCl3) δH = 7.20 (2H, d, J = 8.6 Hz, 
CHCHCOCH3), 6.80 (2H, d, J = 8.6 Hz, CHCHCOCH3), 3.72 (3H, s, OCH3), 3.65 (2H, s, 
NHCH2), 2.90 (1H, quintet, J = 6.1 Hz, CHNH), 2.29 (2H, d, J = 6.1 Hz, CH2CO2), 1.65 
(1H, br. s, NH), 1.37 (9H, s, C(CH3)3), 1.30-1.14 (6H, m, CH3CH2CH2CH2), 0.82 (3H, t, J = 
7.2 Hz, CH3CH2); 
13C NMR (75 MHz, CDCl3) δC = 172.4, 158.9, 133.1, 129.7, 114.1, 80.8, 
55.7, 54.8, 50.8, 40.8, 34.4, 28.5, 28.3, 23.2, 14.4; IR (thin film) υmax (cm
-1): 1722 (s, C=O); 
HRMS (ESI): m/z 322.2377, C19H32NO3 [M+H]
+ requires 322.2381. 
 




To a solution of 326a (0.251 g, 0.736 mmol) in MeCN-H2O (5:1, 9.4 mL) was added CAN 
(1.72 g, 2.94 mmol).  The orange solution was stirred at room temperature for 2 hours and 
then saturated NaHCO3(aq) (50 mL) was added.  The mixture was partitioned between 
brine and Et2O and the aqueous layer further extracted with Et2O (2 x 20 mL).  The 
combined organic extracts were dried over anhydrous MgSO4, filtered and concentrated in 
vacuo to afford the title compound as a yellow oil (0.204 g, 82% yield).      
   -30.0 (c 2.9, 
CH2Cl2); 
1H NMR (300 MHz, CDCl3) δH = 8.36 (1H, s, CH=N), 7.76 (2H, d, J = 8.5 Hz, 
CHCHCOCH3), 7.50 (2H, d, J = 7.7 Hz, Ph), 7.41- 7.36 (2H, m, Ph), 7.32-7.27 (1H, m, 
Ph), 6.96 (2H, d, J = 8.5 Hz, CHCHCOCH3), 4.82 (1H, dd, J = 9.5 and 4.9 Hz, CHN=CH), 
3.89 (3H, s, OCH3), 2.97 (1H, dd, J = 15.0 and 1.5 Hz, CH
AHB), 2.86 (1H, dd, J = 14.9 and 
4.8 Hz, CHAHB), 1.39 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.7, 161.7, 
160.5, 143.1, 130.1, 129.2, 128.5, 127.2, 127.0, 113.9, 80.6, 71.4, 55.4, 44.8, 28.1; IR 
(thin film) υmax (cm










To a solution of 326a (0.100 g, 0.293 mmol) in MeCN-H2O (5:1, 3.8 mL) was added CAN 
(0.68 g, 1.17 mmol).  The orange solution was stirred at room temperature for 2 hours and 
then saturated NaHCO3(aq) (50 mL) was added.  The mixture was partitioned between 
brine and Et2O and the aqueous layer further extracted with Et2O (2 x 20 mL).  The 
combined organic extracts were dried over anhydrous MgSO4, filtered and concentrated in 
vacuo.  To the resultant oil dissolved in MeCN-H2O (5:1, 1.2 mL), was added AcOH (0.23 
ml, 3.96 mL) and the mixture stirred at room temperature for 48 hours.  The reaction 
mixture was then diluted with water (5mL) and washed with Et2O (3 x 10).  The aqueous 
layer was basified with saturated NaHCO3(aq) and extracted with Et2O (3 x 20).  The 
combined organics were dried over anhydrous MgSO4, filtered and concentrated in vacuo 
to afford the title compound as a yellow oil (0.044 g, 68% yield).      
   +20.0 (c 1.2, 
CHCl3) (lit.
28     
   +20.0 (c 0.71, CHCl3); 
1H NMR (300 MHz, CDCl3) δH = 7.15-7.33 (5H, 
m, Ph), 4.31 (1H, t, J = 6.9 Hz, CHNH), 2.52 (2H, d, J = 7.0 Hz, CH2CO2), 2.41 (2H, br. s, 
NH2), 1.35 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 171.4, 128.5, 127.3, 126.3, 
80.7, 52.8, 45.4, 28.1; IR (thin film) υmax (cm
-1): 3312 (w, N-H), 1725 (s, C=O); HRMS 
(ESI): m/z 222.1500, C13H20NO2 [M+H]
+ requires 222.1489. 
 




Preparation from 326b employing the same method as that used for 354a that afforded 
the title compound as a colourless oil (0.077 g, 56% yield).      
   +21.7 (c 0.92, CDCl3); 
1H NMR (300 MHz, CDCl3) δH = 7.37 (2H, d, J = 8.5 Hz, CHCHCBr), 7.17 (2H, d, J = 8.5 
Hz, CHCHCBr), 4.29 (1H, br. s, CHNH2), 2.47 (2H, d, J = 6.7 Hz, CH2CO2), 1.76 (2H, br. 
s, NH2), 1.34 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 171.0, 143.7, 131.6, 128.2, 
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121.0, 81.0, 52.2, 45.1, 28.1; I.R. (thin film) υmax (cm
-1): 3662 (m, N-H), 3376 (w, N-H), 
1722 (s, C=O); HRMS (ESI): m/z 300.0620, C13H19BrNO2 [M+H]
+ requires 300.0599. 
 




Preparation from 326c employing the same method as that used for 354a afforded the title 
compound as a yellow oil (0.066 g, 68% yield).      
   +37.6 (c 0.85, CDCl3); 
1H NMR (300 
MHz, CDCl3) δH = 7.44 (1H, d, J = 8.4 Hz, CHCHCCl), 7.20 (1H, d, J = 1.8 Hz, 
CClCHCCl), 7.8 (1H, dd, J = 8.4 and 1.9 Hz, CClCHCH), 4.70 (1H, br. s, CHNH2), 2.60 
(1H, dd, J = 16.0 and 4.0 Hz, NHCHAHB), 2.44 (1H, dd, J = 16.0 and 9.0 Hz, NHCHAHB), 
2.29 (2H, br. s, NH2), 1.36 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.8, 133.4, 
133.3, 129.4, 128.4, 127.5, 81.2, 48.7, 42.8, 28.1; IR (thin film) υmax (cm
-1): 3383 (w, N-H), 
1725 (s, C=O); HRMS (ESI): m/z 312.0525, C13H17Cl2NNaO2 [M+Na]
+ requires 312.0534. 
 




Preparation from 326d employing the same method as that used for 354a afforded the 
title compound as a yellow oil (0.057 g, 51% yield).      
   +16.0 (c 0.5, CDCl3); 
1H NMR 
(300 MHz, CDCl3) δH = 7.68 (2H, d, J = 8.0 Hz, CHCHCCN), 7.55 (2H, d, J = 8.0 Hz, 
CHCHCCN), 4.50 (1H, br. s, CHNH2), 2.63 (2H, d, J = 6.6 Hz, CH2CO2), 2.14 (2H, br. s, 
NH2), 1.46 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 171.6, 132.4, 127.3, 118.8, 
111.3, 81.3, 52.5, 44.8, 28.1; I.R. (thin film) υmax (cm
-1): 2228 (m, CN), 1723 (s, C=O); 
HRMS (ESI): m/z 247.1448, C14H19N2O2 [M+H]
+ requires 247.1447. 
 






Preparation from 326e employing the same method as that used for 354a afforded the title 
compound as a yellow oil (0.057 g, 65% yield).      
   +9.1 (c 0.55, CDCl3); 
1H NMR (300 
MHz, CDCl3) δH = 8.11 (2H, d, J = 8.9 Hz, CHCHCNO2), 7.49 (2H, d, J = 8.6 Hz, 
CHCHCNO2), 4.42 (1H, br. s, CHNH2), 2.51 (2H, d, J = 6.7 Hz, CH2CO2), 1.78 (2H, br. s, 
NH2), 1.34 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.6, 152.2, 147.2, 127.4, 
123.8, 81.3, 52.3, 45.0, 28.1; IR (thin film) υmax (cm
-1): 3382 (w, N-H), 1720 (s, C=O); 
HRMS (ESI): m/z 289.1156, C13H18N2NaO4 [M+Na]
+ requires 289.1164. 
 




Preparation from 326f employing the same method as that used for 354a afforded the title 
compound as a yellow oil (0.048 g, 36% yield).      
   +18.2 (c 0.44, CDCl3); 
1H NMR (300 
MHz, CDCl3) δH = 7.27 (1H, dd, J = 1.7 and 0.7 Hz, CHS), 6.23 (1H, dd, J = 3.1 and 1.8 
Hz, CHCHCS), 6.09 (1H, d, J = 3.2 Hz, CHCCS), 4.31 (1H, dd, J = 8.3 and 4.9 Hz, 
CHNH), 2.68 (1H, dd, J = 15.8 and 5.0 Hz, CHAHBCO2), 2.55 (1H, dd, J = 15.4 and 8.4 Hz, 
CHACHBCO2), 2.34 (1H, br. s, NH2), 1.3 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 
170.8, 157.1, 141.6, 110.1, 104.7, 81.0, 46.8, 42.1, 28.1; IR (thin film) υmax (cm
-1): 1727 (s, 
C=O); HRMS (ESI): m/z 228.1078, C11H18NO2S [M+H]
+ requires 228.1058. 
 





Preparation from 326g employing the same method as that used for 354a afforded the 
title compound as a pale green oil (0.048 g, 73% yield).      
   +12.4 (c 1.05, CDCl3); 
1H 
NMR (300 MHz, CDCl3) δH = 7.12 (1H, dd, J = 4.5 and 1.9 Hz, CHCHO), 6.89-6.84 (2H, 
m, CHOCCH), 4.58 (1H, dd, J = 8.4 and 4.9 Hz, CHNH2), 2.65 (1H, dd, J = 15.9 and 4.9 
Hz, CHAHBCO2), 2.57 (1H, dd, J = 15.9 and 8.4 Hz, CH
AHBCO2), 2.22 (2H, br. s, NH2), 
1.36 (9H, s, C(CH3)3); 
13C NMR (75 MHz, CDCl3) δC = 170.8, 149.0,126.6, 124.0, 123.2, 
81.0, 48.7, 45.6, 28.1; IR (thin film) υmax (cm
-1): 3385 (w, N-H), 1723 (s, C=O); HRMS 
(ESI): m/z 212.1286, C11H18NO3 [M+H]
+ requires 212.1287. 
 
 
6.5 Procedures and Data for Chapter 5 
 




Preparation from 326h employing the same method as that used for 354a afforded the 
title compound as a colourless oil (0.089 g, 60% yield).      
   +33.3 (c 1.2, CDCl3); 
1H 
NMR (300 MHz, CDCl3) δH = 3.13-3.00 (1H, m, CHNH2), 2.31 (1H, dd, J = 15.6 and 4.0 
Hz, CHAHBCO2), 2.10 (1H, dd, J = 15.6 and 8.8 Hz, CH
AHBCO2), 1.61 (2H, br. s, NH2), 
1.39 (9H, s, C(CH3)3), 1.36-1.19 (6H, m, CH2CH2CH2CH3), 0.83 (3H, t, J = 6.3 Hz, 
CH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 172.1, 80.5, 48.4, 43.8, 37.2, 28.2, 28.1, 22.7, 
14.0; IR (thin film) υmax (cm
-1): 3385 (w, N-H), 1723 (s, C=O); HRMS (ESI): m/z 202.1801, 
C11H24NO2 [M+H]








Mg turnings (0.36 g, 15 mmol) were covered with dry THF (4 mL), stirred briskly and 5-
bromo-pent-1-ene 2 (2.03 g, 13.6 mmol) was added as a dry THF (11 mL) solution.  The 
addition was kept at a rate sufficient to maintain the reaction at reflux, and reflux was 
maintained for an hour post addition by heating.  The mixture was cooled to 25 °C and 
ethyl formate (0.47 ml, 5.8 mmol) added dropwise and then heated at reflux for a further 
hour post-addition.  The mixture was cooled to 0 °C and quenched with saturated 
NH4Cl(aq) (8 mL) and stirred for 20 minutes, then extracted with Et2O (3 x 100 mL).  The 
combined organic extracts were washed with saturated Na2CO3(aq), brine and dried over 
anhydrous MgSO4, filtered and concentrated in vacuo.  Purification by silica gel 
chromatography (EtOAc-petrol, 10:1) afforded the title compound as a yellow oil (0.96 g, 
96%).  1H NMR (300 MHz, CDCl3) δH = 5.84-5.65 (2H, m, CH=CH2), 5.00-4.82 (4H, m, 
CH=CH2), 3.60-3.49 (1H, m, CHOH), 2.10-1.91 (4H, m, CH2-CH), 1.55-1.27 (8H, m, 
CHOH-CH2-CH2); 
13C NMR (75 MHz, CDCl3) δC = 138.7, 14.6, 71.7, 36.9, 33.7, 24.9; IR 
(thin film) υmax (cm
-1): 3346 (br., O-H), 1641 (m, C=C); HRMS (ESI): m/z 169.1587, 
C11H21O [M+H]






To a stirred solution of 430 (0.4 g, 2.38 mmol) in CH2Cl2 (30 mL) were added imidazole 
(0.486 g, 7.14 mmol), DMAP (0.044 g, 0.36 mmol) and tert-butyldimethylsilyl chloride 
(1.43 g, 9.52 mmol).  The mixture was stirred at room temperature and monitored by TLC.  
After 24 hours saturated Na2CO3(aq) (10 mL) was added, the mixture was partitioned and 
the organic extracts were dried over anhydrous MgSO4, filtered and concentrated in 
vacuo.  Purification by silica gel chromatography (EtOAc-petrol, 5:1) afforded the title 
compound as a colourless oil (0.35 g, 52%).  1H NMR (300 MHz, CDCl3) δH = 5.77 (2H, 
ddt, J = 17.2, 10.2 and 6.5 Hz, CH=CH2), 5.01-4.87 (4H, m, CH=CH2), 3.61 (1H, quintet, J 
= 6.3 Hz, CHO-Si), 2.06-1.92 (4H, m, CH2-CH=), 1.46-1.28 (8H, m, CHOCH2CH2), 0.85 
(9H, s, Si-C-CH3), 0.00 (6H, s, Si-CH3); 
13C NMR (75 MHz, CDCl3) δC = 139.0, 114.3, 72.0, 
36.5, 33.9, 25.9, 24.6, 18.2, -4.4; IR (thin film) υmax (cm
-1): 1641 (m, C=C); HRMS (ESI): 
m/z 305.2274, C17H34NaOSi [M+Na]








To a stirred solution of 431 (3.2 g, 11.3 mmol) in dry CH2Cl2 (32 mL) were added tert-butyl 
acrylate 432 (4.9 ml, 33.9 mmol) and Grubbs 2nd generation catalyst (0.096 g, 0.113 
mmol).  After stirring at room temperature for 48 hours, TLC analysis showed the reaction 
had gone to completion.  The mixture was filtered through a silica plug and washed 
through with CH2Cl2 (500 mL).  The filtrates were dried over anhydrous MgSO4, filtered 
and concentrated in vacuo to yield the title compound as a yellow oil (4.80 g, 89%) that 
did not require further purification.  1H NMR (250 MHz, CDCl3) δH = 6.88-6.74 (2H, m, CH-
CH2), 5.70 (2H, dt, J = 15.5 and 1.5 Hz, CH=CHCH2), 3.66-3.56 (1H, m, CHO-Si), 2.21-
2.04 (4H, m, CH2-CH), 1.55-1.29 (26H, m, CH2CH2CHO, OC(CH3)3), 0.85 (9H, s, Si-
C(CH3)3), 0.01 (6H, s, Si(CH3)2); 
13C NMR (75 MHz, CDCl3) δC = 66.0, 147.7, 123.2, 80.0, 
71.6, 36.4, 32.1, 28.4, 25.9, 23.7, 18.1, -4.4; IR (thin film) υmax (cm
-1): 1713 (s, C=O), 1653 
(m, C=C); HRMS (ESI): m/z 483.3518, C27H51O5Si [M+H]






A stirred suspension of sodium hydride (60% dispersion, 0.467 g, 11.7 mmol) in dry THF 
(10 mL) was brought to reflux and hydrobenzoin (1.00 g, 4.67 mmol) was subsequently 
added dropwise.  Following the addition the mixture was heated at reflux for a further 30 
minutes and then cooled to 0 °C prior to the addition of methyl iodide (15.0 ml, 100 mmol).  
The reaction was then stirred at room temperature overnight, whereupon TLC analysis 
showed the reaction had gone to completion.  The mixture was cooled to 0 °C and 
quenched with water (10 mL), extracted with EtOAc (3 x 50 mL), washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated in vacuo.  The residue was re-
crystallised from petrol to afford the title compound as a white crystalline solid (0.68 g, 
60%).      
   -15.1 (c 1.8, CHCl3) (lit. value
30     
   -15.2 (c 2.1, CHCl3); 
1H NMR (300 MHz, 
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CDCl3) δH = 7.23-7.15 (6H, m, Ph), 7.08-6.98 (4H, m, Ph), 4.34 (2H, s, CHOCH3), 3.30 
(6H, s, OCH3); 
13C NMR (75 MHz, CDCl3) δC = 138.2, 127.9, 127.6, 87.7, 57.2; IR (thin 
film) υmax (cm
-1): 1492 (w, C=C), 1455 (w, C=C); HRMS (ESI): m/z 265.1188, C16H18NaO2 







To a stirred solution of n-butyllithium (2.6 M in hexanes, 0.48 ml, 1.24 mmol) in dry 
toluene (2 mL), cooled to -78 °C, was added amine 325 (0.25 ml, 1.24 mmol) in dry 
toluene (1 mL) ensuring the temperature was maintained below -60 °C.   The mixture was 
stirred for a further 30 mins at -78 °C and chiral ligand 303 (0.36 g, 1.49 mmol) in dry 
toluene (2 mL) was added dropwise maintaining the temperature below -60 °C.  The 
mixture was stirred for 30 mins at -78 °C and then added dropwise to a solution of 433 
(0.60 g, 1.24 mmol) and chlorotrimethyl-silane (0.78 ml, 6.2 mmol) in dry toluene (3 mL), 
which was cooled to -78 °C.  After being stirred at -78 °C for 5 hours, the mixture was 
quenched with saturated  NH4Cl(aq) (1.5 mL), allowed to stir-warm to room temperature 
and partitioned with saturated Na2CO3(aq) (18 mL).  The aqueous phase was further 
extracted with EtOAc (2 x 50 mL) and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated in vacuo.  Purification by 
silica gel chromatography (EtOAc-petrol, 20:1 followed by CH2Cl2-MeOH, 100:3) afforded 
the title compound as a yellow oil (0.36 g, 30%).      
   +11.6 (c 1.9, CHCl3); 
1H NMR (500 
MHz, CDCl3) δH = 7.23 (2H, d, J = 8.2 Hz, MeOCCHCH), 6.88-6.75 (3H, m, MeOCCH, 
CH=CHCH2), 5.71 (1H, dt, J = 15.4 and 1.9 Hz, CH=CHCH2), 3.76 (3H, s, OCH3), 3.69 
(2H, s, CH2NH), 3.67-3.55 (1H, m, CHOSi), 3.00-2.88 (1H, m, CHNH), 2.33 (2H, d, J = 6.2 
Hz, CH2C=O), 2.19-2.07 (2H, m, CH=CHCH2), 1.71-1.11 (28H, m, 
CH2CH2CH2CHOCH2CH2, OCCH3), 0.85 (9H, s, SiC(CH3)3), 0.00 (6H, s, SiCH3); 
13C NMR 
(126 MHz, CDCl3) δC = 172.0, 158.6, 147.8, 129.3, 123.1, 113.8, 80.4, 80.00, 71.8, 55.3, 












To a stirred solution of 434 (0.68 g, 1.1 mmol) in THF (7 mL) at room temperature was 
added TBAF (1.0 M in THF, 11 ml, 11 mmol) and benzoic acid (0.54 g, 4.39 mmol).  The 
mixture was heated to 60 °C for 17 hours.  After cooling to room temperature water (10 
mL) was added and the solution was extracted with EtOAc (3 x 10 mL).  The combined 
organic extracts were washed with saturated Na2CO3(aq) (3 x 5 mL) and water, dried over 
anhydrous MgSO4, filtered and concentrated to a yellow oil.  Purification by silica gel 
chromatography (CH2Cl2-MeOH, 100:3) afforded the title compound as a colourless oil 
(0.213 g, 38%).      
   +10.5 (c 2.2, CH2Cl2); 
1H NMR (500 MHz, CDCl3) δH = 7.22 (2H, d, 
J = 7.8 Hz, MeOCCHCH), 6.89-6.76 (3H, m, MeOCCHCH, CH=CHCH2), 5.68-5.67 (1H, 
m, CH=CHCH2), 3.76 (3H, s, OCH3), 3.69 (2H, s, CH2N), 3.60-3.50 (1H, m, CHOH), 3.03-
2.88 (1H, m, CHNH), 2.36 (2H, d, J = 5.8 Hz, CH2CO), 2.22-2.09 (2H, m, CH2CH=), 1.90 
(1H, br. s, OH), 1.58-1.30 (28H, m, CH2CH2CH2CHOCH2CH2, OC(CH3)3); 
13C NMR (126 
MHz, CDCl3) δC = 171.9, 166.1, 158.7, 147.6, 129.5, 123.2, 113.8, 80.6, 80.0, 71.2, 55.3, 
54.2, 50.3, 40.1, 37.3, 32.0, 28.2, 24.3, 21.7; IR (thin film) υmax (cm
-1): 1727 (s, C=O); 
HRMS (ESI): m/z 506.3473, C29H48NO6 [M+H]








A stirred solution of oxalyl chloride (2.82 ml, 33.3 mmol) in dry CH2Cl2 (50 mL) was cooled 
to -60 °C. A solution of DMSO (4.73 ml, 66.6 mmol) in dry CH2Cl2 (17 mL) was then added 
dropwise, keeping the temperature below -60 °C.  Taking care to maintain the 
temperature control, the mixture was stirred for a further 10 minutes and then alcohol 430 
(4.0 g, 23.8 mmol), dissolved in dry CH2Cl2 (100 mL), was added dropwise.  The mixture 
was stirred at this temperature for 15 minutes and then triethylamine (19.2 ml, 13.8 mmol) 
in dry CH2Cl2 (50 mL) was added dropwise.  The suspension was then allowed to stir-
warm to room temperature.  After quenching with water (200 mL), the aqueous phase was 
separated and extracted with CH2Cl2 (2 x 200 mL).  The combined organic extracts were 
washed with 1% HCl(aq), water, saturated NaHCO3(aq) and water, dried over anhydrous 
MgSO4, filtered and concentrated to afford the title compound as a yellow oil (3.85 g, 
97%).  1H NMR (300 MHz, CDCl3) δH = 5.79-5.61 (2H, m, CH=CH2), 4.99-4.88 (4H, m, 
CH=CH2), 2.33 (4H, t, J = 7.5 Hz, CH2CO), 1.98 (4H, m, CH2CH=), 1.6 (4H, m, 
CH2CH2CH2);  
13C NMR (75 MHz, CDCl3) δC = 210.9, 138.0, 115.2, 41.9, 33.1, 22.8; IR 
(thin film) υmax (cm
-1): 1711 (s, C=O), 1641 (m, C=C); HRMS (ESI): m/z 189.1260, 
C11H18NaO [M+Na]






To a stirred solution of ketone 448 (3.3 g, 9.9 mmol) in dry toluene was added glycol (3.3 
ml, 59.7 mmol) and p-toluenesulfonic acid monohydrate (0.379 g, 1.99 mmol).  The 
mixture was heated at reflux for 18 hours, then cooled and concentrated in vacuo.  The oil 
was diluted with Et2O (50 mL), washed successively with saturated Na2CO3(aq) (20mL), 
brine (20mL) and water (20mL), dried over anhydrous MgSO4, filtered and concentrated to 
a yellow oil (4.42g).  The oil was taken up in MeOH (40 mL), NaBH4 (0.16 g, 4.19 mmol) 
was added and the reaction mixture was stirred at room temperature for 18 hours.  The 
mixture was concentrated, partitioned between water (20 mL) and CH2Cl2 (20 mL) and the 
aqueous phase was further extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
extracts were washed with water (20 mL), dried over anhydrous MgSO4, filtered and 
concentrated to a yellow oil.  The residue was purified by chromatography on   neutral 
Al2O3 (EtOAc-petrol, 1:100) to afford the title compound as a colourless oil (3.04 g, 73%).  
1H NMR (300 MHz, CDCl3) δH = 5.80-5.65 (2H, m, CH=CH2), 5.00-4.75 (4H, m, CH=CH2), 
227 
 
3.90 (4H, s, OCH2CH2O), 2.05-1.95 (4H, m, CH2CH=), 1.60-1.45 (4H, m, CH2C, 1.45-1.30 
(4H, m, CH2CH2CH2); 
13C NMR (75 MHz, CDCl3) δC = 138.7, 114.6, 111.7, 64.9, 36.6, 
33.9, 23.1; IR (thin film) υmax (cm
-1): 1641 (m, C=C); HRMS (ESI): m/z 211.1687, C13H23O2 
[M+H]+ requires 211.1693. 
 




Preparation from 449 employing the same method as that used for 433 furnished a 
residue that was purified by silica gel chromatography (EtOAc-petrol, 1:30 to 1:9) to afford 
the title compound as a colourless oil (2.01g, 51%).  1H NMR (300 MHz, CDCl3) δH = 6.88 
(2H, dt, J = 15.6 and 6.9 Hz, CH=CHCO), 5.76 (2H, dt, J = 15.6 and 1.5 Hz, CH=CHCO), 
3.95 (4H, s, OCH2CH2O), 2.20 (4H, qd, J = 6.9 and 1.3 Hz, CHCH2CH2), 1.75-1.45 (26H, 
m, OC(CH3)3, CCH2CH2CH2); 
13C NMR (75 MHz, CDCl3) δC = 166.5, 147.8, 123.7, 111.7, 
80.4, 65.4, 37.2, 32.5, 28.6, 22.7; IR (film/cm-1): 1709 (s, C=O), 1652 (m, C=C); HRMS 
(ESI): m/z 433.2566, C23H38NaO6 [M+Na]







Preparation from 4 employing the same method as that used for 434 furnished a residue 
that was purified by silica gel chromatography (CH2Cl2-MeOH saturated with NH3(g), 
100:0.5 to 100:1.5) to afford the title compound as a yellow oil (0.75 g, 40%).      
   -7.5 (c 
0.5, CH2Cl2); Rf 0.19 (CH2Cl2-MeOH, saturated with NH3, 100:1); 
1H NMR (500 MHz, 
CDCl3) δH = 7.18 (2H, d, J = 8.1 Hz, MeOCCHCH), 6.83-6.70 (3H, m, MeOCCH, 
CH=CHCO), 5.67 (1H, dt, J = 15.5 and 1.6 Hz, CH=CHCO), 3.84 (4H, s, OCH2CH2O), 
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3.72 (3H, s, OCH3), 3.66 (2H, s, NHCH2), 2.92 (H, q, J = 6.1 Hz, CHNH), 2.32 (2H, d, J = 
6.1 Hz, CHNCH2CO2), 2.10-1.98 (2H, m, CH2CH=CH), 1.62-1.24 (28H, m, 
CH2CH2CH2C(OCH2)2CH2CH2, OCCH3); 
13C NMR (126 MHz, CDCl3) δC = 172.3, 166.5, 
159.1, 147.9, 129.8, 123.6, 114.2, 111.7, 81.0, 80.4, 65.4, 55.7, 54.7, 50.7, 37.7, 37.1, 
32.5, 28.6, 28.4, 22.7, 20.4; IR (thin film) υmax (cm
-1): 1714 (s, C=O), 1611 (w, C=C); 
HRMS (ESI): m/z 548.3563, C31H50NO7 [M+H]







To a stirred solution of n-butyllithium (2.6 M in hexanes, 2.44 ml, 6.1 mmol) in dry toluene 
(12 mL) cooled to -78 °C was added amine 325 (1.28 g, 6.1 mmol) in dry toluene (7 mL) 
ensuring the temperature was maintained below -60 °C.   The mixture was stirred for 30 
minutes at -78 °C and then chiral ligand 303 (1.66 g, 6.83 mmol) in dry toluene (7 mL) was 
added dropwise maintaining the temperature below -60 °C.  The mixture was then stirred 
for 30 minutes at -78 °C, followed by dropwise addition of 4 (1 g, 2.44 mmol) and 
chlorotrimethyl- silane (3.08 ml, 24.4 mmol) in dry toluene (25 mL).  After stirring at -78 °C 
for 5 hours the mixture was quenched with saturated NH4Cl(aq) (13 mL), allowed to stir-
warm to room temperature and partitioned with saturated NaHCO3(aq) (100 mL).  The 
aqueous phase was further extracted with EtOAc (2 x 100 mL) and the combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated 
in vacuo.  Purification by silica gel chromatography (CH2Cl2-MeOH saturated with NH3, 
100:0.5 to 100:4) afforded the title compound as a yellow oil (0.82 g, 49% yield).      
   
+55.0 (c 0.49, CH2Cl2); Rf = 0.22 (CH2Cl2–MeOH saturated with NH3, 100:4); 
1H NMR (500 
MHz, CDCl3) δH = 7.25 (4H, d, J = 8.6 Hz, CHCHCOCH3), 6.84 (4H, d, J = 8.7 Hz, 
CHCHCOCH3), 3.91 (4H, s, OCH2CH2O), 3.78 (6H, s, OCH3), 3.71 (4H, s, NHCH2), 2.37 
(4H, d, J = 5.9 Hz, CH2C=O), 1.82 (2H, br. s, NH), 1.63-1.53 (4H, m, CH2CO2CH2), 1.50-
1.32 (8H, m, CH2), 1.44 (18H, s, OC(CH3)3); 
13C NMR (126 MHz, CDCl3) δC = 172.0, 
158.6, 132.6, 129.4, 113.8, 111.4, 80.4, 65.9, 65.0, 55.3, 54.3, 50.4, 40.3, 37.3, 34.5, 
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28.2, 20.0, 15.3; IR (thin film) υmax (cm
-1): 1721 (s, C=O); HRMS (ESI): m/z 685.4446, 
C39H61N2O8 [M+H]







To a solution of bis-amine 452 (0.115 g, 0.168 mmol) in acetone (7 mL) was added para-
toluenesulfonic acid monohydrate (0.048 g, 0.252 mmol) and the mixture was stirred at 
room temperature whilst being monitored by TLC.  After 4 hours the reaction mixture was 
concentrated in vacuo, diluted with CH2Cl2 (30 mL), washed with saturated NaHCO3(aq) (3 
x 10 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to afford the 
title compound as an orange oil requiring no further purification (0.089 g, 85% yield).  
    
   +5.2 (c 1.1, CH2Cl2); 
1H NMR (500 MHz, CDCl3) δH = 7.32 (2H, d, J = 8.4 Hz, 
CHCHCOCH3), 7.24 (2H, d, J = 8.6 Hz, CHCHCOCH3), 6.95-6.87 (4H, m, CHCHCOCH3), 
4.52 (1H, br. s, N=CH), 4.20 (1H, d, J = 15.8 Hz, NCHAHB), 3.98 (1H, d, J = 15.7 Hz, 
NCHAHB), 3.96 (6H, s, OCH3), 3.79 (2H, s, CH2NH), 3.57 (1H, br. s, NC=CH), 3.06 (1H, br. 
s, CHNH), 2.46 (4H, br. s, CH2C=O), 2.27-2.22 (2H, m, NCHCH2), 2.05-1.92 (3H, m, 
NC=CHCH2), 1.82-1.45 (6H, m, CH2), 1.51 (9H, s, OC(CH3)3), 1.50 (9H, s, OC(CH3)3); 
13C 
NMR (126 MHz, CDCl3) δC = 172.0, 171.9, 158.9, 158.6, 141.5, 132.0, 129.3, 129.6, 
129.3, 114.1, 113.9, 98.7, 80.4, 78.0, 55.3, 55.2, 54.2, 54.1, 54.0, 53.4, 40.4, 40.2, 34.0, 
33.8, 28.2, 28.0, 24.2, 19.9 ; IR (thin film) υmax (cm
-1): 1725 (s, C=O); HRMS (ESI): m/z 
623.4090, C37H55N2O6 [M+H]












Preparation from 5 employing the same method as that used for 453 afforded the title 
compound as a yellow oil requiring no further purification (0.23 g, 95%).      
   -14.9 (c 
0.91, CH2Cl2); Rf = 0.35 (CH2Cl2- MeOH saturated with NH3, 100:1.5); 
1H NMR (500 MHz, 
toluene-d8) δH = 7.14 (2H, d, J = 7.9 Hz, CHCHCOCH3), 6.98-7.09 (1H, m, CO2CH=CH), 
6.75 (2H, d, J = 7.9 Hz, CHCHCOCH3), 5.90 (1H, d, J = 15.7 Hz, CO2CH=CH), 4.51 (1H, 
br. s, NC=CH), 4.13 (1H, d, J = 15.2 Hz, NCHAHB), 3.92 (1H, d, J = 15.2 Hz, NCHAHB), 
3.71-3.65 (1H, m, CHN), 3.36 (3H, s, OCH3), 2.47 (1H, dd, J = 15.0 and 9.4 Hz, 
CHAHBC=O), 2.41-2.37 (1H, m, C=CCHAHB), 1.97 (1H, dd, J = 14.9 and 4.8 Hz, 
CHAHBC=O), 1.94-1.81 (4H, m, NC=CHCHAHB, C=CCHAHBCH2CH2), 1.47 (9H, s, 
OC(CH3)3), 1.46 (9H, s, OC(CH3)3), 1.44-1.23 (4H, m, NC=CCH2CH2, =CHCH2CH2); 
13C 
NMR (126 MHz, toluene-d8) δC = 171.0, 165.2, 158.9, 147.6, 140.5, 131.7, 128.8, 124.9, 
113.6, 99.6, 79.1, 78.9, 54.3, 53.8, 52.9, 37.8, 33.4, 31.1, 27.7, 27.6, 26.7, 23.7, 19.5; IR 
(thin film) υmax (cm
-1): 3220 (w, NH), 1711 (s, C=O); HRMS (ESI): m/z 486.3227, 
C29H44NO5 [M+H]







To a solution of 5 (0.5 g, 0.913 mmol) in MeOH (5 mL) was added CoCl2.6H2O (2.20 mg, 
0.0091 mmol) and the mixture stirred at room temperature for 30 minutes.  After cooling 
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the mixture to 0 °C, NaBH4 (0.138 g, 3.65 mmol) was added portionwise and the reaction 
mixture was stirred at room temperature for 36 hours.  After cooling the reaction mixture to 
0 °C, NaBH4 (0.138 g, 3.65 mmol) was again added portionwise and the reaction mixture 
was stirred at room temperature for a further 24 hours.  After cooling the reaction mixture 
to 0 °C, water (20 mL) was added and then the methanol was removed in vacuo.The 
remaining aqueous solution was extracted with EtOAc (3 x 20 mL). The combined organic 
extracts were dried over anhydrous MgSO4, filtered and concentrated in vacuo to afford 
the title compound as a yellow oil that required no further purification (0.48 g, 96% yield).  
    
   +13.7 (c 0.95, CHCl3); Rf 0.19 (CH2Cl2- MeOH saturated with NH3, 100:1); 
1H NMR 
(500 MHz, CDCl3) δH = 7.18 (2H, d, J = 8.7 Hz, CHCHCOCH3), 6.78 (2H, d, J = 8.7 Hz, 
CHCHCOCH3), 3.84 (4H, s, OCH2CH2O), 3.72 (3H, s, OCH3), 3.64 (2H, s, CH2NH), 2.95-
2.85 (1H, m, CHNH), 2.30 (2H, d, J = 6.2 Hz, NHCHCH2C=O), 2.13 (2H, t, J = 7.5 Hz, 
CH2C=O), 1.59-1.45 (4H, m, CH2CO2CH2), 1.37 (18H, s, OC(CH3)3), 1.37-1.21 (10H, m, 
CH2); 
13C NMR (126 MHz, CDCl3) δC = 173.2, 172.0, 158.6, 132.7, 129.3, 113.8, 111.6, 
80.4, 79.9, 64.9, 55.3, 54.3, 50.4, 40.4, 37.2, 37.1, 35.5, 34.6, 29.4, 28.1, 25.1, 23.5, 20.0; 
IR (thin film) υmax (cm
-1): 1718 (s, C=O); HRMS (ESI): m/z 572.3563, C31H51NNaO7 







To a solution of 456 (0.66 g, 1.20 mmol) in dry MeOH (18 mL) was added 10% Pd(OH)2/C 
(0.12 g, 0.09 mmol)).  The reaction vessel was then purged  with H2 (x3) and a 760 Torr 
H2 pressure was maintained for 12 hours.  The suspension was filtered through celite, 
eluting with fresh MeOH (30 mL) and then concentrated in vacuo to afford a  colourless oil 
that required no further purification (0.35 g, 68% yield).      
   +7.0 (c 10.0, CDCl3); 
1H 
NMR (500 MHz, CDCl3) δH = 3.85 (4H, s, OCH2CH2O), 3.13-3.02 (1H, m, CHNH2), 2.32 
(1H, dd, J = 15.6 and 3.9 Hz, CHNH2CH
AHB), 2.13 (2H, t, J = 7.4 Hz, C=OCH2), 2.10 (1H, 
dd, J = 15.6 and 8.9 Hz, CHNH2CH
AHB), 1.59 (2H, br. s, NH2), 1.57-1.46 (6H, m, 
C=OCH2CH2, CH2CO2CH2), 1.39 (9H, s, C(CH3)3), 1.37 (9H, s, C(CH3)3), 1.35-1.17 (8H, 
m, CH2); 
13C NMR (126 MHz, CDCl3) δC = 173.2, 172.0, 111.5, 80.5, 79.9, 64.9, 49.4, 
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43.7, 37.7, 37.1, 35.5, 29.4, 28.2, 25.1, 23.5, 20.3; IR (thin film) υmax (cm
-1): 1726 (s, C=O); 
HRMS (ESI): m/z 452.2978, C23H43NNaO6 [M+Na]







Preparation from 457 employing the same method as that used for 453 afforded the title 
compound as a yellow oil requiring no further purification (0.37 g, 85%).      
   -6.33 (c 
1.58, CH2Cl2); 
1H NMR (500 MHz, CDCl3) δH = 3.83 (1H, m, C=NCH), 2.66 (1H, dd, J = 
14.6 and 6.9 Hz, NCHCHAHBC=O), 2.27 (1H, dd, J = 14.5 and 7.9 Hz, NCHCHAHBC=O), 
2.15-2.11 (2H, m, C=OCH2), 1.95 (2H, td, J = 7.5 and 1.9 Hz, CH2CH2C=N), 1.71-1.48 
(6H, m, CH2), 1.46 (9H, s, C(CH3)3), 1.42 (9H, s, C(CH3)3), 1.36-1.28 (2H, m, CH2), 1.27-
1.21 (2H, m, CH2), 1.05-0.91 (2H, m, CH2); 
13C NMR (126 MHz, CDCl3) δC = 172.0, 170.8, 
168.1, 78.9, 78.8, 55.2, 44.0, 39.9, 35.2, 28.8, 28.5, 27.9, 27.8, 27.2, 25.5, 25.0, 18.9; IR 
(thin film) υmax (cm









A solution of 458 (66 mg, 0.180 mmol) in dry toluene (1.6 mL) was heated to 50 °C before 
the dropwise addition of diethyl pyrocarbonate (48 μl, 0.324 mmol).  The reaction mixture 
was kept at 50 °C for a further 7 hours, then cooled to room temperature and 
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concentrated in vacuo. The residue was purified by silica gel chromatography (EtOAc-
petrol, 1:10) to afford the title compound as a yellow oil (57 mg, 72% yield).      
   -25.7 (c 
0.07, CH2Cl2); Rf = 0.42 (EtOAc-petrol, 1:10); 
1H NMR (300 MHz, CDCl3) δH = 5.16-5.09 
(1H, m, CHN), 4.79 (1H, br. s, C=CH), 4.09 (2H, q, J = 7.5 Hz, OCH2CH3), 2.48 (1H, dd, J 
= 11.1 and 4.6 Hz, NCHCHAHBC=O), 2.19 (1H, dd, J = 11.15.8 Hz, NCHCHAHBC=O), 
2.18-2.08 (4H, m, O=CCH2, NCCH2), 1.8 (2H, br. s, C=CHCH2), 1.69-1.61 (3H, m, 
CH2CH2CNCHCH
AHB), 1.55-1.29 (5H, m, NCHCHAHB, O=CCH2CH2CH2), 1.44 (9H, s, 
O=CO(CH3)3), 1.40 (9H, s, O=CO(CH3)3), 1.08 (3H, t, J = 7.5 Hz, OCH2CH3); 
13C NMR (75 
MHz, CDCl3) δC = 172.7, 170.6, 154.4, 138.3, 111.2, 80.2, 79.5, 61.4, 49.9, 37.1, 36.3, 
36.0, 29.8, 28.5, 28.4, 26.6, 25.8, 25.6, 19.9, 15.0; I.R. (thin film) υmax (cm
-1): 3351 (br., N-
H), 1724 (s, C=O); HRMS (ESI): m/z 440.3045, C24H42NO6 [M+H]
+ requires 440.3012. 
 




In a sealed microwave tube, diethyl pyrocarbonate (14 μl, 0.0925 mmol) was added to a 
solution of 458 (17 mg, 0.0463 mmol) in dry ethanol (0.5 mL).  The reaction mixture was 
then heated at 130 °C for 30 minutes using microwave irradiation.  The resultant yellow 
solution was cooled to room temperature and concentrated in vacuo.  The residue was 
then purified by silica gel chromatography (EtOAc-petrol, 1.5:10 to 3.5:10) to afford the 
title compound as a yellow oil (11 mg, 54 % yield).      
   -25.7 (c 0.07, CH2Cl2); 
1H NMR 
(300 MHz, CDCl3) δH = 4.91 (1H, br. s, NH), 4.10 (2H, q, J = 7.2 Hz, OCH2CH3), 4.01 (1H, 
m, CHN) 2.22 (2H, d, J = 5.7 Hz,CHNCH2), 2.11 (4H, m, CH2COCH2),  1.95 (2H, t, J = 7.4 
Hz, O=CCH2CH2), 1.50-1.31 (8H, m, 4xCH2), 1.45 (9H, s, O=CO(CH3)3), 1.41 (9H, s, 
O=CO(CH3)3), 1.19-1.10 (2H, m, CH2), 1.10 (3H, t, J = 7.2 Hz, OCH2CH3); 
13C NMR (75 
MHz, CDCl3) δC = 207.1, 171.6, 169.9, 155.5, 79.3, 78.2, 59.5, 47.1, 41.3, 40.7, 39.5, 
34.4, 33.2, 29.3, 28.0, 27.1, 27.0, 24.2, 22.6, 13.8; IR (thin film) υmax (cm
-1):  3362 (br., N-
H), 1713 (s, C=O); HRMS (ESI): m/z 458.3154, C24H44NO7 [M+H]
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